Novel collagen- based biomaterials for bone regeneration by Choudhery, Haris
  
Some pages of this thesis may have been removed for copyright restrictions. 
If you have discovered material in Aston Research Explorer which is unlawful e.g. breaches 
copyright, (either yours or that of a third party) or any other law, including but not limited to 
those relating to patent, trademark, confidentiality, data protection, obscenity, defamation, 
libel, then please read our Takedown policy and contact the service immediately 
(openaccess@aston.ac.uk) 
1 
 
 
Novel Collagen-Based Biomaterials 
For Bone Regeneration 
 
 
 
Haris Ahmad Choudhery 
 
 
Doctor of Philosophy 
 
October 2018 
 
 
 
©Haris Ahmad Choudhery, 2018 asserts his moral right to be identified as the author of this 
thesis This copy of the thesis has been supplied on condition that anyone who consults it is 
understood to recognise that its copyright belongs to its author and that no quotation from the 
thesis and no information derived from it may be published without appropriate permission or 
acknowledgement. 
2 
 
Aston University 
 
Novel collagen- based biomaterials for bone regeneration 
 
Haris Ahmad Choudhery 
Doctor of Philosophy 
October 2018 
 
Bone is primarily made of type I collagen, which is a highly abundant natural protein. 
Collagen can be crosslinked through several methods including chemical agents, physical 
heating and UV radiation. The result is enhanced physical characteristics such as thermal 
stability, resistance to proteolytic breakdown, mechanical strength and increased overall 
biocompatibility. However, with these methods there are drawbacks; including toxicity of 
residual cross-linking agents, or difficulties with scaling. In recent years, collagen has been 
cross-linked by a safer, efficient and more practical means by using enzymes as biological 
catalysts.  
We demonstrate that crosslinking native collagen with both tissue transglutaminase 
(TG2) and microbial transglutaminase (mTG- from Streptoverticillium mobaraense) leads to an 
increase in the proliferation of human osteoblasts (HOB) and an increase in integrins on their 
cell surface compared to culture on native collagen. These integrins include αV, α5, β1 and β3 
which are all important for the ability of HOBs to mature and differentiate. In addition to this, 
the HOBs were shown to mineralise at a faster rate than on native collagen. Moreover, it was 
demonstrated that integrin expression and mineralisation rates are further increased in HOBs 
on crosslinked collagen by incorporating 45S5 bioglass particles.  
 Investigations here show distinct differences between the micro-structure of the 
scaffolds and the mean pore size between fibrils in native and crosslinked collagen. These 
results suggest that the crosslinked collagen changes the behaviour of HOBs when seeded, 
such that through the Wnt canonical pathway there is an overall increased drive towards 
mineralisation and deposition of collagen by the HOBs.  
 This work shows that crosslinked collagen scaffolds with 45S5 bioglass have the 
potential to be used as biomaterials for bone regeneration and may eventually replace 
allografts and titanium plates.  
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1.1 Type I collagen 
 
Regenerative medicine focuses on the idea of, not just healing tissue after traumatic injury, 
but restoring the tissue’s native function. In the beginning biomaterials were designed to be 
inert and elicited no response from the immune system (Hench & Polak, 2002). However 
through molecular and cellular biology advances a new ideal for medical materials has 
emerged: creating materials which can stimulate native tissue regeneration and restore the 
original functionality. One way to communicate to cells during the healing process is through 
the diverse cues provided by porous biomaterial scaffolds (Hench & Polak, 2002). The 
interconnected pores of scaffolds not only support and direct cellular growth, but can also be 
used as a part of drug and growth factor release. (Mullen et al. 2010). 
One promising approach has been to utilise natural biological polymers, which already 
have innate chemistry to communicate to cells built into the molecule. Of these polymers, type 
I collagen is the most widely used, as it is the major structural component of extra cellular 
matrix (ECM) in living tissue. Type I collagen is the first in a superfamily comprised of 28 
different types, all of which fall under fibrillar (type I falls under this category) or non-fibrillar 
(such as type IV). The versatility of collagen scaffolds is due, in part, to the diverse ways in 
which the structures can be modified. The pore architecture can be designed to mimic the 
anisotropic ECM of native tissues, which is important for tissues such as tendon and meniscus 
(Pawelec et al. 2014 & Davidenko et al. 2010). As a further modifier of biological activity, 
collagen can also be combined with other polymers, such as chitosan or elastin, which 
influences chemical and mechanical properties (Martinez et al. 2015 & Grover et al. 2012). 
Cellular response to biomaterials is dictated by a combination of mechanical, architectural 
and chemical cues from the scaffold. Sensing cues from the environment is a complex and 
dynamic process (Shiller et al. 2013). The mechanism used by cells, notably a class of trans-
membrane receptors known as integrins, can control many functions, including differentiation 
(Huebsch et al. 2010). For tissue engineering scaffolds, tailoring biological response is linked 
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to controlling the ligands, or cell signalling moieties, which are presented to cells and react with 
receptors. 
 Throughout decades of research, it has been determined that collagen is not a single 
molecule, but a large family of molecules. The defining feature of a collagen is a protein 
composed of three polypeptide chains incorporating at least one region with a repeating amino 
acid sequence (Fratzl et al. 2008). Collagen Type I, for example, has a repeating sequence of 
glycine-X-Y which forms a right-handed triple helix. At least 28 different types of collagen have 
been found thus far, even excluding the proteins with collagenous regions which have not been 
called collagen for historical reasons (Fratzl et al. 2008). Within the collagen superfamily, 
members are further classified based on their structure and distribution. 
 The most widespread collagens are the fibrillar collagens, composed primarily of a 
triple-helical region with a characteristic repeating band where fibers connect, known as D-
banding (Fratzl et al. 2008). Collagen types I, II and III all belong to the fibrillary group of 
collagens and vary in amino acid composition and distribution within the body (Friess, 1998). 
Collagen type I is the most common, constituting the major structural protein for skin, tendon 
and bone. For this reason and the ones outlined above, collagen has been investigated as a 
scaffold to be used in bone regeneration. 
  
1.2 Transglutaminases 
 
Transglutaminases (EC 2.3.2.13, henceforth TGs) are a group of ubiquitous enzymes that 
are found throughout many mammals, plants, invertebrates and the human body. They 
catalyse post-translation modifications of proteins by the formation of isopeptide bonds (Griffin 
et al., 2002). This is carried out in one of two ways: either through protein crosslinking via ε-(γ-
glutamyl) lysine bonds or via a calcium-dependent reaction. Here, transglutaminases form a 
covalent bond between the γ-carboxamide group of peptide-bound glutamine and the ε-amino 
group of a peptide-bound lysine (or primary amine). Clarke et al. were the first group to derive 
19 
 
mammalian transglutaminase from the guinea pig liver in 1959. Key stages of a cell’s life cycle, 
including its reproduction, growth and even death, are influenced by the presence of 
transglutaminases. These enzymes are able to affect the proliferation and differentiation of 
several types of cells (Beninati and Piacentini, 2004), hence why so many researchers are now 
looking into these molecules. 
By cross-linking and forming these isopeptide bonds, proteins become highly resistant 
to mechanical forces and proteolytic degradation. This type of cross-linking in humans is 
carried out by, but not limited to, type 2 tissue transglutaminase (TG2), primarily expressed in 
skin, hair, blood clotting and in wound healing (Lorand and Conrad, 1984). It has been found 
that TG2 amino acid and cDNA sequences are highly conserved between most species 
including guinea pig (liver), bovine, mice, chickens and humans (Ikura et al., 1988, Nakanishi 
et al., 1991, Gentile et al., 1991, Weraarchakulboonmark et al., 1992). TG2 is a monomer that 
is composed of 685-691 amino acids and has a molecular weight of approximately 77-85kDa. 
When compared to mouse and guinea pigs, human TG2 has nearly 80% homology between 
the amino acid sequences. Of this sequence, 49 out of 51 residues in the active site region are 
identical (Gentile et al., 1991). 
To date there is nine different transglutaminase isoenzymes that have been identified 
in mammals, however, only six have been isolated and characterised at the protein level. The 
nine transglutaminases and their characteristics are summarised below. 
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Table 1.1: A summary of transglutaminases and their basic properties. 
Mammalian Transglutaminase family Molecular 
mass (kDa)  
Regulation and GTP activity  Description and use  
Factor XIII 83 
 
Activated by thrombin and Ca2+; also requires 
reducing agent 
Perhaps the most well-known of all TGs is Factor XIII, which 
is a key zymogen in the blood clotting network It is converted 
via proteolysis into active Factor XIIIa during wound healing 
when fibrin clots are formed (Griffin et al., 2002) 
Keratinocyte /Type 1 transglutaminase (TG1) 90 Protease and Ca2+ 
required for activation, reducing agent 
required 
TG1 is a keratinocyte which exists in both membrane-bound 
and soluble forms. It’s main purpose is to be activated via 
proteolysis and plays a key role in the terminal differentiation 
of keratinocytes (Griffin et al., 2002) 
Tissue/ Type 2 transglutaminase (TG2) 78 Ca2+ required for activation, reducing agent 
also required 
The most ubiquitous transglutaminase seen in the body. 
This multifunctional protein governs cell-matrix interactions, 
tissue repair and a variety of other cell functions 
(Aeschlimann and Thomazy, 2000 & Fesus and Piacentini, 
2002) 
Epidermal/ Type 3 transglutaminase (TG3) 77 Latent (protease 
activated); Ca2+ activated, 
reducing agent required 
Epidermal transglutaminase is similar to TG1 in that it also 
undergoes proteolysis in order to become active. It is also 
involved in the terminal differentiation of keratinocytes 
(Eckert et al., 2005). 
Prostate/ Type 4 transglutaminase (TG4) 77 Ca2+ activated, 
reducing agent required 
A prostatic secretory transglutaminase that is essential for 
fertility in rodents and potentially in humans (Iismaa, 2016) 
TG5 80 Ca2+ activated Is seen to cross-link keratins as well as many other 
differentiation-specific structural proteins, including 
involucrin, loricrin, filaggrin and small proline-rich proteins, in 
the formation of the cornified cell envelope of the stratum 
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corneum the outermost “dead” layer of the epidermis (Kalinin 
et al, 2002) 
TG6 70 Ca2+ activated Catalyses cross-linking between proteins and the 
conjugation of polyamines to proteins. Mutations in this gene 
are linked to spinocerebellar ataxia type 35 (SCA35) (Wang 
et al., 2010a) 
TGM7  80 Ca2+ activated Possible biomarker for neurodegenerative disease  
Band 4.2 72 No enzyme activity Membrane; structural protein, membrane skeletal 
component in erythrocyte (Yawata, 1994) 
Microbial Transglutaminase / mTG 39 No Ca2+ required for activation This transglutaminase is not found in mammals. Is found 
instead in Streptomyces mobaraensis. Unlike many other 
transglutaminases mTG is calcium-independent and has a 
lower molecular weight (Yokoyama et al., 2004) 
22 
 
1.3 Microbial transglutaminase (mTG) 
 
 Other than the transglutaminases that have been found in mammals, there have been 
discoveries of transglutaminase in other organisms. One of the first non-mammalian sourced 
transglutaminases was sourced from a culture of Streptomyces mobaraensis (formerly known 
as Streptoverticillium mobaraense) and commonly known as microbial transglutaminase or 
mTG (Ando et al., 1989). Since then this transglutaminase has been found in other species of 
Streptomyces, where it is secreted as a zymogen from the cytoplasm membrane and activated 
through proteolytic cleavage (Pasternack et al., 1989). Streptomyces mobaraensis was found 
to secrete the enzyme into the culture medium, and thus its purification was relatively simple, 
which led to its rapid commercialisation. Microbial transglutaminase was first commercially 
described by researchers at Ajinomoto Co., Inc. in 1989. Since then, it has become one of the 
most widely used enzymes for the cross-linking of proteins and peptides in many food and 
biotechnological applications (Steffen et al., 2017). In mammals, “side-chain to side-chain” 
isopeptide bonds confer mechanical strength and increase resistance to degradation, much 
like TG2. However, in Bacillus subtilis (when heat treated), the enzymatic activity of mTG 
causes crosslinking of GerQ in spores, which leads to increased spore formation and stability 
(Kuwana et al., 2006) 
 
1.3.1 Enzymatic properties of mTG 
 
  There are major differences between the mammalian sourced TG2 and mTG. The 
former is far larger, measuring 78kDa. The latter is only 38 kDa and consists of 331 amino 
acids (Kanaji et al., 1993). Moreover, there is very little amino acid sequence homology 
between mammalian transglutaminases (Duran et al., 1998). The active site on TG2 is made 
up of three crucial amino acids: cysteine 277 (Cys 277), histidine 335 (His 335) and aspartic 
acid 358 (Asp 358). In contrast to this, only the cysteine (Cys 64) has been identified as the 
sole catalytic residue in mTG’s sequence, it has recently been proposed that mTG uses a 
cysteine protease-like mechanism in which Asp 255 plays the role of the histidine residue 
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(normally seen in animal transglutaminases) (Rachel and Pelletier, 2013). Interestingly, unlike 
animal-based transglutaminases (including TG2) mTG activity is not dependent on the 
presence of GTP or Ca2+. This property has made it very useful in the modification of food 
proteins since caseins, soybean globulins, myosins and many more, are sensitive to Ca2+ ions 
and are easily precipitated by them. On the other hand, it has since been discovered that, in 
the absence of reducing agents, Cu2+, Zn2+, Pb2+  and Li+  are found to be strongly inhibitory to 
mTG activity. This is because heavy metals are thought to bind the thiol group of the single 
cysteine residue which strongly supports the idea that this particular residue forms part of the 
active site of mTG (Yokoyama et al., 2004).   
mTG is a simple monomeric protein with just a single domain, unlike TG2, and has a 
higher optimum temperature of 55°C and a lower optimum pH of 5.5 (Ho et al., 2000). Moreover 
mTG has shown activity at a pH as low as 4 and as high as 9 (Ando et al., 1989). It has even 
been reported to retain some activity between 10°C and near freezing temperatures. Looking 
at specificity, it has been shown that mTG is able to crosslink a wide array of proteins including 
wheat glutens, egg yolk, albumin proteins, myosins, fibrins, collagen, caseins as well as many 
others (Nonaka et al., 1992, Nonaka et al., 1997).  
  
1.3.2 Structure of mTG  
 
 mTG has no detectable sequence homology to TG2, apart from the transglutaminase 
fold, and exhibits a different structure compared to it as well (Strop, 2014, Makarova et al., 
1999). The crystal structure of mTG was determined at 2.4Å resolution (Kashiwagi et al., 
2002). The monomeric molecule forms a single, compact disc-shaped domain (overall 
dimensions 65 x 59 x 41Å), which folds to form a deep cleft at the edge of the molecule. The 
catalytic Cys 64 residue is located at the bottom of a 16Å deep cleft. It is produced as a 
zymogen, whereby the N-terminus folds into a helical structure that occupies the active site 
and blocks substrate access (Yang et al., 2012). Dissociation of the N-terminus helical 
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structure by endogenous metalloprotease and tripeptidyl aminopeptidase activates the 
zymogen.  
 
As seen in Figure 1.1A) the overall structure contains 11 α-helices and 8 β-strands; one 
of the β-sheets is surrounded by α-helices, which are clustered into three regions. The central 
β-sheet forms a seven-stranded anti-parallel structure which is severely twisted between 
β5and β6 strands. Here, there is only one hydrogen bond present between the main chains of 
these strands (Trp 258 and Thr 237). In Figure 1.1, the first cluster of α-helices is composed of 
the α1, α2 and α3 helices and the key Cys 64 residue is in the loop between α2 and α3 helices. 
The second cluster comprises of α4, α5 and α10. Finally, the third cluster is made up of α6, α7 
α8 and α9.   
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A) 
B) 
Cysteine 64 
Aspartic acid 255 
Histidine 274 
Figure 1: A) Schematic ribbon structure of mTG.  The secondary structure is 
numbered for clarity. The side chain of cysteine 64 is represented as a “ball and stick 
model”. Adapted from Yokoyama et al. 2004. B) A top down view of a ribbon model 
of mTG depicting the active site triad. 
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Both TG2 and mTG contain a Cys-His-Asp catalytic triad, however, there are 
differences in the structural orientation between the two. For instance, relative to the active site 
cysteine, the position of His and Asp are reversed in the two enzymes (Strop, 2014). It has 
been proposed that Asp 255 plays a similar role to the catalytic triad histidine in TG2. Alanine 
mutagenesis confirmed the critical role of Asp 255 in mTG, whereby the activity of Ala 255 
mutant was reduced to background levels. This is further supported by mutagenesis of His 
274, here the catalytic activity was reduced by approximately 50%, suggesting that while it has 
a role it does not play a critical one in mTG (Kashiwagi et al., 2002).   
 
1.3.3 Production of mTG 
 
 The gene that codes for mTG contains a 1,221 nucleotide open reading frame that 
encodes a 407 amino acid protein. This corresponds to a predicted pre-region of 31 amino 
acids, the pro-region of 45 amino acids and the mature region of 331 amino acids. Proteases 
in the culture medium of S. mobaraensis process the pro-region, which inhibits enzyme activity 
and increases enzyme thermostability (Pasternack et al., 1998). In the past, mTG was 
produced from S. mobaraensis by conventional fermentation. Recently though, more efficient 
systems have been described that produce mTG in host-vector systems such as S. lividans 
and E. coli. In the latter system, Salis et al. yielded a very high amount of mTG; over 6 g/l 
LacZ1–8PNP1–20Met-MTGase fusion protein per batch-fed fermentation process (Salis et al., 
2015). 
 The characteristics of mTG outlined above, i.e Ca2+ independence, smaller molecular 
weight and size, higher reaction rate are all more advantageous compared to TG2 when it 
comes to commercial meat processing (increasing its gelation, water-binding, emulsion 
stability). It is because of these properties that mTG is so widely used in the food industry to 
improve the physical properties of meat, fish and other protein-rich foods (Nonaka et al., 1997).  
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1.4 Transglutaminase 2 
 
TG2 has many different names: the official name is TGM2, but more common terms 
include tissue transglutaminase (tTG), cytosolic transglutaminase (cTG) and erythrocyte 
transglutaminase. Many different types of cells in the body express TG2 to varying degrees, 
which is why it has been described as the most ubiquitous of all the transglutaminases. The 
transamidating activity of TG2 is regulated by Ca2+ and GTP/GDP binding, where binding of 
Ca2+ results in active TG2 and binding of GTP/GDP results in inactivated TG2 (Smethurst and 
Griffin, 1996).  
 
1.4.1 Transamidating and deamidation ability of TG2 
 
In 1959, Clarke et al. were the first to reveal transamidation activity carried out by TG2 
and this discovery sparked further interest in TG2 for the next two decades by researchers 
across the globe (Folk, 1983). Two important steps make up the biochemical mechanism that 
underlies the enzyme’s reaction. The first step is a rate limiting one that involves the formation 
of the thioester bond between the cysteine in the active site of TG2 and the substrate. During 
this step, the sulphur on the Cys 277 carries out a nucleophilic attack on the -carboxamide 
group of a glutamine residue, thereby releasing ammonia as a by-product, as shown in Figure 
1.2. During the second step, the acyl intermediate is attacked by the nucleophilic substrate; 
here, if the attacking nucleophile is primary amine (a small amine group or -amino group of a 
peptide-bound lysine residue), the reaction is called transamidation. However if a water 
molecule, acts as a nucleophile then it is called deamidation.  
The results of TG2 transamidation are two-fold: the modification of the substrate protein 
with small amines or the formation of an isopeptide bond between acyl-acceptor and acyl-
donor proteins. If the nucleophilic substrate is a small primary amine, then the result of the 
transamidation reaction ends with the addition of a small amine group to the substrate protein, 
which can then change its biological properties. N,N-bis(-glutamyl)polyamine formation is the 
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result of polyamine incorporation into a protein followed by another transamidation with another 
protein.  
 
. 
 
Deamidation results in the conversion of an acyl-donor glutamine residue into a 
glutamate residue, and was first thought to occur only under specific conditions. For example, 
a limited number of primary amines acting as acyl-acceptors would mean that water would act 
as an attacking group. It has also been reported that deamidation is favoured in a low pH 
environment (Fleckenstein et al., 2002). A study conducting the crosslinking of small heat-
shock proteins (sHsps) by TG2 showed that only one glutamine residue goes deamidation 
Figure 1.2: A series of post-translational reactions which are catalysed by the 
transamidase activity of TG2. A-B) Represent the two step catalysis reaction carried out by 
TG2. C) Represents the path taken when TG2 carries out a crosslinking reaction. D) 
Represents the polyamine incorporation reaction. E) Shows how deamidation is carried out 
by TG2 
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while the rest underwent transamidation (Boros et al., 2006). Furthermore, it has also been 
observed that the capacity for deamidation by TG2 is both dependent on structure and perhaps 
by pathological conditions (Stamnaes et al., 2008). 
 
1.4.2 More enzymatic functions of TG2 
 
Regarding location, TG2 is predominantly a cytosolic protein, but is also seen in the 
nucleus and associated with both the inner and outer sides of the cell membrane. It is 
becoming clear that the different activities and conformations are key when discussing the role 
of TG2 in physiological and pathological processes. This versatile protein also carries out 
disulphide isomerase and guanine/adenine nucleotide binding and has hydrolysing abilities 
(Gundemir et al., 2012). It should be noted that ATP/ADP binding has no effect on its 
transamidating activity (Lai et al., 1998). However, the binding of calcium or GTP/GDP will 
inversely regulate the transamidating activity. Put simply, TG2 is only active when bound to 
calcium (open conformation) and inactive (closed conformation) when bound to GTP/GDP 
(Begg et al., 2006, Chen and Mehta, 1999). What makes TG2 so unusual is that it has recently 
been reported to function as a protein disulphide isomerase (PDI), a protein kinase and as a 
DNA hydrolase (Hasegawa et al., 2003, Mishra and Murphy, 2004, Akimov and Belkin, 2001).   
 
1.4.3 Structure and conformation of TG2 
 
 The TG2 enzyme is made up of four domains: an N-terminal -sandwich domain, the 
catalytic core and two C-terminal -barrel domains (Figure 1.3). A catalytic triad for 
transamidating activity has been eluded that consists of Cys 277, His 335 and Asp 358 (Liu et 
al., 2002). It was found that when the cysteine was mutated into serine at position 277, the 
transamidating and GTP/GDP binding capability of TG2 was completely abolished, In addition 
to this there are two more tryptophan residues (Trp 241 and Trp 332) that have been identified 
as critical for TG2 crosslinking activity. Trp 241 and Trp 332 are thought to be necessary to 
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stabilise the enzyme-thioester intermediate that forms during the first step of catalysis (Murthy 
et al., 2002). Mutating tryptophan 241 to alanine abolished transamidating activity but didn’t 
affect GTPase activity. However, swapping tryptophan 332 for phenylalanine resulted in the 
loss of GTP/GDP binding ability. Pinkas et al. discovered that a tyrosine (Tyr 516) seated within 
the catalytic pocket was crucial for crosslinking activity. In the inactive TG2 form, a hydrogen 
bond between Cys 227 and Tyr 516 is formed, which favours the inactive state of the enzyme 
(Gundemir et al., 2012). Figure 1.3 below shows the four domains of TG2 as a linear diagram 
and which residues are seen in the binding sites.  
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The main GTP/ATP binding site has been found to be in a cleft between the catalytic 
core and the first β-barrel. TG2 interacts with GTP in the absence of Mg2+ (Jang et al., 2014). 
Later, in 2010, Han et al. observed that less hydrogen bonding occurred between ATP and the 
binding pocket compared to the GTP complex structure. Furthermore, the residues S482 and 
R580 were shown to participate in GTP binding. Point mutation of R580 led to loss of GTP/GDP 
binding activity and inhibition of transamidase activity (Han et al., 2010). 
As previously stated, the ubiquitous TG2 is an enzyme that plays a part in many cell 
processes and thus has been studied heavily in order to elucidate how it functions within the 
body. In order to achieve this its structure has been described and studied by many. In 2007 
the two major conformations of TG2 were solved with the aid of x-ray crystallography. Liu et 
al. discovered the (inactive) GDP-bound, compact form and the active site covalent inhibitor 
bound, open form (active). The catalytic domain of the GDP-bound crystal structure was 
inaccessible due to the two β-barrel domains preventing binding of the substrate to the 
enzyme. However, the Ac-P(DON)LPF-NH2 inhibitor was used with TG2 to form a stable 
extended conformation or “open form” (Begg et al., 2006, Mariani et al., 2000). In this open 
form, the transamidating active sites were exposed to substrates, and it was believed that a 
disulphide bond between Cys 370 and Cys 371 was the key to stabilising this extended open 
form. The two major conformations of TG2 that were solved using x-ray crystallography are 
shown in Figure 1.4 below. 
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A) 
Fibronectin binding 
site 
N-terminal 
Catalytic domain 
GDP (bound) 
β barrel 1 
β barrel 2 
B) 
Fibronectin binding 
site 
N-terminal 
Catalytic domain 
Ca2+ 
β barrel 1 
β barrel 2 
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Figure 1.4: Representative models of TG2 derived through x-ray crystallography. 
Conformations of TG2 are represented as ribbon models. For each conformation blue 
represents the N-terminal, orange the fibronectin domain, green represents the catalytic 
domain, yellow and red represent the first and second β-barrels respectively. A) Represents 
the GDP bound closed conformation of TG2. B) The conformation when TG2 is open with 
calcium bound to it (represented as a pink ball).C) Conformation of TG2 when Cys 277 is 
bound to Ac-P(DON)LPF-NH2 inhibitor. 
 
β barrel 1 
C) 
Calcium 
Catalytic 
domain 
Ac-P(DON)LPF-
NH2 inhibitor 
bound to 
cysteine 277 
His 335 
Asp 358 
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1.4.4 Regulation of TG2 gene expression 
 
At first it was thought that the expression of human TG2 (by the gene TGM2) occurred 
via several activators. As shown in the Figure 1.5, there are four Sp1 binding sites that have 
been revealed within TG2 and numerous activator regulating sites. These regulator sites 
include: nuclear factor κβ (NFκβ), interleukin-6 response element (IL-6), tumour growth factor-
β1 (TGFβ1) response element, retinoic acid response elements (RRE1 and RRE2) and a 
glucocorticoid response element (GRE). Of all the activators of TG2, the most studied is 
retinoic acid (RA), which activates the retinoid response elements roughly 1.7kb upstream of 
the transcription start site (Nagy et al., 1996). This reaction occurs as a tripartite response: 
Firstly the ligand activates either retinoic acid receptors (RAR) or retinoid x receptor 
heterodimers (RXR) or RAR/RXR homodimers. Following on from this, the RRE binds to the 
RAR/RXR heterodimers via three hexanucleotide half-sites (two canonical and one non-
canonical). Finally, the complex binds to the Sp1 binding site with the help of other co-
activators (Griffin et al., 2002).  
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1.4.5 The role of TG2 in cell adhesion and signalling 
 
Although the majority of cellular TG2 is found in the cytosol, the role of TG2 is 
dependent on the location of the enzyme itself (Bruce and Peters, 1983). TG2 is also located 
on the plasma membrane (Begg et al., 2006), in the mitochondria (Rodolfo et al., 2004) and 
the nucleus (Bruce and Peters, 1983, Lesort et al., 1998). Furthermore, there are studies 
showing that TG2 is present in the extracellular matrix (ECM) (Zemskov et al., 2006, Upchurch 
et al., 1991). Athough TG2 is considered as a stress-related protein whose expression radically 
increases upon stress or injury (see Figure 1.5), it is also expressed continously in several 
cells including endothelial cells, fibroblasts, and smooth muscle cells (Jones et al., 1997, Ou 
et al., 2000).  
TG2 interacts with many different proteins and enzymes in the body. It has been well-
established to promote cell-ECM adhesion and cell migration (Belkin, 2011). Table 1.2 lists the  
endogenous and exogenous substrates and binding partners of TG2. 
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Table 1.2: Exogenous and endogenous substrates and binding partners of TG2 (Griffin et al., 2002, Esposito and 
Caputo, 2005) 
ECM and cell 
surface 
Cytosol Organelle 
Proteins 
Nucleus Others 
β-casein Actin 
 
α-oxoglutarate Calbindin 
 
Candida albicans 
surface proteins 
Collagen Aldolase A 
 
Acetycholine  
esterase 
Core histones glycoproteins 
gp120 
and gp41 
Fibronectin β -crystallin 
 
band III Importin-α3 Hepatitis C virus 
core protein 
Fibronogen β -tubulin 
 
CD38 pRB 
 
HIV aspartyl  
proteinase 
IGFBP-1 C-CAM 
 
Cytochromes  Pea legumin 
Laminin GADPH 
 
Erythrocyte (band 3)  Soy protein 
LTBP-1 Glucagon Histone  H2B  Wheat gliadin 
Midkine GST 
 
  Whey proteins 
Osteocalcin Lipocortin I    
Osteonectin Melittin    
Osteopontin Myosin    
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 In addition to this, it triggers the organisation of extracellular matrix proteins through 
two different pathways: The first is integrin-TG2 interaction and syndecan-4-TG2 complexes 
(Belkin, 2011). The second is through an RGD-ligand independent manner, TG2 was also 
found to associate with the membrane protein heparan sulphate proteoglycan (HSPG) 
syndecan-4 to promote cell-ECM adhesion (Telci et al., 2008). This adhesion pathway is 
hypothesised to be crucial for cell survival during injury/tissue remodelling. This is because 
TG2/fibronectin (FN)/syndecan-4 complexes activate PKC leading to the activation of 1 
integrins even when they are blocked by RGD peptides. These FN/TG2/syndecan-4 
complexes can also be activated by proteins including syndecan-2 via PKC (Wang et al., 
2010b). Some of the most important integrin subunits that TG2 non-covalently interacts with 
include 1,  3, 5, V, and 5 on cells. It should be noted that the binding sites for TG2 and 
integrins do not overlap on fibronectin. This means that the affinities of TG2 with these two 
proteins on the cell surface significantly enhance the interaction of cells with finbronectin (FN) 
and further promote cell adhesion and ECM-triggered signalling (Akimov and Belkin, 2000, 
Akimov and Belkin, 2001). In the absence of integrin-ligand interactions, TG2 may also be able 
to induce integrin clustering (Janiak et al., 2006). These TG2/integrin complexes have been 
found to decrease the activity of the Src-p190RhoGAP regulatory pathway, thus increasing the 
Phospholipase A2 Phosphorylase 
kinase 
   
Substance P RhoA    
Vitronectin Secretory vesicle 
IV 
   
 Tau protein    
 Thymosin β    
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activation levels of RhoA GTPase and its downstream signalling target, ROCK (Janiak et al., 
2006).  
In summary, the association of TG2 with cell membrane integrins and ECM proteins 
can be considered an amplifer of outside-in adhesion signalling.  
 
1.4.6 The role of TG2 in wound healing 
 
TG2 is active in different stages of the wound healing process via both transamidation-
dependent and independent mechanisms. Soon after mechanical or chemical injury of 
fibroblasts, it has been observed that TG2 is secreted into the ECM and co-localises with ECM 
proteins (Upchurch et al., 1991). It has been established that TG2 crosslinking activity is found 
in every layer of skin, as shown in a rat dermal skin wound model (Bowness et al., 1988). 
Moreover, within wound areas, TG2 expression and activity in vascular endothelial cells and 
erythrocytes were suggested to support and amplify FXIIIa-mediated blood clot formation 
(Murthy et al., 1991, Barsigian et al., 1991, Auld et al., 2001). Recently, it has been theorised 
that TG2-promoted cell adhesion is crucial in the wound healing process. Here, TG2/FN 
complexes can interact with cell membrane syndecan receptors and enhance cell adhesion 
and survival when cells undergo anoikis (Telci et al. 2005; Verdario et al., 2003). Furthermore, 
an increase in TG2 mRNA expression is also linked to collagen-producing phenotypes during 
matrix remodelling stages (Schnabel et al., 2004, Klingberg et al., 2013). It is important to note 
that these two opposite actions may occur distinctly depending on different cell types, the type 
of stimulus and the intracellular localisation of TG2. In situations where myofibroblasts persist 
in the extracellular matrix, a fibrotic phenotype develops. In wounds, this is manifested as 
hypertrophic scar or keloid (Sayah et al., 1999; Kothari et al. 2014). In conclusion, in order to 
determine whether normal wound healing or abnormal scar tissue formation will take place, 
there has to be a balance struck within cells regarding the pro-apoptotic (see 1.3.7 below) and 
anti-apoptotic abilities of TG2.  
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1.4.7 The involvement of TG2 in pathological conditions 
 
TG2 is now known to have numerous roles in multiple diseases and disorders such as 
coeliac disease, cancer and fibrosis. Specifically, it was been found by Fesus et al. that TG2 
is involved in apoptosis. Here, levels of enzyme expression correlated with the cellular 
regression found in livers of rats after the induction of hyperplasia (Fesus et al., 1987). 
Following on from this, it was discovered that TG2 stabilises apoptotic cells via intracellular 
cross-linking in order to prevent loss of intracellular components before clearance by 
phagocytosis (Melino & Piacentini., 1998).  
TG2 has also been found to have physiological roles. When cells respond to stress or are 
damaged, TG2 is up-regulated and externalised into the matrix. Once externalised, TG2 
contributes to a chronic inflammatory response through excessive matrix deposition, ECM 
crosslinking and tissue fibrosis. Chronic inflammation and near constant TGF- activation are 
observed in several fibrotic disease models including pulmonary (Richards et al., 1991), renal 
(Johnson et al., 1997, Johnson et al., 1999, Johnson et al., 2007) and liver fibrosis (Skill et al., 
2001). TG2 crosslinks large pools of latent TGF-binding protein-1 (LTBP-1) in the ECM, 
which in turn makes the extracellular matrix resistant to degradation (Johnson et al., 2007).  
TG2 also plays a role  in coeliac disease in that deamidation of glutamine residues in gliadin 
results in their increased binding affinity to the disease-predisposing human leukocyte antigen 
(HLA) DQ2 and DQ8 molecules. Thus causing a strong immune response to be launched via 
the activation of T-lymphocytes (Lindfors et al., 2011). Similarly, a high activity of TG2 is seen 
in Alzheimer’s disease due to the polymerisation of proteins such as beta-amyloid precursor 
protein and Ab peptides in affected brains (Benilova et al., 2012).  
Recently, it has been shown that S100A4 (a biomarker for highly metastatic cancer) is a 
substrate for TG2. Crosslinking of S100A4 by TG2 can be inhibited by the TG2 specific inhibitor 
R294, leading to the abolishment of S100A4-enhanced cell migration. The mechanism for this 
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S100A4/TG2-related cell migration involves the activation of the syndecan-4 and α5β1 integrin 
co-signalling pathway linked by PKCα (Wang and Griffin, 2013). Furthermore, tumour cells 
have been found to contain modified forms of TG2 that are inactive even when secreted into 
the ECM (Beninati, 1995). 
 
1.5 Involvement of TG2 in physiological bone development 
 
Transglutaminases have been associated with the promotion of chondrocyte and 
osteoblast differentiation as well as matrix mineralisation (Yin et al., 2012a). Through recent 
studies, it has been theorised that one or more transglutaminases involved in the processes 
mentioned above might be mediated by the protein crosslinking activity of transglutaminases. 
Either by the GTPase activity of TG2 or through non-catalytic signalling effects (Nurminskaya 
and Kaartinen, 2006).  
Bone development starts during embryogenesis, continues postnatally and further 
continues to be remodelled throughout a lifetime. It is a complex process that is controlled 
locally as well as systematically by growth factors, hormones and extracellular molecules such 
as bone morphogenic proteins (BMPs) 2, 4 and 7. Of the nine members of the TG family, only 
two have been discovered in cartilage and osseous tissue, these are TG2 and FXIIIa. Through 
immunohistochemistry, it was first demonstrated that TG2 is upregulated in the hypertrophic 
zone of the growth plate in juvenile rats (Aeschlimann et al., 1993). Following this, a significant 
increase in FXIIIA expression was discovered in the hypertrophic zone of the avian embryonic 
growth plate (Nurminskaya and Linsenmayer, 1996).  
TGs are very important in early bone formation; this was shown through the expression 
patterns of TG2 and FXIIIa in early embryonic limb development (using a chicken model) that 
were analysed to understand their potential roles. As early as 4 days into development, the 
formation of the tibia begins in the regions of mesenchymal condensation. By 6.5 days, both 
TG2 and FXIIIa are present throughout the areas of chondrocyte condensation. There were 
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higher levels of both transglutaminases in the hypertrophic zone and epiphyseal regions of the 
long bone. Towards the end of embryonic development, the expression of both enzymes is 
more restricted and only expressed in the superficial layers of cells (Pechak et al., 1986, 
Nurminskaya and Linsenmayer, 1996). These results suggest that there is an early activation 
of TG2 and FXIIIa in the mesenchymal condensation phase, but then later on during 
development, the expression of these enzymes is restricted to proliferative chondroblasts close 
to the epiphyses.  
Further study in the expression of transglutaminases in the perichondrium/ periosteum 
region revealed more clues of their role in osteoblasts. Through immunohistochemistry, it was 
shown that by day 6 of development, there was an absence of transglutaminase 2 and FXIII 
expression in the perichondrium during the mesenchymal condensation phase. However, by 
day 9 when ossification has taken place in the periosteum, expression of transglutaminase 
and FXIII was detected (Nurminskaya and Kaartinen, 2006). This suggests that TG2 and FXIII 
are expressed in the cells undergoing differentiation into osteoblasts. This study suggests that 
the initiation of TG2 and FXIII synthesis by osteoblasts correlates with the deposition of the 
mineral matrix (Nurminskaya and Linsenmayer, 1996). 
 The transamidating activity of TG2 has been shown to be crucial in bone development, 
and TG2 induces mineralisation. It has been show that, when TG2 is blocked with inhibitors, 
the outcome was impaired mineralisation occurs in MC3T3-E1 pre-osteoblast cultures (Al-
Jallad et al., 2006). This work lead other research groups to theorise that TG2 could be playing 
different roles in mineralisation. These include potentially inducing mineralisation through its 
ATPase activity (Nakano et al., 2007, Nakano et al., 2010) or by activating the Wnt pathway 
by activating LRP5/-catenin (Faverman et al., 2008, Beazley et al., 2012).    
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1.5.1 TG2 and its involvement in matrix maturation 
 
Transglutaminases are well-established as matrix stabilisers and several substrates (bone 
matrix proteins) that they affect including collagen I, ostepontin, bone sialoprotein and FN 
(Kaartinen et al., 1999; Kaartinen et al., 1997; Forsprecher et al., 2011). Of all the 
transglutaminases, TG2 has been related to secretion and deposition of ECM proteins the 
most. In addition to this, TG2 crosslinking of ECM proteins has been shown to improve cell 
adhesion, proliferation and differentiation (Png and Tong, 2013, Nadalutti et al., 2011). 
The organic bone matrix is mostly comprised of type I collagen (~90%) and, as stated 
previously, is a well-known TG2 substrate in mineralised tissue. Upregulation of TG2 has been 
observed to increase deposition of collagen I in many fibrotic conditions such as lung fibrosis 
(Jones et al., 2005 & Shweke et al., 2008) kidney fibrosis (Johnson et al., 2007) and cardiac 
fibrosis (Wang et al., 2018). Regarding extracellular collagen, polymerisation could take place 
via intermolecular crosslinking (Chau et al., 2005) or between non-collagenous bone matrix 
proteins and collagen. A well-organised fibrillar collagen network forms the foundation of 
mineralisation and transglutaminases are suggested to play a role in fibre organisation through 
their crosslinking ability (Pawelec et al., 2016). Evidence has also shown that 
transglutaminases can promote collagen synthesis and assembly which leads to the promotion 
of cell differentiation (Al-Jallad et al., 2006). On the whole, TG2 promotes mineralisation in 
osteoblasts, promotes matrix protein secretion, deposition and maturation through 
crosslinking-mediated modification of ECM which further enhances cell attachment. 
  
1.5.2 Transamidating independent pathway 
 
     At this time there are several theories regarding TG2-containing adhesive/signalling 
pathways which have been proposed. One of the most studied is the involvement of TG2 in 
RGD dependent integrin signalling. Akimov et al. first showed in 2000 that TG2 non-covalently 
interacts with 1 and 3 integrins (located on the cell surface) and regulates the interaction 
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between FN and the integrins. It was theorised that TG2 acts as an integrin-associated 
coreceptor to improve cell adhesion and spreading. This interaction between extracellular TG2 
and integrins leads to integrin clustering on the cell surface, FN deposition and finally 
mineralisation (Akimov et al., 2000, Zemskov et al., 2006). 
 Telci et al. also reported on another important TG2 adhesion pathway, here TG2 and 
FN bound to syndecan-4 could associate with β1integrin. This triggers an outside-in signal 
through PKCα and triggers an RGD-independent cell adhesion process. These complexes 
also trigger an inside-out response from syndecan-2, which then modulates cytoskeletal 
organisation through the ROCK pathway to maintain the RGD- independent adhesion of 
osteoblasts (Wang et al., 2011). 
Nurminskaya et al. revealed in several cell cultures that the additon of exogenous TG2 
promotes pre osteoblast dfferentiation, chondrocyte maturation and calcification of vascular 
smooth muscle cells (VSMCs) (Faverman et al., 2008, Nurminskaya et al., 2003). These 
experiments showed a correlation between extracellular TG2 and the mineralisation process 
in several cell lines. The following theories were put forward by these researchers: 
The first is that exogenous TG2 promotes pre-osteoblast differentiation and matrix 
mineralisaion in a crosslinking activity independent mechanism (Yin et al., 2012a). This is 
supported by the revelation that there are no changes in the pattern of protein crosslinking 
after pre-osteoblasts were treated with chondrocyte-derived TG2. Cells that were transfected 
with mutant inactive TG2 were still able to develop hypertrophic differentiation. However, 
extracellular TG2 induced hypertrophy was not affected by the use of GTP-bound, 
transamidase inactive TG2 (Johnson and Terkeltaub, 2005). 
Secondly, TG2 bound to GTP acts as a molecular switch for hypertrophic differentiation 
and calcification of chondrocytes, in which its transamidase and GTPase activities are not 
required. Johnson and Terkeltaub (2005) suggest this might be down to the nucleotide-bound 
form of TG2 being in a conformation that is ideal for triggering collagen expression and 
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calcification of chondrocytes in response to specific agonists (such as BMP2 and other wnt 
ligands). It should be noted that transamidating activity inhibitors are reported to change 
conformation of TG2 (Pinkas et al., 2007).  
The third and final theory is that direct binding of TG2 to cell surface proteins in pre- 
osteoblasts, without the formation of cross-links has been demonstrated. This cell surface 
receptor superfamily that directly interacts with TG2 has been identifed as low density 
lipoprotein receptor related-protein (LRP). The interaction with this group of proteins and TG2 
leads to internalisation and degradation of surface TG2 and further regulates cell adhesion 
and signalling. Using immunoprecipitation, it has been shown that LRP5 interacts with TG2 
and is involved in pathological calcification of VSMCs (Faverman et al., 2008). For over a 
decade now, LRP5 has been implicated in  bone formation, as mutants with loss-of-function of 
LRP5 present a severe osteoporosis phenotype (Gong et al., 2001). Moreover, gain of function 
mutant studies with LRP5 showed a high bone mass phenotype (Boyden et al., 2002). It has 
now been asserted that -catenin singalling, a major component of the canonical Wnt pathway, 
directly regulates osteoblast maturation via interaction with LRP5.  Although there is contention 
regarding whether crosslinking activity is essential for exogenous TG2-induced mineralisation 
(Beazley et al., 2012), the interaction between LRP5 and TG2 as well as the downstream 
activation of -catenin pathway might play a common role in calcified tissue. Figure 1.6 shows 
the Wnt signalling pathways and their antagonists.  
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Figure 1.6 Scheme of Wnt signalling and its antagonists. (A) Binding of Wnt to Frizzled 
and co-receptors, LRP5/6, activates the canonical pathway. Axin is recruited to LRP5/6 and 
subsequently degraded. The disruption of the link between β-catenin and glycogen synthase 
kinase 3 beta (GSK-3 β) causes β-catenin to be released. Intracellular β-catenin is stabilised 
due to free from phosphorylation. (B) Presence of Wnt signalling antagonists, such as 
secreted Frizzled-related protein (sFRP), Wnt inhibitory factor-1 (WIF-1) and Cerberus 
(CER), block both the canonical and non-canonical pathways. Bone morphogenetic protein 
(BMP) and Nodal are two subsets of transforming growth factor beta (TGF-β) superfamily. 
(C) Interaction among antagonist Dickkopf-1 (Dkk-1) and LRP5/6 and the co-receptor 
Kremen 1/2 (Krm, green) triggers LRP5/6 endocytosis. The canonical pathway is inactive 
due to absence of LRP5/6–Wnt–Frizzled complex. β-catenin is phosphorylated by GSK-3β 
and thereby undergoes degradation. However, the non-canonical pathway remains active via 
interaction of Wnt with Frizzled without LRP5/6. (Kawano and Kypta, 2003).  
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1.6 Bone regeneration and biomaterials for tissue repair 
 
 Due to the ubiquitous expression of TG2 throughout the body and its involvement in 
various tissue developmental and wound healing processes, it is possible that TG2-based 
biomaterials could be beneficial for wound healing. Below, the advantages and potential uses 
of TG2 crosslinked biomaterials for soft and hard tissue repair are summarised below.  
 
1.6.1 Tissue engineering 
 
 It was in 1988 that Robert Nerem first coined the term “tissue engineering” at a National 
Science Foundation workshop. This term was further extended and formalised in a review 
paper in Science by Langar and Vacanti. Here, the modern day definition was given:  
“Tissue engineering is an interdisciplinary field that applies the priniciples of 
engineering and the life sciences toward the development of biological subsitutes that restore, 
maintain or improve tissue function” (Langer and Vacanti, 1993).  
In short, tissue engineering introduces a great promise and potential for producing 
engineered replacements as alternatives therapies for human disease and injury.  
 The first step is understanding cell-cell interactions, then choosing the appropriate 
matrices based on cell-matrix interaction and finally to supplement with extra biochemical 
signalling or growth factors. Thus, it is clear that cell sources, biomaterials and growth factors 
are the three fundamental elements in tissue engineering. Furthermore, there is a need  for 
vascularisation to occur to provide blood and nutrients to engineered tissues. This need has 
recently been drawing more attention, especially within the field of bioengineered tissue 
reconstruction (Naderi et al., 2011). Following this approach, some achievement has been 
made in basic research and in a clinical setting including skin, bone, heart valves, cartilage, 
esophagus, blood vessels, liver, pancreas, nerves and tracheal constructs (Horch, 2006).  
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 Of all the tissue engineering subdivisions, bioengineered bone substrates are 
considered as one of the most studied and successful. At present, there is a demand for bone 
substitues to repair and replace diseased or damaged tisue, degenerative disease and cancer. 
Moreover, due to the increasing aging population, there is a surging demand for substitutes to 
replace, restore or regenerate bone. This is a major clinical need in the fields of spinal, dental, 
cranial, orthopaedic and maxillofacial surgery. After transfused blood products, bone implants 
are the second most impanted materials and yet the availability and quality of bone substitutes 
fall shorter than the current requirement (Wang and Yeung, 2017). Thus, developing 
appropriate bone constructs to meet these growing needs is vital. However, due to the 
complexities of regenerating complex tissues and organs such as heart, muscle, kidney, liver 
and lung, there are still major milestones to be reached in tissue engineering. However, whilst 
growing relatively “simple” tissue such as cornea is becoming a reality (Ruberti and Zieske, 
2008), the quality and quantity of artificial grafts is far below the clinical demand for more 
complex tissues (Lash et al., 2015).  
 
1.6.2 Bone tissue engineering 
 
During 2015 in the US the annual medication and treatment costs for hip fractures 
alone was estimated to be between 10.3 and 15.2 billion dollars (Dy et al., 2011). Furthermore, 
5% of the 1.2 million cases of overall fractures showed non-union or delayed healing after 
surgery (Leighton et al., 2017). In 2010, it was estimated that worldwide there were 4 million 
operations that involved bone grafting or bone substitutes (Brydone et al., 2010). The aging 
society has meant that the number of joint replacement operations has increased greatly which 
further highlights the requirement of bioengineered bone tissue. To illustrate this point, during 
2011-2012, it was estimated that 180,000 cases of primary knee and hip replacement 
procedures were entered into the National Joint Registry in the UK. Of this total, around 9% of 
primary joint replacements underwent revision surgery (NJR, 2011). It is clear, therefore, that 
the need to continue research in bone engineering is urgent. The sections below summarise 
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the biology of bone as well as current options of bone grafting and recent developments in cell 
engineering. 
  
1.6.3 The biology of bone 
 
Bone is described as a rigid organ that provides mechanical support for anchoring 
muscles, confers protection to organs and facilitates movement. Bones also 
produce red and white blood cells and store minerals. Bones come in many different shapes 
and sizes and have a complex internal and external structure. They are lightweight yet strong 
and hard, and serve multiple functions as listed above. Bone is a unique organ in that its 
complex cellular composition is made up of both organic and inorganic architecture which is 
classified as micro and macro composite tissue. The mineralised matrix consists of an organic 
phase (collagen, 35% dry weight) which is responsible for its rigidity, viscoelasticity and a 
mineral phase. The latter is made of up of carbonated apatite (65% dry weight) for structural 
reinforcement, stiffness and mineral homeostasis. Finally, there are also non-collagenous 
proteins present that form a  microenvironment that is stimulatory towards cellular functions 
(Hutmacher, 2013).  
Looking at the morphology of bone, there can be two categories in which bone can fall 
under: cortical (or compact) bone and trabecular bone (cancellous or spongy). Cortical bone 
is formed of a condensed layer that consists of densely packed collagen fibrils in concentric 
lamellae. It has a low porosity when compared to other bone tissues, ranging from 5-30%. This 
type of bone is responsible for the mechanical strength and rigidity in the skeleton and 
contributes to 80% of the total bone mass in adults. Trabecular bone, on the other hand, is 
composed of a porous latticework of matrix and primarily functions to store minerals in the 
body (Deakin, 2006). Bone tissue can be categorised through the hierarchical organisation of 
its constituents at the macrostructure (cancellous and cortical bone), the microstructure 
(Haversian systems, osteons), sub-microstructure (lamellae), nanostructure (fibrillar collagen 
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and embedded minerals) and finally the sub-nanostructure (minerals, collagen and non-
collagenous proteins) (Rho et al., 1998). This macroscopic hierarchy of structure is 
summarised in Figure 1.7. 
 
 
Macroscopically, bone is seen as a hard dense cylindrical shell of cortical bone, along 
the shaft of which the bone becomes thinner with greater distance from the ends. At these 
proximal and distal ends of the bone, cortical bone encompasses the porous trabecular bone 
to optimise articular load transfer (Webster and Ahn, 2007). When comparing densities, 
trabecular bone has a porosity of 50%-90% with an average spacing of around 1 mm and 
average density of 0.2g/cm3 (Barrere et al., 2008). Whereas cortical bone is much denser with 
a porosity of 3-12% and an average density of 1.8g/cm3 (Cooper et al., 2004).  
Looking at the microscopic scale, both trabecular struts and cortical bone are 
composed of mineralised collagen fibres, which are stacked parallel to form layers. These are 
Figure 1.7: Hierarchical structure of bone from macrostructure through to sub-
nanostructure. Adapted from (Rho et al., 1998). 
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called lamellae (3-7m thick) (Webster and Ahn, 2007). In mature bone these lamellae wrap 
in concentric layers around a canal which is called the Haversian canal. This contains the nerve 
and blood vessels to form an osteon. This is a cylindrical structure that runs parallel to the axis 
of the bone. On the nanostructure level, collagen fibres are surrounded by mineral.     
Several types of bone cells and bone extracellular matrix form the mineralised bone 
matrix. Regarding bone cells, there are four types: osteoclasts, osteocytes, bone lining cells 
and osteoblasts. In addition to these four integral types there are also more cell types that are 
contained within the bone marrow within the central intramedullary canal of the bone shaft 
(Marks and Popoff, 1988). Part of the organ’s purpose is to serve as a place to store minerals 
that are used by the body’s endocrine system in order to regulate phosphate and calcium 
homeostasis. Recent studies have shown that bone exerts an endocrine function itself. It is 
thought that this is because the bones themselves are producing hormones that regulate 
phosphate and glucose homeostasis (DiGirolamo et al., 2012). 
Bone is a connective tissue that is highly dynamic. It undergoes continuous remodelling 
via a removal of bone through osteoclasts and formation of new bone by osteoblasts. This 
well-orchestrated relationship of removal and formation shifts to adapt the bone’s structure and 
functional demands such as mechanical loading and nutritional needs (Hutmacher, 2013). The 
mechanical properties of bone depends on its composition (mineralisation and porosity etc.) 
as well as the structural organisation (trabecular or cortical bone architecture, collagen fibre 
orientation etc. (Martin, 1991).        
Osteoprogenitor cells differentiate to osteoblasts, which go on to synthesise bone 
matrix which is composed of mostly type I collagen. It is thought that flattened bone lining cells 
(FBLs) are quiescent osteoblasts which line non-remodelling bone surfaces. These FBLs are 
thought to be important in the maintenance of mineral homeostasis and regulate remodelling 
signals (Miller et al., 1989). Osteoblasts secrete matrix and become trapped inside it as they 
transition to osteocytes (which are shaped like stars as opposed to the triangular shaped 
osteoblasts). Osteocytes reside and network inside lacunae, similar to the way the nervous 
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system works, via long cytoplasmic extensions in tiny canals called canaliculi. Even though 
osteocytes have a low synthetic activity, there have been studies that showed they are actively 
involved in turnover of bony matrix via numerous mechanisms (Schaffler et al., 2014). 
Mesenchymal stem cells (MSCs) are multipotent cells that are able to differentiate into 
different lineages of mesenchymal tissue, including cartilage, fat, bone and various connective 
tissues (Phinney & Prockop, 2007). These cells have been now isolated from adult blood, tooth 
pulp and bone marrow. One of the master modulators in the differentiation of MSCs into 
Osteoprogenitor cells is the canonical Wnt/-catenin pathway (Logan and Nusse, 2004). 
Studies have also shown that high and low bone mass phenotypes are associated with 
activation of LRP5 (a co-receptor of Wnt protein receptor) (Gong et al., 2001, Boyden et al., 
2002). It has even been shown that myogenic cells can give rise to osteoprogenitor de-
differentiation under certain circumstances (Doherty et al., 1998). Here blood vessel pericytes 
could undergo de-differentiation and develop into osteoblasts, chondrocytes fibroblasts and 
adipocytes (Mills et al. 2013). 
 There is a significant morphology shift seen in osteoblast precursors as they are seen 
to transition from spindle-like cells to a large cuboidal shape when they are fully differentiated 
into mature osteoblasts. Functioning and mature osteoblasts are also seen to be surrounded 
by alkaline phosphatase (ALP) positive osteoprogenitor cells in bone remodelling nodules. 
After decades of research, it has now been established that there are three major stages of 
osteoblast differentiation and mineralisation which are summarised in the Figure 1.8 (Stein et 
al., 1990). 
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 Osteoclasts are generally believed to be derived from mononuclear precursor cells of 
monocyte-macrophage lineage in bone marrow (Nijweide et al., 1986). Regarding osteoclast 
formation, there are two key cytokines; receptor activator of nuclear factor B ligand (RANKL) 
and macrophage colony-stimulating factor (M-CSF). Both stromal cells and osteoblasts are 
needed in osteoclastogenesis. This process is regulated by soluble and membrane bound 
RANKL and M-CSF that are regulated by the stromal cells and osteoblasts (Teitelbaum and 
Ross, 2003). On osteoclast precursor cells, RANKL signals through receptor activator of 
nuclear factor B (RANK) to mediate osteoclast differentiation, activation and survival during 
normal bone modelling and remodelling processes. However, osteoprotegerin (OPG) can bind 
to RANKL and prevent RANK binding to it (Boyce and Xing, 2007). M-CSF, on the other hand, 
promotes survival, proliferation and differentiation of osteoclast precursors and regulates the 
cytoskeleton of cells. Osteoclasts are known to be responsible for resorbing bone mineral into 
the blood stream during bone remodelling. Cell integrins are crucial for the interaction between 
osteoclasts and bone matrix and bone matrix peptides. One of the key integrins is 1, which is 
          Proliferation                                 Matrix maturation                               Mineralisation     
Figure 1.8: The three main stages of osteoblast differentiation. 1- Proliferation, where 
cells are rapidly dividing and starting to secrete ECM proteins such as fibronectin and type I 
collagen. 2- Matrix maturation, here there is an increased release of ALP and secretion of 
bone matrix proteins (BMPs) like osteopontin and osteonectin.  3- Mineralisation, secretion 
of osteocalcin, deposition of Ca2+ into bone matrix and decline in ALP activity.  
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anchored and expressed in osteoclasts, which binds to collagen, fibronectin and laminin 
(Pawelec et al., 2016).  
 
1.6.4 Bone development 
 
 The first stage in the development of mesenchymal tissues is called condensation, here 
previously dispersed populations of MSCs gather together and differentiate into a single type 
of tissue such as cartilage, bone, tendon, muscle, etc. There are two mechanisms that are 
involved in skeletal development: endochondral ossification and intramembranous 
development which occur after MSC condensation. The majority of the skeleton, including all 
long bones, are formed through endochondral ossification, whereas the development of the 
skull and mandible would be formed through intramembranous ossification (Scotti et al., 2013, 
Opperman, 2000).  
Endochondral ossification starts with precursor cells differentiating into pre-
chondrocytes and forming the cartilage scaffold. Following this, the chondrocytes are then 
replaced with mineralised bone matrix. This primary ossification occurs at the centre of the 
long bone, where the chondrocytes have stopped proliferating and have become hypertrophic. 
They will also mineralise the matrix and secrete vascular endothelial growth factor (VEGF) to 
promote vascular invasion and attract chondroclasts. Hypertrophic chondrocytes cause 
adjacent perichondral cells to differentiate into osteoblasts, which in turn secrete collagen type 
1- rich matrix that results in the formation of the bone collar. The hypertrophic chondrocytes 
then undergo apoptosis leaving behind the cartilage matrix behind as a scaffold for osteoblast 
mineralisation (Majidinia et al., 2018). Growth plates are zones of proliferating chondrocytes, 
which lengthen the long bones that are in between primary and secondary ossification centres 
(Kronenberg, 2003).  
 
As stated above, flat bone growth and bone widening of long bones occurs through 
intramembranous ossification. In this process, MSCs are directly differentiated into pre-
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osteoblasts and then osteoblasts. However, this is not a process that is well characterised at 
time of writing.   
 
1.6.5 Healing from bone fracture 
 
 Today, bone fracture repair is considered to be a regenerative process. Fracture 
healing is a fascinating process whereby the formation of new bone tissue is indiscernible from 
uninjured bone (Fazzalari, 2011). This feature of bone regeneration is very different from soft 
tissues, whereby a fibrous scar is produced at the site of injury. Bone repair after a fracture is 
made up of two mechanisms: direct remodelling with minimal callus formation and indirect 
remodelling with callus formation through a combination of both intra-membranous and 
endochondral ossification, the latter is more prominent in fracture healing. In general, the 
process consists of three overlapping phases: inflammation, renewal and remodelling (Wang 
et al., 2013).  
After a bone becomes fractured, just like in other tissue injuries, there is an 
inflammatory response that peaks after 24 hours after initiation (Marsell and Einhorn, 2011). 
During this phase, there is an intricate network of pro-inflammatory signals and growth factors 
at play. This results in the expression of several inflammatory molecules, including tumour 
necrosis factor  (TNF) and interleukins (IL-1, IL-6, IL-11, IL-8) (Fazzalari, 2011, Rundle et 
al., 2006). After this, polymorphonuclear neutrophils (PMNs) and macrophages are recruited 
so that the fracture derived-microdebris and micro-organisms can be endocytosed (Schett, 
2011). Soon after this, platelets are induced as a consequence of injury to blood vessels, which 
produce platelet-derived growth factor (PDGF), transforming growth factor-β1 (TGF-1), 
tumour derived growth factor- (TGF-), insulin-like growth factors (IGFs) and fibroblast growth 
factor-2 (FGF-2). These are all released by macrophages in order to form the initial hematoma 
(Cho et al., 2002, Lieberman et al., 2002). In addition, at the fracture site, BMPs will also be 
expressed by osteoprogenitor cells. All these factors culminate in the recruitment of MSCs.  
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In the renewal phase, the recruited MSCs present at the fracture site proliferate and 
differentiate into osteoblasts to form bone through intramembranous ossification, around 7-10 
days after the fracture. Following on from this is the start of chondrogenesis in the injured 
tissue (Cho et al., 2002). It is important to note that, at this point there is an absence of 
inflammatory mediators. BMPs and TGF-β2 signalling induces endochondral bone formation 
in the cartilaginous callus (Cho et al., 2002, Gerstenfeld et al., 2003). At the end of this phase 
the cartilage that has been formed calcifies and is then replaced with woven bone (Fayaz et 
al., 2011). When the remodelling phase commences osteoprogenitor cells then differentiate 
into osteoblasts and osteoclasts. Both osteoblasts and osteoclasts mediate the replacement 
of the woven bone with lamellar bone through their reforming and resorbing actions 
(Mountziaris and Mikos, 2008). Furthermore, it is thought that (human) growth hormone and 
parathyroid hormone also play a part of the remodelling phase and contribute to the healing 
speed and strengthens the fracture callus (Nakajima et al., 2002). In addition to the signalling 
pathways that are involved in MSC differentiation, chondrocyte maturation, angiogenesis and 
ossification seem to all have similar events occurring during foetal skeletal development 
(Mountziaris and Mikos, 2008). Nevertheless, the absence of inflammatory response in 
embryonic development (as well as the involvement of embryonic stem cells) is the key 
difference between fracture healing and foetal skeletogenesis (Hall and Miyake, 2000).  
   
 
1.6.6 Biomaterials and current options for clinical regeneration 
 
When certain pathological fractures or when large bone defects occur and bone repair fails, 
clinical intervention is required (Dimitriou et al., 2011). Furthermore, the capacity of bone to 
repair itself can also be diminished by numerous conditions such as bone infection, infection 
in the periphery tissues, insufficient blood supply and systemic diseases (Dimitriou et al., 
2011). This is where bone grafts are utilised. In general bone grafts are an implanted material 
which induces bone repair through osteogenesis, osteoconduction and osteoinduction either 
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in combination with other materials or alone (Bauer and Muschler, 2000). The decision of which 
appropriate type of bone graft to use depends on graft size, tissue viability, defect size, shape 
and volume to name a few (Sheikh et al., 2015). There are four main categories that materials 
used in bone grafts can be separated into to repair bone defects: autografts, allografts, 
xenografts and bone graft substitute (Sheikh et al., 2015). In order for a bone graft material to 
be successful in regenerating bone there are four major characteristics that they have to 
demonstrate 
 Osteogenesis: The capacity to generate bone tissue via the differentiation of 
osteoblasts from osteoprogenitors (Greenwald et al., 2001) 
 Osteoinductivity: The capacity for the bone graft materials to be able to promote 
the production of bone-forming cells. 
 Osteoconductivity: Where the graft material is able to be reabsorbed into the 
body after serving as a scaffold for new bone growth. 
 Osseointegration: The capacity for the graft materials to bind with periphery 
bone tissues without generating any intervening layer of fibrous tissue. 
These are the qualities that are necessary for an ideal bone graft material in successful 
bone regeneration.  
Autografting (autologous or autogenous) are the current gold standard of bone grafting 
material and is defined as transplantation of a cancellous or cortical bone tissue from one part 
of the body to another within the same individual (Zimmermann and Moghaddam, 2011). 
Autografts are comprised of surviving cells which include osteoinductive factors such as BMP-
2, BMP-7, FGF, IGF and PDGF (Bauer and Muschler, 2000). They will also lack 
immunogenicity as well as retain immediate viability after transplantation (Janicki and 
Schmidmaier, 2011). All of these factors are what make autografts the best bone grafting 
material available. However, due to the additional surgery that is required for the harvesting of 
grafts from another site on the body, there is an increased risk of donor pain, infection, 
complications and morbidity. In addition, there is only a finite amount of autograft material 
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available from the donor. These limitations may be overcome by introducing other graft 
materials (Janicki and Schmidmaier, 2011).  
A common substitute for autografts are allografts, which are obtained from one 
individual and implanted into another individual of the same species (Ehrler and Vaccaro, 
2000). Either cortical, cancellous or even a combination of both materials can be used as either 
intact or divided forms (Parikh, 2002). Allografts can be harvested from either living donors or 
cadavers, as it is possible for the latter to retain their cellular and organic content (Zimmermann 
and Moghaddam, 2011). The disadvantages mentioned above for autografts do not apply to 
allografts. In fact, unlike autografts, there is a broad range of shapes and sizes of allograft 
materials and a higher availability of them too. However, allografts are not perfect, as there 
can be a lack of viable cells and thus a lower osteogenic potential, Moreover there is a risk of 
transmitting bacterial infections and viral diseases. These can include but are not limited to 
HIV, hepatitis B and C. It has been found that, due to the low osteogenic potential, there is a 
lower rate of healing and that the grafts can also trigger immunological reactions in the host 
body (Gomes et al., 2008, Oryan et al., 2012, Parikh, 2002).  
The third option for graft materials are xenografts, also known as xenogenic or 
heterologous grafts. Heterologous grafts come from a different species to humans and are 
commonly sourced from porcine and bovine species (Oryan et al., 2012; Develioglu et al., 
2009). The biggest advantage to these heterologous grafts is that they can be considered an 
unlimited supply. On the other hand, the major downsides are the possibility that zoonotic 
diseases can be transmitted to the host and there is also a risk of prion infections. In addition, 
there is also a lack of osteogenic characteristics which results in a poor clinical outcome (Oryan 
et al., 2012).  
The final option is to use bone graft substitutes when managing bone defects. These 
substitutes are usually formed of natural tissue scaffolds such as collagen, alginate, elastin, 
chitosan and cellulose. Synthetic materials such as mono, bi- and tricalcium phosphate 
including hydroxyapatite (HA), bi-tricalcium phosphate (b-TCP) and calcium-phosphate 
cements as well as glass ceramics (Finkemeier, 2002, Dimitriou et al., 2005). These materials 
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are advantageous since they are able to trigger proliferation, migration and differentiation of 
bone cells that are crucial for bone regeneration. 
However, more research into the mechanisms behind these advantages are still being 
researched and more synthetic materials are being researched every year.    
 
 
 
1.7 45S5 bioglass   
 
In 1971, Hench et al. began investigating silicate bioglass glasses as 3-D bone tissue 
scaffolds. Since then the field has been growing and today has expanded into tissue 
engineering and cellular biology (Baino and Vitale-Brovarone, 2011). Bioglasses are inorganic 
materials are able to react to physiological tissues and form bonds to bone through the 
formation of bone-like hydroxyapatite layers.This leads to effective biological interaction and 
fixation of bone tissue with the material surface (Hench, 1998). Looking specifically at 45S5 
bioglass, the reactions on the material surface include the release and exchange of critical 
concentrations of Si, Ca, P and Na ions. This in turn encourages favourable intracellular and 
extracellular repsonses that promote rapid bone formation (Gerhardt and Boccaccini, 2010). 
These biogl can not only act as scaffolds but also serve as carriers for the delivery of metal 
ions to mediate cellular functions. 
When Hench et al. found that certain silicate-based glass compositions could be 
bonded chemically to rat bone, they termed these glasses as “bioactive”. Bioglasses were 
classified as materials that elicited a specific biological response at the surface of the material 
which resulted in the formation of a bond between the tissues and the materials (Hench et al., 
1972). One of the oldest compositions of bioglass is the famous 45S5 Bioglass which has 
multiple successful clinical applications in tissue engineering. The meaning behind the name 
is that the composition is 45% wt SiO2 , incorporating 25% wt Na2O, 25% wt CaO, 5% wt P2O5. 
The 5 in 45S5 represents the 5:1 ratio of CaO to P2O5 and this high ratio, coupled with the high 
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amounts of Na2O, is why the glass surface is highly reactive in physiological environments 
(Hench, 1993).  
 
After much research, it is now widely believed and accepted that to create a bond with 
bone a biologically active apatite surface layer must form at the biomaterial-bone interface 
(Hench, 2006). Therefore, the fundamental necessity of bone bonding property of bioglasses 
is the chemical reactivity in physiological body fluids resulting in the formation of 
hydroxycarbonate apatite (HCA) layer to which bone can bond and collagen fibres (CF).  It 
was further found that the products that reacted with the bioglass upregulate the genes that 
control osteogenesis (Xynos et al., 2000, Xynos et al., 2001). Briefly, ion leaching/exchange 
and dissolution of the bioglass network and precipitation/growth of the calcium-deficient HCA 
layer, encourages the colonisation, proliferation and differentiation of osteoblasts (Hench, 
1993). Figure 1.9 displays SEM images of HCA binding to collagen fibrils.  
 
 
       
 
Figure 1.9: SEM images of the HCA layer bonding to bone. (A) SEM micrograph 
of collagen fibrils incorporated within the HCA layer growing on a 4585 Bioglass 
substrate in vitro (B) Close-up (11300x) of the HCA crystals bonding to a collagen 
fibril. Adapted from Hench et al. 1993. 
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In parallel to the chemical reactions on the material surface, recent studies have shown 
that ion dissolution and release from bioglass activate gene expression in osteogenitor cells 
that give rise to enhanced bone regeneration (Xynos et al., 2000).  
This study aims to investigate the differences in the physical characteristics of collagen 
scaffolds, which have been crosslinked using transglutaminases with and without bioglass 
particles. Alongside this characterisation of physical characteristics, the validation of inhibitors 
on TG2 and mTG will be assessed. And the determination of the amount of crosslink per mole 
of collagen in crosslinked collagen scaffolds will also be determined. Following this, the 
differences in integrin expression (if any) of human osteoblasts seeded on native, crosslinked 
collagen and scaffolds with bioglass will be investigated. In addition to this the rates of 
mineralisation between the scaffolds will also be assessed using von Kossa staining. The main 
objectives of the thesis are listed below: 
1.  The micro and macro structural differences between native, crosslinked collagen and 
collagen scaffolds with 45S5 bioglass using sedimentation assays as well as SEM. 
2. The mineralisation rates of HOBs on the various collagen scaffolds 
3. Plausible mechanism/pathway that explain the observed rates of mineralisation. 
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Chapter 2: Materials and Methods 
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2.1 Materials 
 
2.1.1 General chemicals 
 
All water used was deionised using Purelab Option-S 7/15 system purchased from 
ELGA. Sterilisation of disposable pipette tips, chemical and stock solutions was autoclaved 
at 121°C for 1 hour or by filtration through a 0.45m Millex syringe filter purchased from 
Merck Millipore, Watford, UK. All general chemicals were purchased from Sigma-Aldrich, 
Poole, UK unless otherwise stated. 
Recombinant human tissue transglutaminase 2 (rhTG2) and mTG were purchased 
from Zedira GmBH, Germany with the activity between 14-17U/mg as stated in certificate 
of analysis. Biotin-Cadaverine was purchased from Zedira GmBH, Germany. Silver (I) 
nitrate was purchased from Fisher Scientific UK Ltd, Leicestershire UK. Collagenase from 
Clostridium histolyticum, subtilisin, pronase, leucine aminopeptidase (LAP), prolidase and 
carboxypeptidase Y were all purchased from Sigma-Aldrich, Poole, UK. Inhibitors 1-155 
and R281 were kindly provided by Dr Vivian Wang. 45S5 bioglass particles (between 40- 
60 µm) with the composition of: 5 wt% SiO2, 24.5 wt% CaO, 24.5 wt% Na2O, and 6.0 wt% 
P2O5) and cobalt bioglass (53 wt% SiO2, 6 wt % Na2O, 12 wt % K2O, 5 wt % MgO, 20 wt 
% CaO, and 4 wt % P2O5)  were both kindly provided by Dr Richard Martin. 
2.1.2 Cell culture  
 
Dulbecco’s Modified Eagle Medium (DMEM) with glucose (4.5 g/l), L-glutamine 
(200mM), non-essential amino acid (NEAA) concentrate (100x) and penicillin/streptomycin 
(100x) solution were all purchased from Corning, U.K. Fetal bovine serum (FBS) was 
purchased from Labtech Sussex, UK.  
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 2.1.3 Immunochemicals 
 
 All monoclonal and polyclonal mouse α1, α2, α5, αV, β1, β3 and rabbit LRP5 and β –
catenin antibodies as well as secondary anti mouse and anti rabbit antibodies were purchased 
from Santa Cruz, California USA.  
2.1.4 Western blot chemicals 
 
Tris-glycine-SDS buffer (10X) and 30% (w/v) solution containing methylene bis 
acrylamide (in a 29:1 mix) were purchased from Melford Biolaboratories Ltd, Suffolk, UK.  
Pure nitrocellulose blotting membranes were purchased from Pall Corporation, UK. Blotting 
pads were purchased from VWR, UK. Enhanced chemiluminescence ECL reagents were 
purchased from Cynagen Bologna, Italy. 
 
2.1.5 Mineralisation and collagen staining kits 
 
Silver Quest staining kit was purchased from Invitrogen Ltd, Paisley UK. Silver nitrate 
and sodium thiosulfate were both purchased from Sigma Aldrich Poole, UK.  
 
2.1.6 Sub cellular fractionation 
 
A subcellular Protein Fractionation Kit was purchased from Thermo Scientific 
Massachusetts, USA.  
 2.2 Methods 
 
2.2.1 Cell culture  
 
Human osteoblasts (HOBs, passage 18) which were spontaneously immortalized were 
kindly gifted from Prof Sandra Downes and Dr S Anderson, University of Nottingham). 
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 HOBs were cultured in Dulbecco’s Modified Eagle medium with L-glutamine (DMEM) 
containing 10% (v/v) heat-inactivated foetal bovine serum (FBS), 1% NEAA (v/v) and 1% 
penicillin/streptomycin (v/v), hereafter described as complete medium (CM).  All flasks were 
kept in a humidified incubator at 37°C the CO2 concentration was set at 5% (v/v).  
2.2.2 Passaging cells 
 
Passaging of cells took place regularly in order to ensure that HOBs were healthy and 
were not allowed to reach over 90% confluency. After the removal of all medium, the 
monolayers in flasks were washed once with PBS (pH 7.4) to remove any residual complete 
medium. Following this, the cells were treated with 0.25% trypsin in 2mM EDTA solution for 5 
minutes. Once cells had been observed to have detached from the flask (using a light 
microscope) double the volume of complete medium (to that of trypsin) was added to inactivate 
trypsin. The suspension was then centrifuged at 300g for 5 minutes, from which a cell pellet 
was formed. This pellet was either re-suspended in serum free medium (DMEM) for use in 
investigations or seeded into the appropriate cell culture flask or vessel and then kept in a 
humidified incubator at 37°C in 5% CO2 (v/v). 
2.2.3 Cryopreservation 
 
 Healthy cell cultures were grown to approximately 90% confluency before 
tryspinisation. After centrifugation the cell pellet was then suspended in 1ml of “freezing 
mixture” consisting of 10% (v/v) DMSO in FBS. This solution was aliquoted into cryogenic 
tubes before being stored in a -20°C freezer for 1 hour, after which time it was stored in a -
80°C freezer. Following this the cryogenic tubes were then transferred in vapour phase liquid 
nitrogen freezer tanks for long term storage.  
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2.2.4 Retrieving cells from storage 
 
 Cells were kept at room temperature (19°C) until completely thawed and were then 
transferred to a sterile centrifuge tube. Complete medium was then added drop-wise whilst 
mixing the solution regularly to allow for slow dilution. The suspension was then centrifuged 
(300g for 5 minutes) to remove the freezing mixture. Using the appropriate growth medium, 
cells were then re-suspended and transferred into the appropriate tissue culture flask and 
incubated in a humidified-atmosphere incubator at 37°C (with 5% CO2 v/v). The respective 
medium was then changed no more than 8 hours thereafter to remove the remaining DMSO. 
 
2.2.5 Differentiation of HOBs 
 
Cells (passage 20-25) were seeded into either 96-well plates (100 µl) or in 35mm tissue 
culture plates at a density of 8x104/cm2 in 2 ml complete medium (10% FBS in DMEM) for 16 
hours. Following this the differentiation treatment began by replacing the complete medium 
with 50g/ml ascorbic acid and 10 mM -glycerophosphate in complete medium. This is 
differentiation medium (henceforth referred to as DM). Differentiation medium was replaced 
every 48 hours for 10 days to carry out both mineralisation assays.  
 
2.3 Protein expression assays 
 
2.3.1 Protein concentration 
 
Lowry protein assay was performed (using the Bio-Rad RC kit purchased from Life 
Sciences, Hemel Hempstead UK). As per the manufacturer’s instructions, a set of bovine 
serum albumin (BSA) standards ranging from 0.2-1 mg/ml were created and 5 l of these 
samples were added in triplicate to a 96-well plate. 25 l of “reagent A” and 200 l of “reagent 
B” were then added to the BSA standards. The plate was incubated at room temperature 
(19°C) for 15 minutes to allow full colour development, the plate was then read at 750nm using 
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a Spectrafluor plate reader. The concentrations of the proteins in cell lysates were determined 
against the linear standard curve produced by the BSA protein standards.  
2.3.2 Lysing and collecting whole cell lysates 
 
HOBs were seeded in either 35mm (2 ml complete medium) or 60mm petri dishes (4 
ml complete medium) at a density of 8x104/cm2. Once the cell media had been discarded, the 
cells were then removed using lysis buffer (0.025M Tris, 0.15M NaCl, 0.001M EDTA, 1% 
Nonidet P-40 (NP-40), 5% glycerol; pH 7.4) that was supplemented with 0.2mM PMSF and 
1% protease inhibitor cocktail (P8340) (purchased from Sigma-Aldrich Dorset, UK). After 5 
minutes of incubation at room temperature (19°C) the cell lysates were transferred to 
Eppendorf tubes and centrifuged at 13,000g for 5 minutes at 4°C to pellet the cell debris.  
For the removal of cells bound to the collagen matrix, 75l of cell lysis buffer of the 
following composition was added to each 35mm plate: 1% (v/v) NP-40, 0.5% (w/v) sodium 
deoxycholate, 0.1% (w/v) SDS, 1mM sodium fluoride, 1mM sodium orthovanadate, 2mM in 
EDTA in Tris-HCl (pH 7.4) with freshly added 0.1mM of PMSF and 1% (v/v) protease inhibitor 
complex (PIC). 
To lyse cells, the culture medium was removed from the HOBs seeded on collagen 
matrices before being washed with PBS (pH 7.4). 70 l of the cell lysis buffer outlined above 
was then added to the plates for approximately 5 minutes before collection and then left on ice 
for 30 minutes. The protein concentration was measured using a DC Protein Assay kit (Bio-
Rad, UK) (see 2.3.1). The samples were solubilised in 2x Laemmli buffer (60 mM Tris-Cl pH 
6.8, 2% SDS, 10% glycerol, 5% -mercaptoethanol, 0.01% bromophenol blue) then boiled for 
5 minutes before being loaded onto a gel or frozen at -80°C for storage.  
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2.3.3 Transglutaminase activity assay  
 
 5 µg/ml microbial transglutaminase (Zedira, Germany) was dissolved in 50 mM Tris-
HCl (pH 7.4) buffer before immediate use. The synthetic CBZ-glutaminyl-glycine peptidic 
analogue R281 was used as an irreversible site-directed microbial transglutaminase inhibitor 
at a concentration of 250 µM. To inhibit the enzyme, R281 was incubated with mTG for an 
hour at room temperature (19°C). 
 5 µg/ml recombinant human TG2 (Zedira, Germany) was solubilised in 50 mM Tris-HCl 
(pH 7.4) before being used. 1-155 is a cell permeable irreversible inhibitor of TG2 that targets 
the active site cysteine.  
 The activity assay was based on a modified technique first used by Slaughter et al. 
(Slaughter et al., 1992). First 96-well plates were coated overnight with 50 l N,N’-
dimethylcasein purchased from Sigma-Aldrich Poole, UK (10 mg/ml) per well at 4°C overnight 
or 37°C for 1 hour. The plate was washed three times with 50 mM Tris-HCl, pH 7.4 and then 
blocked with 3% BSA in PBS pH 7.4 (heat inactivated at 78°C), at room temperature (19°C)  
for 30 minutes. The reaction was started by the addition of 100 l of solution containing 
mTG/TG2, 100 µM biotin-cadaverine, 10 mM DTT in Tris-HCl for 1 hour. This is also 
supplemented with 500 µM R281/ 25 M 1-155 inhibitor for the negative control. After this 
incubation the samples were washed three times with TBS-Tween 20 then blocked with BSA 
blocking buffer at 37°C for 30 minutes in a humidified incubator. Blocking buffer was made up 
of 3% BSA in Tris-HCl (w/v) pH 7.4 which was heat inactivated (78°C for 3 minutes). Afterwards 
100 l of ExtrAvidin® peroxidase conjugate [diluted 1:1000 in blocking buffer (3% w/v BSA in 
Tris-HCl pH 7.4)] was added to the samples for 1 hour. After a further three washes with TBS-
Tween 20, the reaction was developed using 100 μl per well SIGMAFAST o-phenylenediamine 
dihydrochloride (OPD) tablets (Sigma-Aldrich, UK) dissolved in 20 ml dH2O, with a final 
concentration of 0.4mg/ml. The colour development was terminated by addition of 50 μl of 3M 
HCl and the absorbance was read at 490 nm using a plate reader.  
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2.4 Collagen purification and assays 
 
2.4.1 Isolation and purification 
 
 Type I collagen was sourced in house by dissecting tendons from rat tails and 
dissolving them in 0.02M acetic acid, which was then left to stir constantly at 4°C overnight. 
The solution was centrifuged at 4000g for 3 hours at 4°C to remove insoluble non-collagenous 
material before the pH of the solution was neutralised to pH 7 by adding 1M NaOH to the 
solution with gentle stirring. This adjusted solution was stirred for 2 hours at 4°C which allowed 
for the collagen to precipitate. The final step was to centrifuge the suspension at 4000g for 40 
minutes at 4°C. The resulting collagen samples were solubilised in 0.2M acetic acid and the 
suspension was stirred at 4°C overnight. 
2.4.2 Collagen concentration assay 
 
 SircolTM soluble collagen assay (purchased from Bioclolor life science assays) was 
used to calculate the concentration of collagen from the neutralised collagen solution. 
Following the instructions, a reagent blank was first made up using 0.2M acetic acid. Aliquots 
of 5, 10 and 15 g were created for the collagen reference standard curve also made up in 
0.2M acetic acid. 1:10, 1:50, 1:100 and 1:1000 dilutions of purified collagen were then made 
up to individual 100 l samples to be tested. To each sample 1 ml of Sircol dye reagent was 
added to fully saturate the collagen within the 100 µl samples (including reagent blanks and 
standards).  
 Samples were incubated on a vertical shaker platform for 30 minutes so that a collagen-
dye complex could form and precipitate. Samples were then spun in a micro centrifuge at 
12,000 rpm for 10 minutes. Supernatants were then removed by inverting the sample tubes. 
Following this 750 l of ice-cold acid-salt wash reagent was gently layered onto the collagen-
dye pellet in order to remove unbound excess dye. The samples were once again centrifuged 
at 12,000 rpm for 10 minutes before the acid-salt wash was removed. To release the collagen 
bound dye, 250l alkali reagent was added to all samples and vortexed to dissolve all the 
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bound dye. The colour of the sample is light stable and following the manufacturer’s 
instructions all samples were read within 2 to 3 hours. Measurement of absorbance was carried 
out by transferring 200 l of each sample to individual wells of a 96-well plate. A SpectraFluor 
plate reader was used to measure absorbances from all the samples at 550 nm. From the 3 
collagen concentration standards, a standard curve was obtained for collagen samples to be 
measured against.      
2.4.3 Modification of collagen by transglutaminase 
  
 Neutralised collagen was treated with mTG, TG2, 40-60 m 45S5 bioglass (10 mg/ml) 
in various combinations for the investigations. For collagen scaffolds that contained TG2, 5mM 
DTT and 10mM CaCl2 in 10 mM Tris buffer (pH 7.4) were directly added to the neutralised 
collagen along with 10X PBS and dH2O in order to make up a final of volume 2 ml (in a 35 mm 
plate). Stock solutions of 1 mg/ml TG2, 13.1 mg/ml mTG, 1M DTT and 1M CaCl2 were used to 
minimise total volume changes. Both mTG and TG2 were always added to the collagen mixture 
last before being placed in a humidified-atmosphere incubator at 37°C and 5% CO2 overnight.  
2.4.4 Coomassie blue staining of collagen 
 
Native and cross-linked collagen scaffolds were crosslinked overnight on non-treated 
35mm petri dishes before 3x105 HOBs were seeded onto them in complete medium. Following 
the necessary incubation period (humidified incubator at 37°C and 5% CO2) the media was 
discarded and washed once with PBS. Afterwards the collagen scaffolds were stained with 
0.1% Coomassie blue stain solution (G-250) (50% (v/v) methanol; 10% acetic acid; 40% (v/v) 
dH2O). Samples were gently shaken for 5 minutes at room temperature (19°C) before the 
Coomassie blue stain was discarded and the scaffolds were washed three times with distilled 
water.  
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2.4.5 Coomassie blue degradation assay 
 
 Native and cross-linked collagen samples were allowed to polymerise/crosslink 
overnight on non-treated 35mm plates before HOBs  were seeded in complete medium. Plates 
were stored in a humidified incubator at 37°C at 5% CO2 for 3 days. 2 ml complete medium 
replaced every 24 hours to ensure the survival of HOBs. After 3 days the media from each 
plate was discarded and sodium-deoxycholate (0.5%) (w/v) in 10mM Tris-HCl pH 7.4 was 
added to the plates to remove the cells from the collagen matrix. After two washes with distilled 
water, the samples were stained with 0.1% (w/v) Coomassie blue stain solution (50% (v/v) 
methanol; 10% (v/v) acetic acid; 40% (v/v) dH2O). The samples were left for 5 minutes on 
shaker before a final rinse with distilled water. 
 To analyse the stained collagen samples, a GeneBox was used to capture images with 
the UV light setting activated. Processing of images took place using imageJ (Schneider et al. 
2012) by converting the images to 8-bit and carrying out densitometry analyses to generate 
the mean pixel densitometry count.      
2.4.6 Collagen sedimentation  
 
 To study the effects of crosslinking collagen, changes in deamidation and addition of 
bioglass nanoparticles on a macromolecular level, scaffolds were centrifuged as follows: 
Collagen scaffold solutions (10X PBS, distilled water, collagen, Transglutaminase and/or 45S5 
bioglass between 2- 4 ml) were crosslinked in 35mm petri dishes overnight before being 
transferred into 7ml clear screw cap tube (purchased from Falcon, USA). Samples were then 
centrifuged for 15 minutes at 2500rpm. Images were then captured on Nikon Coolpix 5400 
camera. 
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 2.5 Analysis of cell proteins 
 
 
2.5.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
 
 The gels used consisted of two layers; a separating gel with a final acrylamide 
concentration of 5.5-10% (w/v) and a 4% (w/v) stacking gel. These were made from a 30% 
stock solution of acrylamide (w/v) and 0.8% (w/v) N-N’-methylene bisacrylamide. For the 
stacking gels, Tris-SDS (pH 6.8) was used (0.5M Tris HCl containing 0,4% SDS), whereas the 
separating gels consisted of a Tris-SDS solution where the pH was 8.8 (1.5M Tris HCl 
containing 4% SDS). 10% ammonium persulfate and TEMED were also added to the solutions 
last before being loaded onto the glass loading plate. Table 2.1 below describes the volumes 
used: 
 
Table 2.1: The recipes for different concentrations of acrylamide in separating gels 
Stock 
Solutions 
Final acrylamide concentration in the separating gel (%) ml 
5 6 7 7.5 8 9 10 12 13 15 
30% 
acrylamide/ 
0.8 
bisacrylamide 
2.5 3.00 3.50 3.75 4.00 4.50 5.00 6.00 6.50 7.50 
4X Tri-HCl 
SDS (pH 8.8)  
3.75 3.75 3.75 3.75 3.75 3.75 3.75 3.75 3.75 3.75 
dH2O 8.75 8.25 7.75 7.50 7.25 6.75 6.25 5.25 4.75 3.75 
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 To ensure that the gel’s top surface was flat and even, 1ml of propan-2-ol was overlaid 
on top of the separating gel which was then allowed to crosslink for approximately 1 hour at 
room temperature (19°C). Following crosslinking the iso-propan-2-ol was removed and the 
surface of the separating gel washed with distilled water before the stacking gel was added. 
The stacking gel consisted of 325µl 30% (w/v) acrylamide and 0.8% (w/v) N-N’-biscacrylamide 
solution, 62.5µl of Tris-SDS pH 6.8and 1.5ml of distilled water, 25l 10% (w/v) ammonium 
persulphate and 5l of TEMED. Aftr mixing the stacking gel solution it was quickly added on 
top of the separating gel and the appropriate comb was inserted to form the sample wells. 
Approximately 45 minutes was required before the stacking gel had crosslinked at room 
temperature (19°C). To run the samples, the gel combs were removed and washed with “1X 
Running Buffer” which consisted of Tris-glycine (pH 8.5) 0.025M Tris and 0.1% (w/v) SDS. 
Sample volumes were normalised against protein concentration (between 50-60µg) and added 
to the same respective volume of 2X Laemmli loading buffer before being loaded onto the 
wells. 5µl of rainbow marker (New England Bio labs) was loaded into each gel also. 
Electrophoresis was carried out at 120V for approximately 75 minutes and terminated when 
the blue marker dye from the Laemmli buffer nearly reached the bottom of the gel. 
 
2.5.2 Western blotting  
 
 First nitrocellulose transfer membranes, blotting pads and absorbent filter paper were 
first pre-soaked with transfer buffer (48.8mM Tris-HCl, 39mM glycine and 20% (v/v) methanol).  
10% 
ammonium 
persulphate 
0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 
TEMED 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
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 Transfer was carried out using a Biorad tank (purchased from Biorad Hertfordshire, 
UK) and power supply which was set to 300mA for 75 minutes in an ice box. After transfer, the 
nitrocellulose membrane was separated from the gel and rinsed gels with water before being 
incubated in blocking buffer (5% (w/v) dried milk powder in PBS pH 7.4) for one hour at room 
temperature (19°C). After this, the respective primary antibody (1:1000 dilution) in blocking 
buffer (outlined above) was added to the nitrocellulose paper and left overnight on a shaker 
platform at 4°C. Blots were washed with 0.5% (v/v) TBS-Tween, pH 7.4, four times. A species 
specific secondary HRP conjugated antibody in blocking buffer (1:1000 dilution) was then 
added to the blot for 2 hours at room temperature (19°C) on a shaker-platform. Subsequently, 
the blot was washed with 0.5% (v/v) TBS-Tween. Development was carried out using ECL 
chemiluminescence substrate which reacted to the HRP conjugate of the secondary antibody. 
Excess ECL was removed before the blot was covered in cling film and the light emission was 
detected using a SynGene GeneBox. 
 
2.5.3 Membrane stripping      
 
 The membranes were then re-probed for -actin as a loading control. To do this the 
nitrocellulose blots were washed in TBS Tween 20 and then incubated with stripping buffer 
(62.5 mM Tris-HCl (pH 6.7), 2% SDS (w/v) and 100 mM 2-mercaptoethanol) at 50°C for 30 
minutes. The Western blot method outlined above (2.5.3) was then carried out after the 
membranes had been incubated for one hour in blocking buffer. 
 
2.6 Determination of cell behaviour 
 
2.6.1 Cell proliferation 
 
 The proliferation of 2 x 104 HOBs (either with or without treatment/ crosslinking enzyme) 
was measured in 96-well plates using XTT reagents which changes colour according to the 
redox state of the solution. These reagents were mixed prior to being added to the samples 
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which were then incubated at 37°C in 5% CO2/ for four hours. Following this, 100l of the 
culture supernatant from each sample well was transferred to a new 96-well flat bottomed plate 
and the orange coloured solution was quantified using a plate reader where the absorbance 
was measured at 490 nm (and the reference wavelength at 750 nm). 
2.6.2 Mineralisation of HOB cultures 
 
 2 x 104 HOBs in 100 µl DM were cultured in 96-well plates. Either on tissue culture 
plastic, native collagen, mTG cross-linked, TG2-crosslinked and incubated at 37°C in 5% CO2 
for up to 10 days with regular change of medium every 48 hours. After 10 consecutive days 
post addition of differentiation medium (10% FBS, 50 g/ml Ascorbic acid, 10 mM -
glycerophosphate in DMEM) the mineralised bone matrix was then visualised using von Kossa 
staining. Using this method silver ions replace calcium in the matrix to form a precipitation 
complex with phosphate groups. Samples were washed with distilled water, fixed in 3.7% 
paraformaldehyde for 30 minutes and then dehydrated in 70% ethanol for 1 hour. Following 
this the dehydrated samples were washed with distilled water before 2% silver nitrate (Sigma-
Aldrich Poole, UK) was added to them. Samples were then exposed to UV light for 20 minutes, 
washed with distilled water five times and fixed with 5% sodium thiosulphate (Sigma-Aldrich 
Poole, UK) for 3 minutes. After a final wash with distilled water the samples were viewed at 
10X and 40X magnification using a Nikon CK2 microscope. Images of non-overlapping fields 
were then photographed before they were converted into negative images. Using these 
negative images mineralisation areas were then quantified using Image J software (Schneider, 
et al. 2012).  
 
2.7 Using SEM to analyse crosslinked surface topography 
 
 
 Following the overnight crosslinking of collagen scaffolds (method outlined above), 
complete medium was used to wash each scaffold and it was allowed to air dry. Following this, 
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the collagen samples were freeze dried for 24 hours. This involved cooling the samples to -
20°C at a constant cooling rate of 1°C/min and holding samples at this temperature for 20 
minutes to allow the scaffolds to freeze. The temperature was then increased to -10°C and 
held for 7 hours. The final step was to remove any water crystals by sublimation, the 
temperature was increased to 0°C for 17 hours at 200 mTorr.  Once the collagen scaffolds 
were completely dried, the samples were then sputter-coated with gold and for SEM 
observation with the kind help of Prof M Salhawa.  
 
2.8 Collagen staining assay 
  
In order to detect and stain for collagen deposition in the ECM, a Silver Quest collagen 
staining kit (purchased from Invitrogen) was used. First, 3x105 HOB cells were seeded onto 
35mm petri dishes for 10 days with differentiation medium (media changes every 48 hours). 
After 10 days the medium was discarded from each plate and cells were washed with PBS. 
Cells were then manually scraped with 500 l PBS before 0.1 mg/ml pepsin (50mM acetic 
acid) was added to the samples. Samples were left in a shaking incubator at 37°C for 2 hours 
before the medium was collected in an Eppendorf tube. Neutralising solution (200 mM Tris and 
150 mM NaCl in distilled water) was added to each sample and centrifuged at 12,000g for 10 
minutes. After the supernatant was discarded, samples were denatured using 6X Laemmli 
buffer and boiled for 5 minutes. These samples were then analysed by SDS-PAGE using a 5% 
separating gel.  
 Following electrophoresis, the gel was removed from the cassette and rinsed briefly in 
distilled water. Each gel was then fixed using 100 ml of fixative solution (prepared according 
to the Silver Quest kit instructions) and incubated for an hour at room temperature (19°C) on 
a shaker overnight at 4°C. The fixative solution was discarded before being washed in 30% 
ethanol for 10 minutes. Following this wash, 100 ml of “sensitising solution” was added to the 
gel for 10 minutes (to allow protein bands to bind to silver ions). Once the sensitising solution 
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was decanted the gel was washed again using 30% ethanol followed by a 10 minute wash with 
distilled water. The gels were then stained using the kit’s “staining solution” for 15 minutes. 
Once the gels had been sufficiently stained, the solution was decanted and washed with 
distilled water for 30 seconds. After this, the distilled water was discarded, 100 ml of developing 
solution was added to each gel for 8-10 minutes until the desired band intensity was achieved.  
 Once the bands became visible, 10 ml of “stopper solution” was immediately added to 
the gel which was still immersed in developing solution. Gels were gently agitated until a colour 
change from pink to colourless appeared. The inactivated developing solution was then 
decanted and washed with distilled water for a final time for 10 minutes.  
 Gels were then imaged using a Syngene GeneBox with the UV light setting activated, 
images that were captured were then analysed using ImageJ densitometry analysis software. 
 
2.9 Sub cellular fractionation protocol  
 
 3x105 HOBs were seeded onto 35 mm petri dishes and grown using differentiation 
medium for 2, 3, 4, or 6 days with media changes every 24 hours. At the appropriate time point, 
media was discarded from the petri dish and cells were washed with PBS. Using 1 ml of ice 
cold PBS, cells were gently scraped off using a cell scraper. If HOBs were grown on collagen 
scaffolds then 0.125% collagenase (from type III from Clostridium histolyticum, purchased from 
Invitrogen Paisley, UK) was used to degrade collagen. Cells were centrifuged for 5 minutes at 
300g and the pellet was discarded.  
 A whole lysate sample (of 20 l) of cell/PBS solution was aliquoted and added to an 
equal volume of cell lysis buffer and a protein concentration assay was carried out on the 
sample as outlined above. A protein concentration assay was also carried out on the remaining 
cell/PBS solution. Using the sub-cellular fractionation kit (Thermo Scientific Massachusetts, 
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USA) cytoplasmic extraction buffer (CEB) was then prepared using 0.1mM PMSF and 1% 
protease inhibitor cocktail according to the kit’s instructions.  
Cell/PBS solution was added to the CEB solution and mixed for 7 minutes at 4°C. 
Following this the samples were centrifuged at 500g for 3 minutes at 4°C. The supernatant 
was removed and stored on ice before each pellet was washed three times with ice cold PBS.  
The pellets were then vortexed and suspended in ice cold “membrane extraction buffer” 
(MEB) which was prepared with 0.1mM PMSF and 1% PIC according to the kit’s instructions. 
The samples were then gently mixed for 10 minutes at 4°C before the samples were 
centrifuged at 3000g for 5 minutes at 4°C. After this the supernatants were removed and stored 
on ice.  
Pellets were washed three times with ice cold PBS before being re-suspended in 
“nuclear extraction buffer” (NEB) with 0.1 mM PMSF and 1% PIC as per the kit’s instructions. 
The samples were then incubated with gentle shaking at 4°C for 30 minutes before being 
centrifuged at 5000g for 5 minutes. The final supernatant was then removed and stored on ice. 
The concentrations of the three sets of sub-cellular fractions: cytoplasmic, membrane-bound 
and nuclear were then measured using the Lowry method as described in section 2.3.1.  
 
2.10 Amino acid analysis of crosslink proteolytic digestion for crosslink 
analysis 
 
 Collagen samples were crosslinked overnight in 35mm untreated petri dishes before 
being transferred to 2 ml screw cap Eppendorf tubes and boiled for 10 minutes. Afterwards the 
samples were cooled before 0.01 mg/ml collagenase sourced from Clostridium histolyticum in 
0.1M ammonium hydrogen carbonate pH 8 for 24 hours at 37°C with gentle shaking. Following 
this, 3 consecutive additions of subtilisin (0.01 mg/ml in ammonium hydrogen carbonate) were 
added once every 24 hours. 0.015 mg/ml pronase (in ammonium hydrogen carbonate, pH 8) 
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was then added to the samples for 24 hours before being boiled for 15 minutes. Following this 
there were two consecutive leucine aminopeptidase and prolidase additions, every 24 hours. 
The final step was to add 0.01 mg/ml carboxy peptidase Y (in ammonium hydrogen carbonate) 
for 24 hours at 30°C with gentle shaking.   
Samples (10-100 μl) were mixed with an equal volume of loading buffer (0.2M lithium 
citrate, 0.1% phenol pH 2.2) and loaded onto a Biochrom 30 amino acid analyser physiological 
system using lithium buffers (Biochrom, UK). Buffers 1-6 were obtained from Biochrom. A 
modified separation method was used (Table 2.2) and detection was by ninhydrin. Dipeptide 
was determined by addition of known amounts of ε (γ-glutamyl)lysine to the sample and 
comparing peak areas. 
 
  
Table 2.2: A series of lithium buffers used during the amino acid separation phase 
 
TIME (min) BUFFER COLUMN 
TEMPERATURE 
0-9 1 25°C 
9-32 2 25°C 
32-67 3 25°C 
67-107 3 25°C 
107-123 6 75°C 
123-135 1 75°C 
135-147 1 65°C 
147-159 1 35°C 
159-171 1 25°C 
 
2.10.1 Ammonia analysis 
 
 Using ammonium hydroxide standards, collagen samples were allowed to crosslink for 
2 hours before being centrifuged for 15 minutes at 2500rpm. The collagen pellet was then 
discarded and the 50 µl of the supernatant was loaded at a concentration of 1:1 with loading 
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buffer and run on the Biochrom 30 amino acid analyser using the standard method. A set of 
ammonia standards were created from a stock solution of ammonia bicarbonate and used to 
quantify the amount of ammonia released.  
 
 
2.11 Statistical analysis 
 
 For normally distributed multiple data comparisons, one-way and two-way ANOVA 
tests were used followed by Bonferoni post-hoc test.  Results were expressed as mean ±SD. 
Where the statistical significance between control and treated samples were evaluated at a 
95% confidence level (p<0.05), the data set would be considered to be statistically significant 
and represented with a *, ** or *** above the bars. The calculations were performed using 
Graphpad Prism 5 statistical package (Graphpad Software, La Jolla California USA). 
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Chapter 3: Characterisation of novel type I 
collagen scaffolds generated using 
transglutaminases 
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3.1 Introduction 
 
 Due to the ubiquitous expression of TG2 throughout the body and its involvement in 
various tissue developmental and wound healing processes, it is possible that  TG2 modified  
biomaterials could be beneficial for wound healing. Futhermore, the crosslinking effects  of 
mTG,has still not been fully explored for its potential in enhancing bone tissue mineralisation.  
 Organic bone matrix is mostly comprised of type I collagen (~90%) and, as stated 
previously, is a well-known TG2 substrate in mineralised tissue. Regarding extracellular 
collagen, polymerisation could take place via intermolecular crosslinking (Chau et al., 2005) or 
between non-collagenous bone matrix proteins and collagen (Mosher et al., 1979). A well -
organised fibrillar collagen network forms the foundation of mineralisation, and 
transglutaminases are suggested to play a role in fibre organisation through their crosslinking 
ability (Collighan and Griffin, 2009). Evidence has also shown that transglutaminases can 
promote collagen synthesis and assembly, which leads to the promotion of cell differentiation 
(Al-Jallad et al., 2006). On the whole, TG2 promotes mineralisation in osteoblasts, promotes 
matrix protein secretion, deposition and maturation through crosslinking-mediated modification 
of the ECM, which further enhances cell attachment. By incorporating transglutaminases as 
well as 45S5 bioglass it may be possible to create a novel collagen scaffold that allows for an 
increased rate of bone regeneration. Along with 45S5 bioglass, bioglass incorporating cobalt 
ions was also tested. Cobalt ions are released in certain glass scaffolds in order cause a 
decrease in oxygen in the wound defective bone site.  When hypoxia occurs, a cascade of 
processes is initiated that results in the production of new blood vessels (Jones, 2015). 
 The aim of this chapter was to evaluate whether any crosslink bonds could be detected 
in the “in house prepared type I collagen” and assess the micro and macromolecular 
differences of crossliked collagen scaffolds. In addition to test whether the R281 and 1-155 
inhibitors are effective at the inhibiting ability of transglutaminases to form crosslinks between 
collagen strands. This is so that the inhibitors can be used as controls to separate the effects 
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of transglutaminase protein from transglutaminase activity. Secondly, to observe the effects of 
crosslinking collagen with TG2 and mTG on a macro and micromolecular level using 
sedimentation (via centrifugation) and scanning electron microscopy. Finally to investigate how 
human osteoblast cells interact with the native, crosslinked and collagen scaffolds mixed with 
45S5 bioglass.    
 
 
3.2 Characterisation of transglutaminase inhibitors, type 1 collagen and 
optimisation of collagen crosslinking  
 
3.2.1 Assessment of type I collagen purity 
 
 In order to test the purity of the collagen that is sourced and purified in house, SDS 
polyacrylamide gel electrophoresis (PAGE) was carried out (Figure 3.1). Using a 5% 
acrylamide gel (see Materials and Methods), the 1 and 2 chains (with N and C terminal sites 
cleaved) are present at the expected sizes of 130 and 115kDa. Type I collagen is a 
heterotrimer of two 1 and one 2 chain, where there is double the number of 1 chains 
compared to 2 chains which is why the band at 130kDa is double the size of the 115kDa 
band.  
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Figure 3.1: Coomassie blue stain for type 1 collagen following separation by 
SDS PAGE: A) Here the denatured α1 and α 2 chains are visible close together. 
0.19 mg of collagen was loaded onto the well before PAGE was carried out as 
stated in the Materials and Methods. B) Western blot for type I collagen that is 
purified and sold by Sigma Aldrich which has the same corresponding α bands. 
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3.2.2 Assessing the concentration of 1-155 required to inhibit TG2 
 
 1-155 is a cell permeable, irreversible inhibitor that is a substrate analogue that binds 
at the active site to selectively inhibit TG2 activity (Zonca et al., 2017) and has been reported 
by Moro et al. to selectively inhibit TG2 activity. In Figure 3.2  it is been shown to inhibit almost 
all TG2 activity at a concentration of 25 M, which is similar to what has been reported in the 
literature (Zonca et al., 2017).  
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Figure 3.2: TG2 inhibition activity assay. TG2 activity with varying concentrations of 1-155 
was measured through biotin cadaverine incorporation assay as described in the materials and 
methods chapter. 5 µg/ml TG2 treated without 1-155 was used as a positive control and a 
sample without any TG2 was used as a negative control. The data represents mean values +/- 
SD where n=3. Statistical analysis was carried out using a one way ANOVA test where the 
inhibition of TG2 samples was compared against a negative control. P-values corresponding 
to P< 0.001 are represented with a ***. 
 
 
 
 
 
 
 
 
 
 
0.0
0.5
1.0
1.5
Positive control
Negative control
50nM
25nM
10nM
5nM
2.5nM
1nM
***
***
***
Activity assay samples
A
b
s
o
rb
a
n
c
e
 (
4
9
0
-6
3
0
n
m
)
88 
 
3.2.3 Assessing the concentration of R281 required to inhibit mTG 
 
 R281 is a non-cell-permeable inhibitor that has been reported by Zonca et al. to inhibit 
both TG2 and mTG. In Figure 3.3 it is shown that R281 can inhibit mTG activity when incubated 
with the enzyme between 250-500 µM.  
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Figure 3.3: R281 inhibition activity assay. mTG activity with varying concentrations of R281 
was measured through biotin cadaverine incorporation assay as described in the materials and 
methods chapter. 5µg/ml of mTG treated without R281 was used as a positive control and a 
sample without any mTG was used as a negative control. The data represents mean values 
+/- SD where n=3. Statistical analysis was carried out using a one way ANOVA test where the 
inhibition of mTG samples was compared against a negative control. P-values corresponding 
to P< 0.001 are represented with a ***. 
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3.2.4 Dependence of TG2 activity on reduction by DTT 
 
 For TG2 to actively form crosslinks, it must be activated by Ca2+ ions and be reduced 
by a reagent such as 1-4, dithiothreitol (DTT). However in high concentrations of DTT can be 
toxic to cells and therefore it should be used at low concentrations As expected, the higher the 
concentration of DTT in a sample, the higher the observed absorption. Since high 
concentrations of DTT are toxic, 5mM DTT was chosen to reduce TG2 in collagen scaffolds.  
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Figure 3.4: DTT activity assay.  TG2 activity with varying concentrations of R281 was 
measured through biotin cadaverine incorporation assay as described in the materials and 
methods chapter. 5µg/ml of mTG treated without R281 was used as a positive control and a 
sample without any mTG was used as a negative control. The data represents mean values 
+/- SD where n=3. Statistical analysis was carried out using a one way ANOVA test where 
the absorbance of samples were compared against a blank control. P-values corresponding 
to p< 0.05 are represented with a * and where p<0.01 are represented with a **. 
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3.2.5 The effect of collagen pH on TG2 activity  
 
 Due to the collagen solution being solubilised in 0.2 M acetic acid, the pH must be 
neutralised from 5 to 7 in order for enzymes such as TG2 to be stable and functional. To 
determine the effect of pH on TG2, a biotin cadaverine activity assay was carried out to 
ascertain the optimum pH that yields the highest level of TG2 activity. Figure 3.5 shows that 
collagen neutralised to pH 7 gave the highest activity, which is also reported in the literature 
(Fleckenstein et al., 2002) 
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Figure 3.5: TG2 pH activity assay. After 5µg/ml of TG2 was added to collagen solutions of 
varying pHs a biotin cadaverine incorporation assay was carried out as described in the 
materials and methods chapter.  A sample without any TG2 was used as a negative control. 
The data represents mean values +/- SD where n=3. Statistical analysis was carried out using 
a one way ANOVA test where the absorbance of samples were compared against a blank 
control. P-values corresponding to p<0.01 are represented with a **. 
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3.3 Effect of transglutaminase cross-linking on collagen properties  
 
3.3.1 Observing the macromolecular effects of mTG and TG2 crosslinked collagen  
 
To observe the effects of crosslinking collagen on a macromolecular scale, 2.5 mg/ml 
collagen was allowed to crosslink overnight in untreated 35 mm plastic plates and then 
collected into individual 7 ml bijou tubes and centrifuged for 15 minutes at 1500 g. Figure 3.6 
shows the difference in the overall structure that is seen between cross-linked and non-cross 
linked collagen. The native collagen sample shows that the collagen had not been sedimented 
and floated even after the centrifugation process. The second sample from the left contained 
an R281 inactivated form of mTG which is why it looks similar to the native collagen sample. 
The third sample is of the activated mTG and the crosslinked collagen is much more compact 
and sedimented, which sits at the base of the bijou tube. Likewise, the TG2 crosslinked 
collagen is also more compact and dense than the non-crosslinked samples. 
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Figure 3.6: Image of centrifuged collagen samples. 4 ml collagen samples were 
crosslinked overnight before being collected and centrifuged for 10 minutes at 1500g. 
The concentration of all collagen samples was 1mg/ml, from right to left: A) Native 
collagen, B) inactive mTG crosslinked collagen, C) mTG crosslinked collagen and D) 
recombinant human TG2. Data are representative of one experiment where n=3. 
A                           B                        C                      D 
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3.3.2 Observing the macromolecular effects of TG2 crosslinked collagen without 
calcium and DTT  
In Figure 3.7, the effects of subtracting calcium and the reducing agent DTT from the 
TG2 collagen solution is shown. Both of these are needed for TG2 transamidating activity as 
discussed in chapter 4. The collagen solution was allowed to crosslink overnight in untreated 
35 mm plastic plates and then collected into individual 7 ml bijou tubes before the samples 
were centrifuged for 15 minutes at 1500g. Once again there is a difference between the native 
collagen and the TG2 sample. TG2 samples without calcium and DTT show a similar 
macromolecular structure to the native collagen. Their sediments are less compact than the 
TG2 sample that contains the calcium and DTT.  
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Figure 3.7: Image of centrifuged collagen samples. 2.5 mg/ml collagen samples were 
crosslinked overnight before being collected and centrifuged for 15 minutes at 1500 g. 
The concentration of all 2 ml collagen samples was 2.5 mg/ml, from left to right: Native 
collagen, TG2 crosslinked collagen, TG2 crosslinked collagen without calcium and TG2 
crosslinked collagen without DTT. Data are representative of one experiment where 
n=3. 
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3.3.3 SEM imaging of collagen scaffolds 
 
SEM images shown in Figure 3.8A and 3.8B are of a 2.5 mg/ml sample of native 
collagen which were taken at 96X and 390X magnification, respectively. Figures 3.8C and 
3.8D are SEM images of mTG crosslinked collagen (at 96X and 390X respectively) and 3.8E 
and 3.8F are images of TG2 crosslinked collagen (at 96X and 390X respectively). The 
difference in morphology between all three collagen samples is striking in respect to the gaps 
(in black) between collagen fibres (white). Between Figure 3.8A, 3.8C and 3.8E the gaps 
between the strands become narrower due to the crosslinking effect. Interestingly Figures 3.8E 
and 3.8F show a different structure altogether as the collagen fibrils have lost their definition 
and pores are no longer visible between fibrils. 
By using ImageJ software, the space between collagen fibres in each image taken at 
96X magnification was measured and averaged. By quantifying the mean pore size, it was 
possible to quantify which collagen samples had the shortest and longest average space 
between their respective collagen strands (Figure 3.8G).    
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Figure 3.8: SEM images of native and crosslinked collagen: A) Collagen samples were 
crosslinked overnight before being collected and centrifuged for 15 minutes at 1500g. The 
concentration of all collagen samples was 2.5 mg/ml, from left to right: native collagen, TG2 
crosslinked collagen, TG2 crosslinked collagen without calcium and TG2 crosslinked collagen 
without DTT. B) SEM image of 2.5 mg/ml native collagen at 96X magnification C) SEM image 
of 2.5mg/ml native collagen at 390X magnification D) SEM image of 2.5 mg/ml mTG 
crosslinked collagen at 96X magnification E) SEM image of 2.5mg/ml mTG crosslinked 
collagen at 390X magnification F) SEM image of 2.5 mg/ml TG2 crosslinked collagen at 96X 
magnification G) SEM image of 2.5 mg/ml TG2 crosslinked collagen at 390X magnification. H) 
SEM images were analysed using ImageJ and the average pore size was measured and 
plotted. The data represents mean values +/- SD where n=3. Statistical analysis was carried 
out using a one way ANOVA test where the size of collagen pores were compared against 
those of the native collagen sample. P-values corresponding to p< 0.01 are represented with 
a ** and where p<0.001 are represented with a ***. 
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3.3.4 SDS PAGE of native mTG and TG2 crosslinked collagen 
 
In order to further show crosslinking is taking place in the collagen scaffolds (2.5 
mg/ml), crosslinked samples were allowed to crosslink overnight and separated  by  SDS 
PAGE then stained using Coomassie brilliant blue dye to identify the presence of the bands. 
In Figure 3.9 there is a significant difference in the bands between the crosslinked collagen 
and the native collagen bands. Due to the crosslinking effect, the bands in the crosslinked 
samples are thicker and therefore remain in the loading gel. Furthermore, the  bands in the 
crosslinked collagen samples are less visible compared to those in the native and 
transglutaminase inhibited bands.  
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Figure 3.9: Observation and quantification of native and crosslinked collagen bands A) 
Native and cross linked collagen samples (2.5mg/ml) were allowed to crosslink overnight in 
96well plates. A 5.5% bis-acrylamide gel was used to carry out a western blot then stained 
with Coomassie blue dye. The image was taken from a GeneBox using GeneSys software. B) 
Using ImageJ software, the image was converted and bands were analysed. The data 
represents mean values +/- SD where n=3. Statistical analysis was carried out using a one 
way ANOVA test where the mean pixel densitometry values of crosslinked collagen scaffolds 
were compared with those given by native collagen scaffolds. P-values corresponding to 
P<0.01 are represented with a **. 
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 3.3.5 Determination of the (γ-glutamyl)lysine content of TG cross-linked collagen 
 
In order to prove that the (-glutamyl) lysine isopeptide bond or “crosslink” is being 
formed, samples of collagen scaffold were digested and analysed. To measure the presence 
of crosslink various samples of collagen including: native collagen, 10 g and 50 g of TG2, 5 
g of mTG that were added to collagen, R281 inactivated mTG and 1-155 inactivated TG2 
were exhaustively proteolytically digested. The digestion process is outlined in the Materials 
and methods chapter and the analysed results using a Biochrom 30 amino acid analyser are 
shown in Figure 3.10. The collagen sample that contained 5 g of mTG gave the highest 
amount of crosslink per nmol of collagen. Followed by the samples of collagen that contained 
50 g and 10 g of TG2 respectively. The inactivated mTG and TG2 samples contianed almost 
no crosslink, as did the native collagen sample. 
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Figure 3.10: Amino acid analyser crosslink assay. 100µl of digested collagen (per sample) 
was loaded in a 1:1 ratio with lithium loading buffer and loaded onto the amino acid analyser. 
Hydroxyproline and ε(-glutamyl) isopeptide bond standards were also ran on the analyser so 
that standard curves could be created for the respective samples. From the standard curves 
the amount of crosslink per nmol of collagen was then calculated. The data represents mean 
values +/- SD where n=3. Statistical analysis was carried out using a one way ANOVA test 
where the nmol of crosslink per nmol of collagen present in crosslinked scaffolds is compared 
to the base amount of crosslink found in native collagen. The p-values corresponding to P< 
0.001 are represented with a ***. 
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3.3.6 Effect of pH on the deamidation activity of TG2 
 
TG2 has been described as a Swiss army knife given its many functions, including 
crosslinking and deamidation. To measure how much deamidation is occurring at different pH 
levels, three collagen scaffolds that contained 5g/ml TG2 were crosslink at pH 5, 6 and 7. To 
measure the amount of deamidation, samples were analysed through the amino acid analyser 
to detect the amount of ammonia released. Figure 3.11 shows that the negative control of 
native collagen gave the least amount of ammonia and the sample of collagen containing TG2 
at pH 6 gave the highest concentration of ammonia. Due to the acidic conditions at pH 5, the 
enzyme is likely to denature which may explain the reduction of ammonia released. 
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Figure 3.11: Observation of different pH level collagen scaffolds and deamidation assay 
for collagen scaffolds: A) Image of centrifuged collagen samples. 2.5 mg/ml collagen 
samples were crosslinked overnight before being collected and centrifuged for 15 minutes at 
1500g. The concentration of TG2 in all collagen samples was 5 µg/ml. From right to left: pH 5, 
pH 6 and pH 7.B) After the collagen samples were crosslinked overnight. Samples were 
centrifuged and 100 µl of supernatant (per sample) was loaded in a 1:1 ratio with lithium loading 
buffer and loaded onto the amino acid analyser. A set of ammonia standards were also run on 
the analyser so that a standard curve could be created for the respective samples. From the 
standard curve the nmol of ammonia released per nmol of collagen loaded per sample was 
then calculated. The data represents mean values +/- SD where n=2. Statistical analysis was 
carried out using a one way ANOVA test where the p-values corresponding to P< 0.001 are 
represented with a ***. 
A) 
B) 
pH 5               pH 6                pH 7 
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3.4 Cellular response of HOB cells to native and crosslinked collagen 
 
3.4.1 Proliferation of human osteoblasts on native and crosslinked collagen 
 
An XTT proliferation assay was carried out to observe the difference between the viable 
cell number of HOBs after growth on native collagen, mTG crosslinked collagen and TG2 
crosslinked collagen. 20 x104 HOBs cultured in 100 µl complete medium (CM, 10% foetal 
bovine serum in Dulbecco’s Modified Eagle Medium) were seeded onto native collagen coated 
wells (2.5mg/ml), mTG crosslinked collagen wells and TG2-crosslinked collagen. Samples 
proliferated over the course of 6 days and the absorbances were measured at 490 nm and 
630 nm.In Figure 3.12 the day 2 samples all showed relatively similar proliferation rates, 
however after 4 days osteoblasts grown on mTG and TG2 crosslinked collagen had a far higher 
rate of proliferation than cells on native collagen. Three days post seeding the proliferation of 
HOBs grown on TG2 on average still remained higher than the other samples. This suggests 
that HOBs mitochondrial/metabolic activity can increase over time on collagen scaffolds.   
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Figure 3.12: XTT proliferation assay for native and crosslinked collagen. HOBs seeded 
onto the different collagen matrices were monitored between day 2 and day 6 (post seeding) 
after they had been seeded onto a 96-well plate. The three conditions in which HOBs were 
seeded (from left to right) are: Native collagen, mTG crosslinked collagen and TG2 cross-
linked collagen. A Biotek plate reader was used to measure the absorbances of each sample 
at 490nm and 630nm. The absorbance values for these respective wavelengths were 
subtracted and averaged to give the mean absorbance values shown in the graph. The data 
represent mean values +/- SD where n=3. Statistical analysis was carried out using a one way 
ANOVA test where the absorbance of samples from crosslinked collagen samples were 
compared to those from native collagen samples. P-values corresponding to P<0.05 are 
represented with a *. 
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3.4.2 Observing the macromolecular effects of mTG and TG2 crosslinked collagen 
with 45S5 bioglass particles 
 
To observe the effects of crosslinking collagen with 45S5 bioglass on a macromolecular 
scale, 2.5 mg/ml collagen was mixed with 10 mg/ml 45S5 bioglass and allowed to crosslink 
overnight in untreated 35 mm plastic plates and then collected into individual 7 ml bijou tubes 
and centrifuged for 15 minutes at 1500g. Figure 3.13 shows the difference in the sedimentation 
that is seen between cross-linked collagen with 45S5 bioglass and non-cross linked collagen. 
The native collagen sample shows that the collagen had not been sedimented and floated after 
the centrifugation process. The second sample from the left contained uncrosslinked collagen 
with bioglass and sedimented more densely than native collagen. The third sample contains 
mTG crosslinked collagen with 45S5 bioglass which was much more compact and sedimented 
than native collagen. Likewise TG2 crosslinked collagen with 45S5 bioglass is also more 
compact and appears denser than the non-crosslinked sample. 
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Figure 3.13: Image of centrifuged collagen samples with 45S5 bioglass. Collagen samples 
(2 ml) were crosslinked overnight before being collected and centrifuged for 10 minutes at 
1500g. The concentration of all collagen samples was 2.5 mg/ml, from left to right: A) Native 
collagen, B) native collagen mixed with 45S5 bioglass, C) mTG crosslinked collagen+ 45S5 
bioglass, and D) TG2 crosslinked collagen + bioglass. Data are representative of one 
experiment where n=3. 
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3.4.3 Proliferation of human osteoblasts on native and crosslinked collagen containing 
45S5 bioglass particles 
 
An XTT proliferation assay was carried out to observe the difference between the viable 
cell numbers of HOBs after growth on native collagen, native collagen mixed with (10 mg/ml) 
45S5 bioglass, mTG crosslinked collagen mixed with (10 mg/ml) 45S5 bioglass and TG2 
crosslinked collagen mixed with (10mg/ml) 45S5 bioglass. HOBs cultured in complete medium 
(CM, 10% foetal bovine serum in Dulbecco’s Modified Eagle Medium) were seeded onto the 
scaffolds with medium changes every 48 hours. Samples were measured over the course of 
6 days and the absorbances were measured at 490 nm and 630 nm. In Figure 3.14 both the 
native collagen and native collagen with bioglass showed relatively similar absorbances for all 
three time points. However, after 4 days, TG2 and mTG crosslinked collagen with bioglass 
absorbances were greater than that of native collagen. This suggests that crosslinked collagen 
mixed with 45S5 bioglass is not impairing HOB proliferation.   
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Figure 3.14: XTT proliferation assay for native and crosslinked collagen mixed with 45S5 
bioglass. HOBs seeded onto the different collagen matrices were monitored between day 2 
and day 6 (post seeding) after they had been seeded onto a 96-well plate. The four conditions 
in which HOBs were seeded (from left to right) are: Native collagen, native collagen+ 45S5 
bioglass, mTG crosslinked collagen+ 45S5 bioglass and TG2 cross-linked collagen+ 45S5 
bioglass. A Biotek plate reader was used to measure the absorbances of each sample at 490 
nm and 630 nm. The absorbance values for these respective wavelengths were subtracted 
and averaged to give the mean absorbance values shown in the graph. The data represents 
mean values +/- SD where n=3. Statistical analysis was carried out using a one way ANOVA 
test where the absorbance of samples from crosslinked collagen samples were compared to 
those from native collagen samples. P-values corresponding to P<0.05 are represented with 
a *. 
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3.4.4 Stability of crosslinked collagen matrices 
 
 Over time, collagen scaffolds are degraded by cells  seeded onto it via interactions with 
the extracellular matrix and the secretion of MMP 8 and MMP 13 (Lu et al., 2011). After seeding 
collagen with HOBs for 3 days, the effects of collagen degradation can be quantified. Once 
cells were removed from the collagen scaffold, the scaffold was stained as outlined in the 
Materials and Methods section. The stained collagen scaffolds were then imaged using the 
GeneBox. 
Representative collagen plates are shown in Figure 3.15. In each case, the mean pixel 
densitometry value of the collagen plates was higher than in those of both the NC plates and 
the inactivated mTG and TG2 plates, indicating that crosslinking of collagen by mTG and TG2 
stabilises the collagen to cell protease degradation. 
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Figure 3.15: Collagen digestion assay. A) 35 mm non-treated plastic tissue culture plates 
coated with five different types of collagen mixture. From left to right: 1) Native collagen, 2) 
R281 inactivated mTG collagen, 3) 1-155 inactivated TG2, 4) mTG crosslinked collagen (5 
µg/ml) and 5) TG2 crosslinked collagen (5 µg/ml). The samples were sustained using complete 
medium for 3 days and following HOBs removal with sodium deoxycholate, were stained with 
Coomassie brilliant blue stain. Samples were captured using the Syngene GeneBox and 
analysed using ImageJ as described in the Materials and Methods. B) Using ImageJ software, 
the image was converted, and scaffolds were analysed. The data represents mean values +/- 
SD where n=3. Statistical analysis was carried out using a one way ANOVA test where the p-
values corresponding to P<0.001 are represented with a ***. 
B) 
A) NC                                      R281+mTG                                     1-155 + TG2 
 mTG                               TG2                     
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3.4.5 Proliferation of human osteoblasts on native and crosslinked collagen 
containing cobalt bioglass 
 
An XTT proliferation assay was carried out to observe the difference between the viable 
cell number of HOBs after growth on native collagen mixed with 10 mg/ml cobalt bioglass. 
HOBs cultured in complete medium (CM, 10% foetal bovine serum in Dulbecco’s Modified 
Eagle Medium) were seeded onto native collagen coated wells (2.5 mg/ml), with and without 
2% and 4% 10 mg/ml cobalt bioglass. Samples were measured over the course of 6 days and 
the absorbances were measured at 490 nm and 630 nm. In Figure 3.16 all the samples 2 days 
post seeding showed relatively similar proliferation rates; however, after 4 days absorbances 
for the cobalt glass samples began to drop below that of the native collagen samples. By 6 
days post seeding, the proliferation rate for 4% cobalt on average still remained lower than the 
other samples. This shows that cobalt glass particles are not viable for HOB proliferation.   
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Figure 3.16: XTT proliferation assay for native and collagen mixed with cobalt bioglass. 
HOBs seeded onto the different collagen matrices were monitored between day 2 and day 6 
(post seeding) after they had been seeded onto a 96-well plate. The three conditions in which 
HOBs were seeded (from left to right) are: Native collagen, collagen with 2% cobalt bioactive 
glass and collagen with 4% cobalt bioglass. A Biotek plate reader was used to measure the 
absorbances of each sample at 490nm and 630nm. The absorbance values for these 
respective wavelengths were subtracted and averaged to give the mean absorbance values 
shown in the graph. The data represents mean values +/- SD where n=3. Statistical analysis 
was carried out using a one way ANOVA test where the absorbance of samples from 
crosslinked collagen samples were compared to those from native collagen samples. P-values 
corresponding to P<0.05 are represented with a *. 
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3.5 Discussion 
 
One of the first investigations carried out was the confirmation that the type 1 collagen 
which was produced in house was pure using SDS PAGE. The gels were stained with 
Coomassie brilliant blue dye and indicated the presence of bands observed at 130 kDa and 
115 kDa showing the denatured α1 and α2 chains respectively that make up type 1 human 
collagen.  
Activity assays revealed that a concentration of 25 µM and above was enough to 
inactivate 5 µg/ml TG2 in a biotin cadaverine incorporation activity assay. In order to inactivate 
mTG, 1-155 had no effect, and so R281 was used at the concentration reported in the literature 
(Zonca et al., 2017). The effects of omitting calcium and dithiothreitol (DTT) from the TG2 
collagen solution was observed in Chapter 3. Ca2+ is required to activate TG2, while DTT is 
needed to maintain the enzyme in a reduced active form. Studies in Chinese Hamster V79 
cells showed that concentrations of DTT in low doses were not toxic to cells (Held and Melder, 
1987). Using a biotin cadaverine assay, it was found that 10 mM DTT was sufficient to reach 
the same level of activity as 100 mM DTT. The activity of TG2 has long been established to be 
optimal at pH7 (or physiological pH) (Fleckenstein et al., 2002, Gundemir et al., 2012) and this 
was supported by data in this chapter. 
Amino acid analysis indicated there was a low level of ε(γ-glutamyl) crosslinking in the 
proteolytically digested native collagen sample when compared to the 1 nmol crosslinked 
standard sample alone. As expected, there was a significant peak representing ε(γ-glutamyl) 
crosslink in the mTG sample, and when spiked with the ε(γ-glutamyl) standard, it was clear 
that the two peaks had the same retention time, confirming the presence of the crosslink in the 
mTG crosslinked collagen. There was roughly half the amount of nmol crosslink per nmol of 
collagen present in TG2 crosslinked collagen than there was in mTG crosslinked collagen.  
118 
 
Likewise, there also seemed to be significant differences in the SEM images taken of 
the native, mTG and TG2 crosslinked images. The mean pore size area between collagen 
fibrils were also different, even between mTG and TG2 crosslinked collagen. This difference 
in structure could be due to the difference in the nmol of crosslink per nmol of hydroxyproline 
present in the two crosslinked collagen scaffolds. 
In order to observe the visible effects of TG crosslinking on collagen, samples were 
crosslinked overnight in untreated 35 mm plastic plates and centrifuged. The difference in the 
overall structure between cross-linked and non-crosslinked collagen was shown to be 
substantial. The native collagen sample was far less sedimented and floated in the water and 
PBS. The inactive form of mTG appeared very similar to the native collagen sample. The active 
mTG and TG2 samples showed a far more sedimented and compact scaffold that was found 
at the base of the bijou tube. This was confirmed that both TG2 and mTG had having a physical 
effect on collagen, which affected its macromolecular structure. This is confirmed by a previous 
study on collagen fibril modification by atomic force microscopy showing that the rigidity of TG2 
crosslinked collagen is three fold higher than compared to native collagen (Wang & Martin, 
2013).  
 The native collagen in Figure 3.7 was shown to be more sedimented than in Figure 3.6 
most likely due to the concentration of collagen to be 2.5mg/ml instead of 1mg/ml, but there is 
a clear difference between the structure seen between it and the TG2 sample. Centrifuged 
crosslinked collagen samples with 45S5 bioglass were seen to be more sedimented than 
native collagen samples with and without 45S5 bioglass. Similar to the native collagen sample, 
the TG2 samples without calcium and DTT showed a similar macromolecular structure to 
native collagen. 
 This confirms that both Calcium (upon which TG2 is dependent upon to be active) and 
the reducing agent DTT which maintains activity are both needed for the modification of 
collagen fibril structure by TG2. It is well-known that TG2 is calcium dependent with regards to 
its transamidase activity (Verderio et al. 2004) and thus the enzyme alone will have had little 
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crosslinking effect on the collagen without calcium, explaining why it had a similar morphology 
to the native collagen sample. The sample that contained calcium but not the reducing reagent 
DTT also had a similar morphology when centrifuged to the native collagen sample. Thus 
transamidating activity is likely to only be transient until TG2 becomes oxidised, which is why 
it resembles the structure of native collagen (Pinka et al. 2007). 
When observing the deamidation limits of TG2, there was no clear relationship between 
lowering the pH and the amount of ammonia released. In the literature, it was first reported 
that deamination was only favoured by certain conditions like pH conditions under 7 
(Fleckenstein et al., 2002). Recently though, a study has been published that shows that a 
glutamine residue is Hsp20 was specifically demainated while other glutamine residues are 
transamidated (Boros et al., 2006). We have shown that deamidation is low at pH 7, peaks at 
pH 6 and drops at pH 5, likely due to enzyme denaturation. 
The cell proliferation data indicate a clear trend for all samples, showing that as time 
increased so did the number of viable HOBs in each group. This indicates that the inclusion of 
45S5 glass nanoparticles may not be toxic to the cell. However this need to be confirmed by 
more tests such as an LDH assay and other proliferation assays. Moreover, it can be seen that 
the inclusion of glass into the mixture had little effect on the cells grown on native collagen 
since the proliferation rates did not vary. When the glass particles were added to the TG2 
collagen mixture, there was a decrease in proliferation by day 6; up until then, it had been 
higher than the average absorbance for each day for samples without bioglass particles. One 
hypothesis for this is that the HOBs are differentiating and mineralising quicker on this collagen 
scaffold than they are on mTG and native collagen scaffolds. Investigations into the underlying 
mechanisms will be discussed in chapter 5. 
 
 As shown by Akhouayri et al. (2010), Chau et al. (2005) and Ignatius et al. (2005), cells 
that are seeded onto collagen will adhere and interact in the matrix, but also degrade it to some 
degree. Since crosslinking collagen with TG2 is known to improve not only mechanical strength 
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but also its resistance to proteolytic digestion the same was to be expected from mTG 
crosslinked collagen.  
 The mean pixel value, which indicates the amount of collagen still present, was 
repeatedly higher for the mTG crosslinked collagen than that of native collagen and the R281 
inactivated mTG treated collagen. Likewise TG2 samples on average showed 0.25 fold less 
digestion compared to native collagen and 1-155 inactivated TG2 collagen. 
 Finally, a cell proliferation assay was carried out on HOBs that were grown on native 
collagen mixed with 2% and 4% 10 mg/ml cobalt bioglass. After 4 days, a decrease in cell 
proliferation was shown in HOBs seeded on 2% cobalt collagen and an even greater decrease 
was shown in HOBs seeded on 4% cobalt collagen. The decrease in cell viability is likely due 
to the cells becoming hypoxic, leading to the cell death (Jones, 2015). To summarise, there is 
a clear difference in micro and overall structure between native, mTG and TG2 crosslinked 
collagen. As well as a difference in the nmol of crosslink per nmol collagen between mTG and 
TG2 crosslinked collagen samples. 
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Chapter 4: Mineralisation of human osteoblasts 
in novel collagen scaffolds 
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4.1 Introduction 
 
 Throughout the human life span, bone undergoes continuous remodelling, which is a 
response to physiological and mechanical environmental stressors. Essentially bone 
remodelling is made up of two reciprocal activities: the resorption of bone matrix by osteoclasts 
and bone formation by osteoblasts. As stated previously, osteoblasts derive from 
mesenchymal stem cells and orchestrate bone formation under the strict regulation of 
hormones, cytokines and the extracellular environment.  
 It has been well-established in recent decades that transglutaminases play a role in 
matrix maturation, calcification and mineralisation (Yin et al., 2012b). TG2 expression has now 
been found in cartilage, specifically in hypertrophic chondrocytes (Aeschlimann et al., 1993, 
Aeschlimann et al., 1996, Nurminskaya et al., 1998, Johnson and Terkeltaub, 2005), as well 
as in MCT3 pre-osteoblasts (Al-Jallad et al. 2006), primary osteoblasts and human and rat 
osteosarcoma cells. However, the mechanism behind transglutaminase-mediated mineral 
deposition has not been well-established. Nai et al. hypothesised that ECM protein assemblies, 
in the presence of TG2, could participate in matrix stabilisation and in cell adhesion processes 
(Chau et al. 2005, Verderio et al. 1998 & Yeh et al. 2014).  
 Furthermore, the importance of transglutaminase activity in mineralisation was 
demonstrated by Al-Jallad et al. (2006) who showed that, by using transamidase inhibitors, it 
was possible to block mineralisation in mouse pre-osteoblasts in vitro, even though TG2/FXIIIa 
double knockouts mice show no abnormality in bone formation. Therefore, it is hypothesised 
that transglutaminase, mediated differentiation could be transamidase dependent, as several 
bone matrix proteins are also transglutaminase substrates, including type I collagen, 
osteocalcin, osteonectin and vitronectin (Mosher and Schad, 1979, Kaartinen et al. 1997). 
These ECM protein assemblies, in the presence of TG2, could contribute to matrix stabilisation 
and cell adhesion processes (Verderio et al. 1998, Chau et al. 2005, Telci et al. 2008). 
Nurminskaya and Kaartinen (2006) suggested that mineralisation induced by transglutaminase 
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crosslinking activity may involve a complex interplay between extracellular matrix proteins and 
the local calcium concentration in mineralised tissue.  
How human osteoblasts react to being seeded onto TG2 and mTG crosslinked 
collagen is assessed in this chapter. Importantly, it has been shown that HOBs are able to 
differentiate small changes in the distance between collagen fibres (Boccaccini et al., 2010). 
These distances in collagen pore size act as signalling cues, which in turn influence cell 
behaviour and induce migration and matrix production, in this case mineralisation.  
Changes in the extracellular matrix such as the concentration of calcium or pH will 
change how HOBs mineralise, as does crosslinking collagen. This was shown by Chau et al. 
(2005), who showed that TG2 crosslinked collagen matrices allowed more HOBs to attach to 
the scaffold compared to native collagen, suggesting that either more RGD sites (Arg-Gly-
Asp triplicate repeating amino acids on collagen helices) are available on crosslinked 
collagen or that cells are exploiting alternative binding sites via upregulation or alternative 
compensatory mediated binding sites.     
The inclusion of bioglass particles could also yield interesting data in terms of whether 
there is a change in mineralisation rates and if so, how this comes about. This aspect will be 
investigated when cells are seeded onto collagen mixed with bioglass particles; one hypothesis 
is that the leaching of calcium from the glass particles into the ECM could affect mineralisation 
rates. This could lead to an increase in mineralisation as HOBs are stimulated further by 
contact with the HCA layer which has been shown by Hench’s group (Hench et al., 1991) to 
form between the bioglass and cells. 
 
 
 
 
 
 
 
124 
 
 
 
4.2 Characterising the mineralisation of collagen scaffolds with mTG and TG2  
 
4.2.1 Mineralisation of HOBs 
 
 HOBs cultured in differentiation medium (10% foetal bovine serum in DMEM 
supplemented with 50 g/ml ascorbic acid and 10 mM -glycerophosphate) for 0, 6, 8 and 10 
days (represented in graph figures as D0, D6, D8 etc). As shown in Figure 4.1, HOBs cultured 
with this medium began to show mineralisation taking place by day 6 and much more positive 
von Kossa staining by day 10. This suggested that a 10-day differentiation treatment course 
was an appropriate time frame to observe osteoblast mineralisation in vitro and this would be 
a suitable model for assessing the effect of mTG and TG2 treatments on mineralisation (Nai 
et al. 2014).  
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Figure 4.1: Mineralisation of HOBs cultured over 10 days on tissue culture plastic. A) 
HOBs were cultured in differentiation medium for 0-10 days. Calcium deposition in extracellular 
matrix was stained black using Von Kossa staining and highlighted by red arrows. Scale bars= 
200 µm. (as described in the Materials and Methods). B) The results represent the mean 
values of pixel density for images that were taken on a Nikon digital camera and inverted on 
ImageJ. Analysis involved each pixel of the image being graded a value of how black it was 
on a scale of 0-255. The results represent mean values +/- S.D, where n=3. Statistical analysis 
was carried out using a one-way ANOVA test where mean pixel densitometry of HOBs was 
compared to the day 0 sample. The p-values corresponding to P< 0.001 are represented with 
a ***. 
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4.2.2 Effect of mTG and TG2 on mineralisation in HOBs 
 
HOBs were cultured in differentiation medium (10% fetal bovine serum in DMEM 
supplied with 50 g/ml ascorbic acid and 10 mM -glycerophosphate) for 6, 8 and 10 days 
(Figure 4.2). Here, HOBs were cultured with this medium along with 5 g/ml recombinant 
human TG2 or mTG, which was added every 48 hours. This is because media is replaced 
every 48 hours.  Mineralisation rates were significantly higher from D6 onwards for the mTG 
and TG2 samples. By day 10, there was a statistical significance in the difference between 
mineralisation of cells grown with just differentiation medium and those grown with 
transglutaminases added with media changes. 
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Figure 4.2: Mineralisation of HOBs with mTG and TG2 added. (A) HOBs cultured with DM, 
5 µg/ml mTG and 5 µg/ml TG2 were subjected to von Kossa staining on day 6, 8 and 10. The 
mineral depositions were stained in black and for all groups increased from day 6 to 10. By 
Day 10 HOBs with 5 µg/ml TG2 added with each media change gave the most mineralisation. 
Samples were viewed at x10 magnification using a Nikon CK2 and photographed with an 
Olympus DP10 digital camera. Scale bars= 200 µm. (B) The mineralised area was visualised 
by von Kossa staining and positive staining was quantified by ImageJ. The results represent 
mean values +/- S.D, where n=3. Statistical analysis was carried out using a one-way ANOVA 
test where the mean pixel densitometry of cells grown without TGs were compared to those 
with TGs added. The p-values corresponding to P< 0.05 are represented with a *. 
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4.2.3 Mineralisation of HOBs when seeded on mTG and TG2 crosslinked collagen 
 
 HOBs were grown on 2.5 mg/ml collagen scaffolds where 5 µg/ml TG2 and mTG were 
added to the collagen scaffolds before they were crosslinked overnight (see Materials and 
Methods) with differentiation medium changes every 48 hours (DM, CM supplied with 50 μg/ml 
ascorbic acid and 10 mM β-glycerophosphate) for 6, 8 and 10 days (Figure 4.3). Mineralisation 
was determined using von Kossa staining. HOBs grown on crosslinked collagen scaffolds were 
shown to have a statistically significantly higher rate of mineralisation.  
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Figure 4.3: Mineralisation of HOBs when seeded onto mTG and TG2 crosslinked 
collagen. (A) HOBs were seeded onto native, 5 µg/ml mTG and 5 µg/ml TG2 crosslinked 
collagen (2.5 mg/ml) and subjected to von Kossa staining on day 6, 8 and 10. The mineral 
depositions were stained in black and for all groups increased from day 6 to 10. Samples were 
viewed at x10 magnification using a Nikon CK2 and photographed with an Olympus DP10 
digital camera. Scale bars= 200 µm. (B) The mineralised area was visualised by von Kossa 
staining and positive staining was quantified by ImageJ. The results represent mean values 
+/- S.D, where n=3. Statistical analysis was carried out using a one-way ANOVA test where 
the mean pixel densitometry of HOBs on native collagen scaffolds were compared to those 
seeded on crosslinked scaffolds. P-values corresponding to P< 0.05 are represented with a *. 
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4.2.4 Mineralisation of HOBs when seeded onto TG2 crosslinked collagen without 
DTT 
 
The effects of omitting calcium and the reducing agent DTT from the TG2 collagen 
solution was observed in Chapter 3. Both of these are needed for TG2 transamidating activity. 
TG2 in collagen samples without DTT show a similar macromolecular structure to native 
collagen. They are not as sedimented or dense as the TG2 sample that contains the calcium 
and DTT. Here, the ability for HOBs to mineralise when seeded onto TG2 crosslinked collagen 
(without DTT) is shown in Figure 4.4. There was a clear difference as HOBs seeded onto TG2 
collagen scaffolds with DTT included, showing a greater mineralisation compared to its 
counterpart without DTT.  
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Figure 4.4: Mineralisation when HOBs were seeded onto TG2 crosslinked collagen 
without DTT. (A) HOBs were seeded onto native, 5 µg/ml TG2 and 5 µg/ml TG2 without 10 
mM DTT crosslinked collagen (2.5mg/ml) and subjected to von Kossa staining on day 6, 8 and 
10. The mineral depositions were stained in black and for all groups increased from day 6 to 
10. Samples were viewed at x10 magnification using a Nikon CK2 and photographed with an 
Olympus DP10 digital camera. Scale bars= 200 µm. (B) The mineralised area was visualised 
by von Kossa staining and positive staining was quantified by ImageJ. The results represent 
mean values +/- S.D, where n=3. Statistical analysis was carried out using a one-way ANOVA 
test where the mean pixel densitometry of HOBs on native collagen scaffolds were compared 
to those seeded on crosslinked scaffolds. The p-values corresponding to P< 0.05 are 
represented with a *. 
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4.2.5 Mineralisation of HOBs when seeded onto TG2 crosslinked collagen without 
Calcium 
 
In Figure 1.8 the effects of subtracting calcium and/or DTT from the TG2 collagen 
solution was observed. These samples show a similar macromolecular structure to native 
collagen due to the lack of crosslinks between collagen fibres. Calcium is needed for TG2 to 
become activated but to show that inactive TG2 does not affecting mineralisation rates, a 
collagen scaffold that contained TG2 and DTT but no calcium was measured against one with 
TG2 and calcium but no DTT (Figure 4.5). There was a clear difference in HOBs seeded onto 
TG2 collagen scaffolds with calcium versus the samples without calcium. When HOBs were 
seeded onto collagen scaffolds with TG2 and calcium, there was a significantly higher amount 
of mineralisation taking place to that of HOBs seeded onto collagen with TG2 and no calcium 
by day 10, suggesting that TG2 in the active state is required for increased mineralisation to 
occur, most likely due to the enzyme catalysing crosslink bonds between collagen fibres. 
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Figure 4.5: Mineralisation of HOBs when HOBs were seeded onto TG2 crosslinked 
collagen without calcium. (A) HOBs were seeded onto native, 5µg/ml TG2 and 5 µg/ml TG2 
without 20 mM Ca2+ crosslinked collagen (2.5 mg/ml) and subjected to von Kossa staining on 
day 6, 8 and 10. The mineral deposits were stained in black and for all groups increased from 
day 6 to 10. Samples were viewed at x10 magnification using a Nikon CK2 and photographed 
with an Olympus DP10 digital camera. Scale bars= 200 µm. (B) The mineralised area was 
visualised by von Kossa staining and positive staining was quantified by ImageJ. The results 
represent mean values +/- S.D, where n=3. Statistical analysis was carried out using a one-
way ANOVA test where the mean pixel densitometry of HOBs on native collagen scaffolds 
were compared to those seeded on crosslinked scaffolds. The p-values corresponding to P< 
0.05 are represented with a *. 
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4.2.6 Mineralisation of HOBs when seeded onto TG2 crosslinked collagen without 
calcium and DTT 
Having shown that both DTT and calcium are required for TG2 to crosslink collagen 
and an increase in mineralisation, samples of collagen alone (without DTT and calcium) were 
tested to see if TG2 alone would affect mineralisation. These scaffolds have already shown a 
similar macromolecular structure to native collagen due to the lack of crosslinks between 
collagen fibres. It was found that TG2 alone was not as effective at mineralising HOBs (when 
seeded on the scaffold for 10 days) and was comparable with cells grown on collagen. 
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Figure 4.6: Mineralisation when HOBs were seeded onto TG2 crosslinked collagen 
without calcium and DTT. (A) HOBs were seeded onto native, 5 µg/ml, 5 µg/ml TG2 without 
DTT and Ca2+ and TG2 crosslinked collagen (2.5 mg/ml) and subjected to von Kossa staining 
on day 6, 8 and 10. The mineral deposits were stained in black and for all groups increased 
from day 6 to 10. Samples were viewed at x10 magnification using a Nikon CK2 and 
photographed with an Olympus DP10 digital camera. Scale bars= 200 µm. (B) The mineralised 
area was visualised by von Kossa staining and positive staining was quantified by ImageJ. The 
results represent mean values +/- S.D, where n=3. Statistical analysis was carried out using a 
one-way ANOVA test where the mean pixel densitometry of HOBs on native collagen scaffolds 
were compared to those seeded on crosslinked scaffolds. The p-values corresponding to P< 
0.05 are represented with a *. 
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4.3 Characterising the mineralisation of collagen scaffolds with 
transglutaminases and transglutaminase inhibitors 
 
4.3.1 Optimising the use of 1-155 inhibitor when cells are seeded onto TG2 
crosslinked collagen 
  
 1-155 is described as a cell permeable, irreversible inhibitor that is a substrate 
analogue which binds at the active site to selectively inhibit TG2 activity  (Zonca et al., 2017) . 
At a concentration of 25 M, it was shown to reduce activity of almost all of the 5 g/ml 
concentration of TG2. First, the method in which 1-155 was added to TG2 and collagen needed 
to be optimised. Three ways of adding the inhibitor to collagen and TG2 were assessed to 
establish the most efficient method to inhibit TG2 crosslinking ability. 
1- 1-155 (25 M) was pre-incubated with active 5 g/ml TG2 for one hour on ice before 
this solution was added to collagen, 10X PBS and water and allowed to crosslink 
overnight (as described in materials and methods) 
2- 1-155 (25M) was added to the collagen mixture containing 5 g/ml TG2 and allowed 
to crosslink overnight (as described in materials and methods ) 
3- 1-155 (25M) was added to cells seeded onto 2.5 mg/ml TG2 crosslinked collagen 
with media changes every 48 hours 
The cells that were seeded onto crosslinked collagen where 1-155 was pre-incubated withTG2 
showed a rate of mineralisation that was similar to cells seeded onto native collagen. There 
was more mineralisation shown in samples where 1-155 and TG2 was added to collagen 
mixture at the same time. This means that some of the TG2 was likely to have been inhibited 
but some remained active and therefore increased the amount of mineralisation in those 
samples compared to that seen in native collagen. However, adding 1-155 to the cells seeded 
onto TG2 crosslinked collagen had almost no effect.   
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Figure 4.7: Mineralisation of HOBs when 1-155 was added to collagen. (A) HOBs seeded 
onto various collagen scaffolds were grown using differentiation medium. The mineral 
depositions were stained in black and for all groups increased from day 6 to 10. Samples were 
viewed at x10 magnification using a Nikon CK2 and photographed with an Olympus DP10 
digital camera. Scale bars= 200 µm. (B) The mineralised area was visualised by von Kossa 
staining and positive staining was quantified by ImageJ. The results represent mean values 
+/- S.D, where n=3. Statistical analysis was carried out using a one-way ANOVA test where 
the mean pixel densitometry of HOBs on native collagen scaffolds were compared to those 
seeded on inhibited crosslinked scaffolds the p-values corresponding to P< 0.05 are 
represented with a *. 
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4.3.2 Optimising the use of R281 inhibitor when cells are seeded onto mTG 
crosslinked collagen 
  
 In the previous chapter, R281 was described as a non-cell-permeable inhibitor which 
has been reported by Zonca (Zonca et al. 2017) to inhibit both TG2 and mTG. It was shown 
that R281 can almost completely inhibit mTG activity when incubated with the enzyme at 250 
µM. As with 1-155 and TG2, the method in which R281 was added to mTG and collagen 
needed to be optimised. Three ways of adding the inhibitor to collagen and mTG were 
investigated. 
1- R281 (250 µM) was pre-incubated with active 5 g/ml mTG for one hour on ice before 
this solution was added to collagen, 10X PBS and water and allowed to crosslink 
overnight (as described in methods in materials) 
2- R281 (250 µM) was added to the collagen mixture containing 5 g/ml mTG and allowed 
to crosslink overnight (as described in methods in materials) 
3- R281 (250 µM) was added to cells seeded onto 2.5 mg/ml mTG crosslinked collagen 
with media changes every 48 hours 
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Figure 4.8: Mineralisation of HOBs when R281 was added to collagen. (A) HOBs seeded 
onto various collagen scaffolds were grown using differentiation medium. The mineral 
depositions were stained in black and for all groups increased from day 6 to 10. Samples were 
viewed at x10 magnification using a Nikon CK2 and photographed with an Olympus DP10 
digital camera. Scale bars= 200 µm. (B) The mineralised area was visualised by von Kossa 
staining and positive staining was quantified by ImageJ. The results represent mean values 
+/- S.D, where n=3. Statistical analysis was carried out using a one-way ANOVA test where 
the mean pixel densitometry of HOBs on native collagen scaffolds were compared to those 
seeded on inhibited crosslinked scaffolds the p-values corresponding to P< 0.05 are 
represented with a *. 
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4.3.3 Assessing the mineralisation effect of 1-155 on HOBs 
  
 In this experiment, 1-155 was added to HOBs alone in order to determine whether its 
presence alone had any effect on the mineralisation rates of HOBs after 6, 8 and 10 days 
(Figure 4.9). It was clear that there was no statistically significant difference between 
mineralisation rates between cells and cells with 25 M 1-155 added. When comparing 
samples where cells had TG2 added versus both TG2 and 1-155 added there was a clear 
difference. Cells where 1-155 and TG2 were added showed similar rates of mineralisation to 
that of cells alone and the cells where 1-155 was added. 
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Figure 4.9: Mineralisation of HOBs when 1-155 was added. (A) HOBs, HOBs with 25 µM 1-
155, HOBs with 5 µg/ml TG2 and HOBs with 25 µM 1-155 and 5 µg/ml TG2 were subjected to 
von Kossa staining on day 6, 8 and 10. The mineral depositions were stained in black and for 
all groups increased from day 6 to 10. Samples were viewed at x10 magnification using a 
Nikon CK2 and photographed with an Olympus DP10 digital camera. Scale bars= 200 µm. (B) 
The mineralised area was visualised by von Kossa staining and positive staining was 
quantified by ImageJ. The results represent mean values +/- S.D, where n=3. Statistical 
analysis was carried out using a one-way ANOVA test where the mean pixel densitometry of 
HOBs on native collagen scaffolds were compared to those seeded on inhibited crosslinked 
scaffolds p-values corresponding to P< 0.05 are represented with a *. 
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4.3.4 Assessing the effect of R281 on mineralisation of HOBs 
  
In this experiment, R281 was added to HOBs in order to determine whether its 
presence alone had any effect on the mineralisation rates of HOBs after 6, 8 and 10 days. It 
was clear from Figure 4.10 that there were no statistically significant changes between 
mineralisation rates between cells and cells with 250 µM R281 added. When comparing 
samples where cells had mTG added versus both mTG and R281 added there was a clear 
difference. Cells where R281 and mTG added showed similar rates of mineralisation to that of 
cells alone and the cells where R281 was added. 
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Figure 4.10: Mineralisation of HOBs when R281 was added. (A) HOBs, HOBs with 250 µM 
R281, HOBs with 5 µg/ml mTG and HOBs with 250 µM R281 and 5 µg/ml mTG were subjected 
to von Kossa staining on day 6, 8 and 10. The mineral depositions were stained in black and 
for all groups increased from day 6 to 10. Samples were viewed at x10 magnification using a 
Nikon CK2 and photographed with an Olympus DP10 digital camera. Scale bars= 200 µm (B) 
The mineralised area was visualised by von Kossa staining and positive staining was 
quantified by ImageJ. The results represent mean values +/- S.D, where n=3. Statistical 
analysis was carried out using a one-way ANOVA test where the mean pixel densitometry of 
HOBs on native collagen scaffolds were compared to those seeded on inhibited crosslinked 
scaffolds. The p-values corresponding to P< 0.05 are represented with a *. 
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4.3.5 Mineralisation of HOBs on mTG crosslinked collagen with 1-155 
  
 It has already been shown that R281 can inhibit both mTG and TG2 (Zonca et al., 2017) 
but it is unknown if 1-155, which inhibits TG2, can also inhibit mTG activity. In order to 
determine whether 1-155 inhibits or decreases mineralisation by cells seeded onto mTG 
crosslinked collagen, mineralisation rates of HOBs after 6, 8 and 10 days were assessed. It 
was clear that there was a statistically significant change in the mineralisation rates of HOBs 
seeded on native collagen and cells with 1-155 (25 M) and mTG added to the collagen. When 
comparing samples where HOBs were seeded onto active mTG crosslinked collagen versus 
HOBs seeded onto mTG with 1-155 in collagen, there was no clear difference.  
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Figure 4.11: Mineralisation of HOBs when 1-155 was added to mTG crosslinked collagen. 
(A) HOBs seeded onto collagen scaffolds with mTG and mTG with 1-155 were grown using 
differentiation medium. The mineral depositions were stained in black and for all groups 
increased from day 6 to 10. Samples were viewed at x10 magnification using a Nikon CK2 and 
photographed with an Olympus DP10 digital camera. Scale bars= 200 µm. (B) The mineralised 
area was visualised by von Kossa staining and positive staining was quantified by ImageJ. The 
results represent mean values +/- S.D, where n=3. Statistical analysis was carried out using a 
one-way ANOVA test where the mean pixel densitometry of HOBs on native collagen scaffolds 
were compared to those seeded on crosslinked scaffolds. The p-values corresponding to P< 
0.05 are represented with a * 
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4.4 Assessing the mineralisation of HOBs on crosslinked collagen and 
crosslinked collagen mixed with glass 
 
4.4.1 Comparing the mineralisation rates between collagen scaffolds with 
transglutaminases and 45S5 bioglass particles 
 
Now that the mineralisation rates for HOBs seeded onto crosslinked collagen has been 
established the next variable to be assessed was how they might mineralise differently if 
seeded onto native and crosslinked scaffolds with 10 mg/ml 45S5 bioglass particles.  
When the mineralisation assay was carried out it was shown that when TG2 and mTG 
were mixed with collagen and bioglass particles a statistically significant higher amount of 
mineralisation took place when compared to the native collagen scaffold. However, there was 
no significance when comparing mineralisation between native collagen and native collagen 
mixed with bioglass particles.  
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Figure 4.12: Mineralisation of HOBs when seeded onto native and crosslinked collagen 
with 45S5 bioglass particles. (A) HOBs seeded onto native and crosslinked collagen 
scaffolds which were grown using differentiation medium. The mineral deposits were stained 
in black and for all groups increased from day 6 to 10. Samples were viewed at x10 
magnification using a Nikon CK2 and photographed with an Olympus DP10 digital camera. 
Scale bars= 200 µm. (B) The mineralised area was visualised by von Kossa staining and 
positive staining was quantified by ImageJ. From left to right: Native collagen, native collagen 
mixed with bioglass, mTG crosslinked scaffold, mTG crosslinked scaffold mixed with bioglass, 
TG2 crosslinked scaffold, TG2 crosslinked scaffold mixed with bioglass, R281 inactivated mTG 
scaffold and 1-155 inactivated TG2 scaffold. The results represent mean values +/- S.D, where 
n=3. Statistical analysis was carried out using a one-way ANOVA test where the mean pixel 
densitometry of HOBs on native collagen scaffolds were compared to those seeded on 
crosslinked scaffolds with and without bioglass. The p-values corresponding to P< 0.05 are 
represented with a *. 
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4.4.2 Assessing the mineralisation rates between collagen scaffolds with transglutaminases 
and 45S5 bioglass particles at earlier time points 
 
In the previous chapter, the XTT cell proliferation analysis of cells grown on TG2 
crosslinked collagen showed a slight fall in absorbance by day 6. We hypothesise that this is 
not a sign that the cells find the ECM to be toxic, since absorbance was increasing up until the 
last day it was measured. Instead, it may have decreased because cells seeded onto the 
crosslinked collagen have mineralised and differentiated quicker than on native collagen. To 
test this theory, the mineralisation rate of cells on native collagen and on crosslinked collagen 
with glass were measured before the normal 6 day starting point. As shown below, there was 
a clear statistical difference between the mineralisation rate between native collagen and 
crosslinked collagen with bioglass particles.  
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Figure 4.13: Mineralisation of HOBs when seeded onto native and crosslinked collagen 
with 45S5 bioglass particles over 5 days. (A) HOBs seeded onto native and crosslinked 
collagen scaffolds which were grown using differentiation medium. The mineral deposits were 
stained in black and for all groups increased from day 3 to 5. Samples were viewed at x10 
magnification using a Nikon CK2 and photographed with an Olympus DP10 digital camera. 
Scale bars= 200 µm. (B) The mineralised area was visualised by von Kossa staining and 
positive staining was quantified by ImageJ. The results represent mean values +/- S.D, where 
n=3. Statistical analysis was carried out using a one-way ANOVA test where the mean pixel 
densitometry of HOBs on native collagen scaffolds were compared to those seeded on 
crosslinked scaffolds with and without bioglass. The p-values corresponding to P< 0.01 are 
represented with a ** and where p< 0.001 is represented with ***. 
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4.5 Crosslinked collagen deposition by human osteoblasts 
 
 
4.5.1 Quantification of crosslinked collagen when transglutaminases are added to 
HOBs on plastic tissue 
 
 To assess collagen deposition by HOBs, cells were allowed to grow on tissue culture 
plastic for 10 days in differentiation medium before being discarded. From the remaining matrix 
bound to the plastic wells, the proteins were digested with pepsin. Samples were then loaded 
onto a 5% acrylamide gel.  Using the Silver Quest staining kit (see Materials and Methods) the 
collagen was then stained and imaged using G-box. 
 Figure 4.14 shows that there was a difference in the collagen deposited in the ECM 
between the control samples and samples where 5 g/ml of TG2 and mTG was added to the 
samples every 48 hours.  
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Figure 4.14: HOB production of collagen in the Extracellular matrix. (A) Cells were 
removed from the wells 10 days post seeding. Resulting ECM was digested and samples and 
ran on 5% bis-acrylamide gel before being stained for collagen using Silver Quest staining kit. 
A representative gel is shown where the red boxes indicated the bands analysed. (B) 
Normalised collagen expression was plotted where the results represent mean values +/- S.D, 
where n=3. Statistical analysis was carried out using a one-way ANOVA test where the mean 
pixel densitometry of bands representing collagen deposition by HOBs  were compared to 
those seeded with TGs. The p-values corresponding to P< 0.001 are represented with *** and 
p=values corresponding to P<0.01 are represented with **. 
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4.6 Discussion 
 
The bone formation process is carried out by osteoblasts under the control of hormones 
and cytokines in the extracellular matrix of bone. The bone matrix itself is mostly made up 
of type 1 collagen, which is secreted from osteoblasts and assembled into macromolecular 
structures to give bone its tensile strength and to act as a scaffold for mineralisation and 
cell adhesion (Al-Jallad et al. 2006). One of the many non-collagenous proteins shown to 
reside within bone matrix are transglutaminases (which, as stated previously, are capable 
of linking primary amines to specific glutamine residues of its protein substrates). In this 
case TG2 and mTG are used to crosslink collagen to non-collagenous matrix components 
such as fibronectin and osteopontin in vitro (Kaartinen et al. 1999). It has been suggested, 
that by stabilising the matrix further (via crosslinking in this manner) mineralisation and cell 
adhesion are increased (Lorand and Graham, 2003; Nurminskaya et al. 2003; Akimov et 
al. 2000; Fortunati et al. 2014). We have shown in this chapter how mineralisation on tissue 
culture plastic begins around 6 days post seeding and increases until a plateau is reached 
approximately after 10 days.   
We have shown that when mTG and TG2 are added to HOBs on tissue culture plastic, 
there is a significant increase in mineralisation compared to HOBs alone. It has also been 
thought that TG2 in the extracellular environment could trigger a signal from the outside to 
the cell to begin mineralisation (Nurminskaya et al. 2003). This was later backed up by 
studies carried out by Faverman et al. who showed that LRP5 binds to TG2, triggering the 
Wnt non-canonical pathway. Once activated, this pathway leads to the release of β-catenin 
from the cytoplasm into the nucleus. This translocation of β-catenin causes TCF/LEF 
transcription factors to be released from the DNA and triggers HOB mineralisation 
(Faverman et al., 2008). We hypothesis that TG2 binds to LRP5 on HOBs as well as 
crosslinking the matrix laid down in the ECM over time by HOBs. In contrast, mTG only 
crosslinks the ECM matrix and does not bind to LRP5 and therefore has less of an effect 
on mineralisation than TG2. 
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The data strongly suggests that the crosslinking of collagen has had a positive effect on 
mineralisation. This is could be due to an increase in the expression of αVβ3 integrins that 
regulate cell proliferation and maturation. Also further stabilisation of the collagen matrix allows 
for greater cell adherence and proliferation. The crosslinking of collagen has already been 
shown to increase the mechanical strength of the overall scaffold compared to native collagen 
scaffolds (Chau, 2005; Fortunati et al. 2014). Moreover, investigations have shown0 
mesenchymal stem cells (MSCs) will change their differentiation fate depending on the 
elasticity of the surface they are seeded on (Discher et al., 2007). Discher et al. found that 
native MSCs would commit to osteogenic cell pathways if seeded on collagen that was 
crosslinked on relatively stiff matrices. This would explain why HOBs seeded on stiffer, 
crosslinked collagen show higher levels of mineralisation.  
As expected, removing calcium from TG2 collagen scaffolds led to a mineralisation that 
was similar to that of native collagen mineralisation. Interestingly, the absence of DTT from the 
TG2 samples led to a decrease in mineralisation. This suggests that TG2 must be also reduced 
and be active in order to allow for a statistically significant increase in mineralisation. This 
implies that TG2 protein alone cannot be responsible for increased mineralisation. 
The data in this chapter show that either R281 or 1-155, when added to cells will not have 
any effect on HOB mineralisation. When added along with mTG or TG2, there is sufficient 
inactivation taking place to reduce the mineralisation rates of those samples to that seen in the 
control HOB sample. It has been shown in the literature that R281 can inhibit both TG2 and 
mTG activity (Zonca et al., 2017), whereas our data show that only TG2 is inhibited by 1-155. 
 Although HOBs on both mTG and TG2 crosslinked collagen mineralised more than 
those on native collagen, there was still a difference in mineralisation rates. This could be 
explained by the differences seen in the stiffness between the two crosslinked collagen 
scaffolds (Lee et al., 2013, Grover et al., 2012, Chau et al., 2005). These differences may lead 
to HOBs reacting differently to the differences in stiffness (Pawelec et al., 2015), causing 
different rates of mineralisation (Discher et al., 2007). It has been reported that epithelial cells 
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seeded on stiffer matrices also upregulate expression of LRP5/6, which could explain the 
upregulation seen on HOBs seeded on crosslinked collagen (Han et al., 2016). 
Another reason for this difference in mineralisation rate could be explained by 
differences in the mean collagen pore size as observed in Chapter 3. Given that HOBs on 
average are 20-30µm in length (Wheeless et al. 2016) and the gaps between collagen fibres 
are nanometres apart, the amount of contact that each HOB has on collagen fibres is different 
between the scaffolds. The changes in distance between collagen fibres or pore alignment is 
known in the literature to be a signalling cue to osteoblasts (Ashworth et al., 2016, Pawelec et 
al., 2015). These signalling cues in turn influence cell behaviour and induce migration and 
matrix production. Given the increased contact that HOBs on crosslinked collagen have this 
could contribute to the increased integrin expression seen in Chapter 5 (Grover et al., 2012).  
 If increased surface area seen on crosslinked collagen increase mineralisation of 
HOBs, then adding 45S5 bioglass would also give more surface area for HOBs to adhere to in 
the overall ECM. Furthermore, from multiple studies it is established that 45S5 bioglass will 
bond to soft tissues as well as bone (Hench et al., 1972, Hench, 1993). Once implanted, the 
surface of the 45S5 bioglass forms a biologically active hydroxycarbonate apatite (HCA layer) 
this is crucial to providing the bonding interface with tissues. The HCA phase that is formed on 
the bioglass is the chemical and structural equivalent of the mineral phase in bone, which in 
turn induces cells to mineralise (Hench, 1993).   
Finally, when mTG and TG2 were added to collagen mixed with bioglass, there was an 
early (day 5) and significant increase in mineralisation this increased rate is shown to start as 
early as day 4-5. Briefly, ion/leaching/exchange and dissolution of the bioglass network and 
precipitation/growth of the calcium deficient HCA layer encourages the colonisation and 
proliferation of osteoblasts (Hench, 1993). These findings by Hench and Xynos could explain 
why increased mineralisation was found in the collagen samples with 45S5 bioglass. One 
interesting observation is that when bioglass is added to native collagen alone, there was an 
increase in mineralisation but this was not shown to be statistically significant. It should also 
be noted that when TGs are added to HOBs grown on culture that after 10 days there seems 
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to be more exogenous type 1 collagen found in the ECM. This could possibly be leading to a 
positive feedback cycle, since HOBs are able to make more contact (via cell surface and 
integrins) to collagen which stimulates further proliferation and mineralisation. 
To summarise, the effect of TG2 increasing mineralisation of HOBs is only seen when 
the enzyme is active and reduced (by calcium and DTT respectively). Similarly, when mTG is 
active there is a significant increase in mineralisation seen in collagen scaffolds too. The 
addition of bioglass particles further increases mineralisation of HOBs on crosslinked collagen 
scaffolds and this is likely due to HOBs interacting with the HCA layer that is formed between 
bioglass particles and HOBs.   
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Chapter 5: Intracellular effects of seeding 
HOBs on novel crosslinked collagen scaffolds 
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5.1 Introduction 
 
In the ECM, there are a variety of cues that are interpreted by cells that lead to different 
integrins being expressed. Integrin ligands are recognised by integrins via their conserved 
amino acid sequences. One of the most studied conserved amino acid sequences on these 
ligands is the RGD sequence (arginine, glycine, aspartate). Many proteins in the ECM, 
including collagen, contain the RGD sequence, which only become, accessible after 
processing (such as crosslinking) or degradation (Barczyk et al., 2010). Thus, collagen only 
reveals these RGD sequence, following crosslinking or denaturation and can recognise 
integrins such as αVβ3 and αVβ5 (Pawelec et al., 2016).  
A variety of integrins have been shown to be expressed by osteoblasts, including αVβ3, 
αVβ5 and α2β1 (Lai and Cheng, 2005). These integrins are expressed on the cell surface and 
modulate cell adhesion, cell spreading, differentiation and mineralisation.  
In addition to these integrins, another important transmembrane protein is involved: low 
density lipoprotein receptor-related protein 5 or LRP5 is an important protein that is involved 
in the Wnt- β-catenin pathway. Once a ligand has bound to LRP5, a cascade of reactions 
leading to the dissociation of β-catenin from glycogen synthase kinase 3β or GSK3 (He et al., 
2004). Once dissociated, β-catenin accumulates in the nucleus, where it can form a complex 
and displace TCF/ LEF transcription factors from the cell’s DNA. This displacement leads to 
cell differentiation (Chau et al., 2009). It has been shown by Faverman et al, (2008) that TG2 
binds to LRP5 to activate the Wnt- β-catenin pathway in vascular smooth muscle cells. 
The synthesis and release of collagen from HOBs is seen during mineralisation and 
differentiation (Rutkovskiy et al., 2016). The collagen produced is an important ECM protein 
as it further adds to the scaffold and in turn becomes mineralised to form bone (Pawelec et al., 
2016) 
Native collagen are only able to recognise integrins such as α1 and α2 via the RGD 
site GFOGER (a 30 amino acid sequence) (Pawelec et al., 2016). TG2 crosslinked collagen 
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expresses “cryptic” RGD peptides in such a way that HOBs perceive the scaffold to be more 
like gelatin than collagen. As seen by the decrease of α1 and α2 integrins seen on HOBs 
seeded on TG2 crosslinked collagen.   
5.2 Integrin expression of HOBs on collagen scaffolds 
 
 
5.2.1 Expression of 3 integrin on human osteoblasts over 3 days 
 
By monitoring 3 integrin expression in whole lysates, it was found that β3 integrin 
expression steadily increased after 3 days (post seeding) when grown on un-treated 96-well 
plates. It was seen that, by day 3, the expression of 3 integrin was approximately 1.6 fold 
higher than it was at day 1. 
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Figure 5.1: Expression of β3 integrin in whole cell lysate. Cell lysates were collected after 
1, 2 and 3 days post seeding and Western blotting was performed to analyse β3 integrin 
expression. A representative Western blot result is shown in (A) β-actin was used as loading 
control and normalised data are shown in the graph. (B). Normalised integrin expression was 
plotted where the results represent mean values +/- S.D, where n=3. Statistical analysis was 
carried out using a one-way ANOVA test where the p-values corresponding to P< 0.001 are 
represented with ***. 
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5.2.2 Expression of αV integrin on human osteoblasts over 3 days 
 
By monitoring αV integrin expression in whole lysates, it was found that αV integrin 
expression was approximately 1.64 fold higher than it was at day 1, as shown in Figure 5.2. 
Since 3 is paired with V on the cell surface it could be expected that the expression of αV 
would also increase, although V can be paired with other integrins.  
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Figure 5.2: Expression of αV integrin in whole cell lysate. Cell lysates were collected after 
1, 2 and 3 days post seeding and Western blotting was performed to analyse αV integrin 
expression. A representative Western blot result is shown in (A) β-actin was used as loading 
control and normalised data are shown in the graph. (B) Normalised integrin expression was 
plotted where the results represent mean values +/- S.D, where n=3. Statistical analysis was 
carried out using a one-way ANOVA test where the p-values corresponding to P< 0.001 are 
represented with ***. 
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5.2.3 Expression of LRP5 on human osteoblasts with transglutaminases added 
 
 Cell lysates were measured for LRP5 using Western blotting, as shown in Figure 5.3. 
It shows that HOBs grown with mTG and TG2 added to express LRP5 1.25 and 1.64 fold 
higher compared to native collagen. This suggests that, as in vascular smooth muscle cells, 
TG2 might be binding to LRP5 in HOBs. However, to conclusively show the binding of TG2 to 
LRP5 further investigation is needed. 
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Figure 5.3: Expression of LRP5 integrin in whole cell lysate. Cell lysates were collected 3 
days post seeding and Western blotting was performed to analyse LRP5 integrin expression. 
A representative Western blot result is shown in (A) β-actin was used as loading control and 
normalised data are shown in the graph. (B) Normalised integrin expression was plotted where 
the results represent mean values +/- S.D, where n=3. Statistical analysis was carried out 
using a one-way ANOVA test where the p-values corresponding to P< 0.001 are represented 
with ***. 
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5.3 Characterisation of integrin expression on human osteoblasts when seeded 
onto collagen scaffolds with transglutaminase  
 
5.3.1 β3 integrin expression in HOBs grown on collagen scaffolds 
 
 To contrast the differences in integrin expression, HOBs were grown on collagen 
scaffolds with and without modification by transglutaminases. In figure 5.4, the expression of 
3 was measured via Western blotting. After 3 days post seeding, HOBs grown on TG2 
crosslinked collagen were seen to express 3 integrin 2.1 fold more than on cells grown on 
native collagen as seen below. Furthermore, the cells grown on mTG crosslinked collagen 
expressed 3 1.62 fold more than HOBs seeded on native collagen. 
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Figure 5.4: Expression of β3 integrin in HOBs seeded onto collagen scaffolds. Cells were 
lysed after 3 days post seeding and Western blotting was performed to analyse β3 integrin 
expression. A representative Western blot result is shown in (A) β-actin was used as loading 
control and normalised data are shown in the graph. (B) Normalised integrin expression was 
plotted where the results represent mean values +/- S.D, where n=3. Statistical analysis was 
carried out using a one-way ANOVA test where the p-values corresponding to P< 0.001 are 
represented with ***. 
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5.3.2αV integrin expression for HOBs grown on collagen scaffolds 
 
Given the changes in β3 integrin expression on HOBs seeded on crosslinked collagen, 
it was necessary to investigate the expression of αV integrin since it forms the other half of the 
αVβ3 signalling complex. HOBs were grown on collagen scaffolds with and without 
modification by transglutaminases. Figure 5.5 shows the expression of V measured via 
Western blotting. There was a 1.71 fold increase in expression of V integrins found in cells 
grown on mTG. In addition a similar increase of 1.78 fold expression of αV in HOBs seeded 
on TG2 crosslinked collagen compared to native collagen. This further demonstrates that 
cellular pathways are being affected by being grown on modified collagen scaffolds. 
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Figure 5.5: Expression of αV integrin in HOBs seeded onto collagen scaffolds. Cells were 
lysed after 3 days post seeding and Western blotting was performed to analyse αV integrin 
expression. A representative Western blot result is shown in (A). β-actin was used as loading 
control and normalised data are shown in the graph. (B) Normalised integrin expression was 
plotted where the results represent mean values +/- S.D, where n=3. Statistical analysis was 
carried out using a one-way ANOVA test where the p-values corresponding to P<0.01 are 
represented with **. 
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5.3.3β1 integrin expression for HOBs grown on collagen scaffolds 
 
 Having observed the expression of the integrin pair αVβ3 (individually), the next step 
was to look at α5 and β1. α5β1 is expressed on the surface of osteoblasts and, along with 
αVβ3, binds to ligands such as BMPs in the ECM to influence the fate of  osteoblasts, including 
proliferation, attachment and mineralisation (Fortunati et al., 2014, Orban et al., 2004). Figure 
5.6 shows that HOBs seeded onto mTG and TG2 collagen were shown to express β1 integrin 
1.5 and 1.79 fold more than HOBs seeded onto native collagen.  
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Figure 5.6: Expression of β1 integrin in HOBs seeded onto collagen scaffolds. Cell 
lysates were lysed after 3 days post seeding and Western blotting was performed to analyse 
β1 integrin expression. A representative Western blot result is shown in (A). β-actin was used 
as loading control and normalised data were shown in the graph. (B) Normalised integrin 
expression was plotted where the results represent mean values +/- S.D, where n=3. Statistical 
analysis was carried out using a one-way ANOVA test where the p-values corresponding to 
P< 0.001 are represented with *** and p=values corresponding to P<0.01 are represented with 
**. 
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5.3.45 integrin expression for HOBs grown on collagen scaffolds 
 
 
Having shown the differences in β1 integrin expression on HOBs seeded on 
crosslinked collagen in Figure 5.6, it was necessary to investigate the expression of α5 integrin 
since it forms the other half of the β1α5 signalling complex.  HOBs were grown on collagen 
scaffolds with and without modification by transglutaminases. Figure 5.7 shows the expression 
of 5 was measured via Western blotting. There was a 1.65 fold increase in expression of 5 
integrins found in cells grown on mTG. Furthermore a 2.13 fold increase in α5 integrin was 
seen in HOBs seeded on TG2 crosslinked collagen compared to native collagen. 
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Figure 5.7: Expression of α5 integrin in HOBs seeded onto collagen scaffolds. Cells were 
lysed after 3 days post seeding and Western blotting was performed to analyse α5 integrin 
expression. A representative Western blot result is shown in (A). β-actin was used as loading 
control and normalised data are showed in chart. (B) Normalised integrin expression was 
plotted where the results represent mean values +/- S.D, where n=3. Statistical analysis was 
carried out using a one-way ANOVA test where the p-values corresponding to P< 0.001 are 
represented with ***. 
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5.3.5 1 integrin expression for HOBs grown on collagen scaffolds 
 
HOBs were grown on collagen scaffolds with and without modification by 
transglutaminases. Expression of 1 was measured via Western blotting in figure 5.8. There 
was nearly a 0.5 fold decrease in expression of 1 integrins found in cells grown on TG2 
crosslinked collagen compared to native collagen. However HOBs on mTG crosslinked 
collaged did not show a decrease in 1 or 2 integrins. 1 integrin is often observed on the 
HOBs surface when they bind to a collagen scaffold (Barczyk et al., 2010).  
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Figure 5.8: Expression of α1 integrin in HOBs seeded onto collagen scaffolds. Cells were 
lysed after 3 days post seeding and Western blotting was performed to analyse α1 integrin 
expression. A representative Western blot result is shown in (A). β-actin was used as loading 
control and normalised data are shown in the graph. (B) Normalised integrin expression was 
plotted where the results represent mean values +/- S.D, where n=3. Statistical analysis was 
carried out using a one-way ANOVA test where the p-values corresponding to P< 0.001 are 
represented with ***. 
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5.3.6 2 integrin expression for HOBs grown on collagen scaffolds 
 
Given that α1 expression levels decreased in HOBs grown on TG2 crosslinked 
collagen, it was necessary to investigate if α2 expression differed. This is because, along with 
α1, α2 is an integrin that does not recognise denatured collagen (Knight et al., 2000).  
HOBs were grown on collagen scaffolds with and without modification by 
transglutaminases. Expression of 2 was measured via Western blotting. There was nearly a 
0.4 fold decrease in expression of 2 integrins found in cells grown on TG2 crosslinked 
collagen compared to native collagen.  
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Figure 5.9: Expression of α2 integrin in HOBs seeded onto collagen scaffolds. Cells were 
lysed after 3 days post seeding and Western blotting was performed to analyse α2 integrin 
expression. A representative Western blot result is shown in (A). β-actin was used as loading 
control and normalised data are shown in the graph. (B) Normalised integrin expression was 
plotted where the results represent mean values +/- S.D, where n=3. Statistical analysis was 
carried out using a one-way ANOVA test where the p-values corresponding to P< 0.001 are 
represented with ***. 
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5.3.7 LRP5 integrin expression for HOBs grown on collagen scaffolds 
 
 Since Figure 5.3 showed that HOBs increase their expression of LRP5 when 
transglutaminases are present. To see if LRP5 expression changed in HOBs grown on 
collagen scaffolds with and without modification by transglutaminases, Western blotting on cell 
lysates was carried out as shown in Figure 5.10. There was a 2.96 fold increase in expression 
of LRP5 found in cells grown on TG2 crosslinked collagen compared to native collagen. 
Similarly a 1.49 increase in fold expression was found in HOBs grown on mTG crosslinked 
collagen. 
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Figure 5.10: Expression of LRP5 integrin in HOBs seeded onto collagen scaffolds. Cells 
were lysed after 3 days post seeding and Western blotting was performed to analyse LRP5 
integrin expression. A representative Western blot result is shown in (A). β-actin was used as 
loading control and normalised data are shown in the graph. (B) Normalised integrin 
expression was plotted where the results represent mean values +/- S.D, where n=3. Statistical 
analysis was carried out using a one-way ANOVA test where the p-values corresponding to 
P< 0.001 are represented with ***. 
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5.4 Characterisation of integrin expression on human osteoblasts when seeded 
onto collagen scaffolds with transglutaminase and 45S5 bioglass 
 
5.4.1 β3 integrin expression for HOBs grown on collagen scaffolds mixed with 45S5 
bioglass 
  
Having shown that β3 integrin expression on HOBs increases over time in Figure 5.1 
and when seeded onto crosslinked collagen in Figure 5.4. It was necessary to investigate the 
impact that 45S5 bioglass might have on cells. β3 integrin expression was measured on HOBs 
seeded on native collagen and crosslinked collagen with 10 mg/ml 45S5 bioglass particles was 
then measured. After seeding HOBs on the collagen scaffolds, cell lysates were collected and 
the expression of β3 integrins was measured using Western blotting. The results are shown in 
Figure 5.11. 
 β3 integrin expression increased in HOBs on all collagen scaffolds that had 45S5 
bioglass mixed with them.  The lowest increase was seen in native collagen mixed with 
bioglass (by 1.25 fold) and the highest increase was found in HOBs seeded on TG2 crosslinked 
with 45S5 bioglass (2.25 fold). The β3 integrin expression was found to be significantly higher 
on HOBs grown on native collagen with glass than without (0.25 fold higher). Similarly, HOBs 
grown on TG2 and mTG crosslinked collagen with glass showed significantly higher 
expression of β3 integrins than their respective scaffolds without glass.  
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Figure 5.11: Expression of β3 integrin in HOBs seeded onto collagen scaffolds with 45S5 
bioglass. Cells were lysed after 3 days post seeding and Western blotting was performed to 
analyse β3 integrin expression. A representative Western blot result is shown in (A). β-actin 
was used as loading control and normalised data are showed in the graph. (B) Normalised 
integrin expression was plotted where the results represent mean values +/- S.D, where n=3. 
Statistical analysis was carried out using a one-way ANOVA test where the p-values 
corresponding to P< 0.05 are represented with *. 
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5.4.2 V integrin expression for HOBs grown on collagen scaffolds mixed with 45S5 
bioglass 
 
Having shown that αV integrin expression on HOBs increases over time in Figure 5.2 
and when seeded onto crosslinked collagen in Figure 5.5. It was necessary to investigate the 
influence of bioglass on cells. The expression of αV integrin expression on HOBs when seeded 
on native collagen and crosslinked collagen with 10µg/ml 45S5 bioglass particles was then 
measured. After seeding HOBs on the collagen scaffolds cell lysates were collected and using 
Western blotting the expression of αV integrins was measured. The results are shown in Figure 
5.12 
 αV integrin expression increased in HOBs on all collagen scaffolds that had 45S5 
bioglass mixed with them.  The lowest increase was seen in native collagen mixed with 
bioglass (by 1.52 fold) and the highest increase was found in HOBs seeded on mTG 
crosslinked with 45S5 bioglass (2.76 fold). As with β3, HOBs grown on TG2 and mTG 
crosslinked collagen with glass showed significantly higher expression of αV integrins than 
their respective scaffolds without glass. 
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Figure 5.12: Expression of αV integrin in HOBs seeded onto collagen scaffolds with 45S5 
bioglass. Cells were lysed after 3 days post seeding and Western blotting was performed to 
analyse αV integrin expression. A representative Western blot result is shown in (A). β-actin 
was used as loading control and normalised data are shown in the graph. (B) Normalised 
integrin expression was plotted where the results represent mean values +/- S.D, where n=3. 
Statistical analysis was carried out using a one-way ANOVA test where the p-values 
corresponding to P< 0.05 are represented with * and P< 0.001 are represented with ***. 
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5.4.3 β1 integrin expression for HOBs grown on collagen scaffolds mixed with 45S5 
bioglass 
 
Figure 5.13 shows that the β1 integrin expression increased in HOBs on all crosslinked 
collagen scaffolds that had 45S5 bioglass mixed with them.  A decrease in expression was 
seen in native collagen which was mixed with bioglass (by 1.2 fold) the highest increase was 
found in HOBs seeded on TG2 crosslinked with 45S5 bioglass (2.3 fold).  
 β1 integrin expression was significantly higher on mTG and TG2 crosslinked collagen 
with bioglass than when grown on their respective collagen scaffolds without bioglass.  
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Figure 5.13: Expression of β1 integrin in HOBs seeded onto collagen scaffolds with 45S5 
bioglass. Cell lysates were lysed after 3 days post seeding and Western blotting was 
performed to analyse β1 integrin expression. A representative western blot result is shown in 
(A). β-actin was used as loading control and normalised data are shown in the graph. (B) 
Normalised integrin expression was plotted where the results represent mean values +/- S.D, 
where n=3. Statistical analysis was carried out using a one-way ANOVA test where the p-
values corresponding to P< 0.05 are represented with * and p=values corresponding to P<0.01 
are represented with **. 
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5.4.4 5 integrin expression for HOBs grown on collagen scaffolds mixed with 45S5 
bioglass 
 
Having shown that α5 integrin increases when seeded onto crosslinked collagen in 
Figure 5.7, it was appropriate to investigate the influence of bioglass on the cells. The 
expression of α5 integrin expression on HOBs when seeded on native collagen and 
crosslinked collagen with 10 µg/ml 45S5 bioglass particles was then measured. After seeding 
HOBs on the collagen scaffolds cell lysates were collected and using western blotting the 
expression of α5 integrins was measured. The results are shown in Figure 5.14. 
 
 α5 integrin expression increased in HOBs on all collagen scaffolds that had 45S5 
bioglass mixed with them.  The lowest increase was seen in native collagen which was mixed 
with bioglass (by 1.24 fold) and the highest increase was found in HOBs seeded on TG2 
crosslinked with 45S5 bioglass (2.51 fold). α5 integrin expression was significantly higher on 
mTG and TG2 crosslinked collagen with bioglass than their respective collagen scaffolds 
without bioglass.  
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Figure 5.14: Expression of α5 integrin in HOBs seeded onto collagen scaffolds with 45S5 
bioglass. Cell lysates were lysed after 3 days post seeding and Western blotting was 
performed to analyse α5 integrin expression. A representative western blot result is shown in 
(A). β-actin was used as loading control and normalised data are shown in the graph. (B) 
Normalised integrin expression was plotted where the results represent mean values +/- S.D, 
where n=3. Statistical analysis was carried out using a one-way ANOVA test where the p-
values corresponding to P< 0.01 are represented with **. 
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Table 5.1: A summary of integrin expression seen on HOBs when seeded on various 
collagen scaffolds 
 
Collagen 
scaffolds 
Expression of integrin relative to that seen on HOBs seeded on 
native collagen. Green = increase in expression and Red = 
decrease in expression 
 α1 α2 α5 αV β1 β3 LRP5 
mTG 0.96 0.95 1.5 1.47 1.2 1.27 1.49 
TG2 0.54 0.35 1.87 1.62 1.62 1.6 2.56 
NC+G   1.24 1.52 0.8 1.25  
mTG+G   2.35 2.32 1.78 1.48  
TG2+G   2.51 2.76 2.3 2.25  
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5.4.5 β-catenin expression in HOBs 
 
 
The expression of β-catenin in HOBs grown on tissue culture plastic was observed 
between 3 and 6 days post seeding the results are shown in Figure 5.15. The Western blots 
show a decrease in the amount of β-catenin present in the cytoplasm and a simultaneous 
increase amount found in the nucleus fraction as time passed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
194 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 catenin 
 bands 
-actin loading 
control 
WCL    Cyt     Mem       Nuc 
1        0.76     0.33     0.19 
Normalised to 
WCL 
Day 3 
A 
WCL    Cyt     Mem      Nuc 
1        0.36       0.44     0.74 
Day 6 
B 
 catenin 
 bands 
Normalised to 
WCL 
-actin loading 
control 
195 
 
 
 
 
 
 
 
D
3
D
6
0.0
0.2
0.4
0.6
Membrane
Days post seeding
F
o
ld
 e
x
p
re
s
s
io
n
 o
f 
B
e
ta
 c
a
te
n
in
 r
e
la
ti
v
e
 t
o
 W
C
L
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15: Expression of β-catenin in HOB cell fractions. Cellular fractions were 
separated through centrifugation (see materials and methods) after 3 and 6 days post seeding 
and Western blotting was performed to analyse β-catenin expression. A representative 
western blot result for day 3 is shown in (A). A representative western blot result for day 3 is 
shown in (B) β-actin was used as loading control and fractions were normalised to the total β-
catenin expression found in the whole lysate. (C-E) Normalised β-catenin expression was 
plotted where the results represent mean values +/- S.D, where n=3 for cytoplasmic, 
membrane bound and nuclear fractions. Statistical analysis was carried out using a one-way 
ANOVA test where the p-values corresponding to P< 0.001 are represented with ***. 
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5.4.6 β-catenin expression in HOBs grown on collagen scaffolds 
 
  
Having shown that β-catenin is translocated from the cytoplasm to the nucleus in Figure 
5.16, the differences in translocation of β-catenin in HOBs seeded on various collagen 
scaffolds were measured. HOBs were seeded on various collagen scaffolds with mTG, TG2 
(5 µg/ml) and 45S5 bioglass, and the results for the translocation of β-catenin from cell lysates 
are shown in Figure 5.17. Western blot analysis shows that there was a significant increase in 
the expression of β-catenin in the nuclear fraction in HOBs seeded on TG2, mTG+G and 
TG2+G by day 6 compared to the amount seen in cells on HOBs seeded on native collagen. 
Interestingly a significant decrease in fold β-catenin expression is also seen in day 3 HOBs 
lysates between those seeded on native collagen and TG2 with bioglass.  
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Figure 5.16: Expression of β-catenin in HOB cell fractions seeded on collagen scaffolds. 
(A) Cellular fractions were separated through centrifugation (see materials and methods) after 
3 and 6 days post seeding and Western blotting was performed to analyse β-catenin 
expression. A representative western blot result for day 3 and 6 is shown whereby β-actin was 
used as loading control and fractions were normalised to the total β-catenin expression found 
in the whole lysate. (B-E) Normalised β-catenin expression was plotted for each cell fraction 
where the results represent mean values +/- S.D, where n=3 for cytoplasmic, membrane bound 
and nuclear fractions. Statistical analysis was carried out using a two-way ANOVA test where 
the p-values corresponding to P< 0.05 are represented with * and p< 0.01 are represented 
with **. 
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5.5 Discussion 
 
The integrins αV and β3 are found paired on osteoblasts cell surface and work to 
facilitate cell spreading and differentiation. Fourel et al. showed that once the integrin receptors 
bind to cell matrix proteins such as collagen/fibronectin a multistep process is set into motion. 
The destruction of the GSK3-β-catenin complex, through the Wnt pathway, also results in the 
translocation of β-catenin from the cytoplasm into the nucleus resulting in HOB differentiation 
and mineralisation. It can also lead to the C-terminal phosphorylation of Smad and second to 
inhibit GSK3 activity via the Srk-FAK-ILK pathway. This leads to both cell spreading and fate 
commitment (Fourel et al. 2014).  
 The findings in this chapter show that HOBs grown in vitro will express αV and β3 
integrins increasingly as time passes (when seeded in DM). This is to be expected since 
previous studies have shown in osteoblasts that mineralisation occurs roughly 5-6 days post 
deeding upon which the “ECM maturation and mineralisation” stage begins within osteoblasts 
(Lian & Stein, 1995). Similarly, there is a rise in the integrin LRP5 could explain the reason 
why the β-catenin expression in cells from day 3 and day 6 change. Typically, in the Wnt 
pathway, the release of β-catenin from the GSK3 complex within the cell cytoplasm leads to 
β-catenin leaving the cytoplasm and entering the nucleus and displacing Groucho protein to 
bind to TCF1 in order to set cell differentiation in motion and mineralisation (Holmen et al. 
2005). 
 
We have shown that even over the course of 3 days there is an increase in the 
expression of αV, α5, β1 and β3 integrins when cells are grown on mTG or TG2 crosslinked 
collagen compared to those grown on native collagen. There are several reasons for this. 
Cellular functions and growth are driven by the ECM and its characteristics; mechanical and 
chemical (Marklein and Burdick, 2010, Brown et al., 2010).  
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One mechanical reason for this increase in integrin expression so early on could be 
seen in chapter 3. The gaps between collagen fibres are significantly smaller in TG2 
crosslinked collagen than in native collagen as seen by the smaller space between fibres. Pore 
alignment and size has been shown to influence cell behaviour including migration and matrix 
production (Pawelec et al., 2015, Ashworth et al., 2016). There is also growing evidence that 
shows cells to be sensitive enough to detect and respond to differences on the nano-scale in 
changes to the environment (Boccaccini et al., 2010). Since HOBs will have more collagen 
fibres to bind and interact with, this could be the reason why αV, α5, β3 and β1 integrins are 
expressed more so in crosslinked collagen scaffolds than in native ones. 
Another mechanical cue which could be driving cell migration and differentiation is the 
difference is collagen stiffness between native and crosslinked collagen. Chau et al. have 
shown rheological differences and an increased mechanical stiffness in crosslinked collagen, 
this substrate stiffness can act as a cellular signal and lead to differences in cell behaviour 
(Roskelley et al., 1995, Discher et al., 2007). This is hypothetical however, since the stiffness 
of these collagen scaffolds were not assessed in this thesis. 
Finally, one of the chemical characteristics that is likely to increase the expression of 
integrins is the increase of RGD peptides. RGD peptides are ligands that have conserved 
amino acid sequences (Barczyk et al., 2010). These peptides are revealed by crosslinked 
collagen (Barczyk et al., 2010) and when collagen is denatured into gelatin (Pawelec et al., 
2016). Importantly, RGD acts as a primary mediator of the response in HOBs and bind to αV, 
α5 and β1 subunits which is why they increase in fold expression on cells grown on crosslinked 
collagen (Orban et al., 2004).   
β3 has been shown to  be upregulated in the literature (Orban et al., 2004, Fortunati et 
al., 2014). A paper by Wozniak et al. showed that differences in mechanical stiffness of the 
collagen and vitronectin substrates can affect the clustering and  expression of αVβ3 (Wozniak 
et al., 2000).   
Native collagen, on the other hand, does not reveal these RGD peptides. Collagen 
recognition is via a different binding site , i.e GFOGER, which is dependent on collagen's 
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helical structure (Knight et al., 2000). Here, α1 and α2 integrins have been reported to bind to 
collagen (Orban et al., 2004), and this is likely to be why expression of these integrins drops 
by around 0.5 fold in HOBs on TG2 crosslinked collagen. The HOBs are no longer able to bind 
to GFOGER sites on crosslinked collagen and are expressed less on the HOBs surface.  
Interestingly, there was  even greater expression of the integrin αVβ3 pair when HOBs 
had been seeded on collagen scaffolds with 45S5 bioglass nanoparticles incorporated into 
them. Here, the expression of β3 in mTG and TG2 crosslinked collagen was 1.65 and 1.24 
times higher than in native collagen. Xynos et al. (2001) showed that these bioglass 
nanoparticles are capable of stimulating osteogenesis and have an impact on gene regulation 
regarding differentiation. 
While β1 integrin expression decreased when HOBs were seeded on native collagen 
with bioglass, α5 integrin expression did increase. α5β1 are a pair of integrins that have been 
shown in the literature to bind to RGD peptides to mediate cell adhesion and promote 
osteogenic differentiation in MSCs (Saidak et al., 2015). Specifically, this pair of integrin 
receptors link the ECM to intracellular bundles of actin filaments. Once transduced, 
extracellular signals cross the plasma membrane resulting in the activation of various 
intracellular signalling cascades, including the Wnt pathway (Schneider et al., 2001). The 
literature also shows how important the α5β1 integrins are to osteoblast mineralisation by 
exposing them to antibodies directed at the integrins and showing significant decrease in 
osteoblast mineralisation (Schneider et al., 2001).  
The synthesis and release of collagen from HOBs is seen during mineralisation and 
differentiation (Rutkovskiy et al., 2016). The collagen produced is an important ECM protein 
as it further adds to the scaffold and in turn becomes mineralised to form bone (Fortunati et 
al., 2014). What has been seen is an increase of collagen type 1 being secreted in the ECM 
when mTG and TG2 are added with media changes. This is explained in the literature, as TG2 
has been shown to be a Wnt ligand that binds to LRP5, which leads to the translocation of β-
catenin from the cytoplasm and into the nucleus (Faverman et al., 2008). 
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As stated already, the translocation of β-catenin from the cytoplasm and into the 
nucleus is crucial in the mineralisation process. It has been shown in the data that this 
translocation occurs between day 3 and 6 and the total amount of β-catenin does not change 
with in the cell. Curiously, the amount of β-catenin in the cytoplasm and nucleus between 
HOBs on all collagen scaffolds was different. It has been shown in the data that translocation 
of β-catenin is occurring earlier than in day 3 on collagen with bioglass, with and without 
transglutaminase.  
The reason for these differences in translocation and activation of the Wnt pathway is 
likely to be due to the HOBs reacting differently to the mechanical and chemical cues. As stated 
previously, these include the differences in collagen stiffness, mean collagen pore size, RGD 
peptides availability and osteogenic stimulation when bioglass is added.  
A slight decrease in proliferation seen at day 6 in HOBs seeded on TG2 crosslinked 
collagen with bioglass (see Chapter 1) might be explained by the increased and more rapid 
translocation of β-catenin seen in the data here. Since there seems to be a more rapid 
translocation, there is a possibility that cells on TG2 crosslinked collagen with glass are 
mineralising and differentiating more quickly than HOBs on native collagen. The increased 
mineralisation and differentiation leads osteoblasts to mature and become trapped. These cells 
are then known as osteocytes (Dallas and Bonewald, 2010).   
 
 
 
 
 
 
 
 
 
 
 
204 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6- General discussion 
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6.1 Background  
 
When biomaterials were first used, they were designed to be inert and elicit no 
response from the immune system (Hench and Polak, 2002). However, as our understanding 
of molecular and cellular biology increased a new standard was set: to create materials which 
could stimulate native tissue regeneration and restore the original functionality. Scaffolds and 
constructs of this kind would not only support the overall function of the tissue but also 
communicate with the body at the cellular level (Hench and Polak, 2002). These scaffolds are 
made from a variety of materials and more natural biological polymers are being introduced 
every year.  
One of the first biological polymers used widely in medical applications was collagen 
(Ehrmann and Gey, 1956). Since the initial investigations carried out by Ehrman and Gey in 
1956, collagen has been used to grow and differentiate many cell types (Lynch et al., 1995, 
Ivarsson et al., 1998, Reznikoff et al., 1987). There are many diverse applications that have 
been found for collagen scaffolds by tailoring their structures. These include osteochondral 
defects, connective tissues, adipose tissues and mammary glands (Tuan-Mu et al., 2016, 
Shepherd et al., 2013, Davidenko et al., 2010). When processed, however, native collagen is 
inherently mechanically weak, thermally unstable and suseptable to proteolytic breakdown. In 
order to overcome this, different techniques have been utilised to crosslink collagen to 
overcome these defficiencies. Even so, these techniques have impractical drawbacks or leave 
residual chemical agents at the large scale production level. Thus, many investigations into 
safer alternatives have been carried out including UVA light and Riboflavin/glucose.  
With this in mind, the aim of this thesis was to use TG2 and mTG to achieve the desired 
crosslinking. Crosslinked collagen with and without 45S5 bioglass was then used as a scaffold 
for human osteoblasts to be seeded on. From this point, the differences in HOB mineralisation 
between native and crosslinked collagen with 45S5 bioglass were investigated. The 
differences in mineralisation rates between the collagen scaffolds were then investigated on 
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the intracellular level, focussing specifically at the integrins expressed, LRP5 expression and 
translocation of β-catenin within the cell.  
 
6.2 How novel collagen scaffolds effect the behaviour of human osteoblasts 
 
 Figure 6.1 is a summary of how both mechanical and chemical cues contribute to the 
increased mineralisation compared to native collagen.  
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Figure 6.1: A graphic depicting the proposed intracellular process of mineralisation 
when HOBs are seeded on crosslinked collagen. Here the increased mechanical stiffness, 
smaller pore size and increased exposure of RGD peptides exposed all contribute to increased 
expression of αVβ3 and α5β1 integrins on the cell surface. Coupled with this is the HCA layer 
formed between the calcium rich 45S5 bioglass and the osteogenic inducing properties of the 
bioglass (Hench, 1993, Hench et al., 1972, Xynos et al., 2000).  The LRP5/6 integrin is also 
expressed more likely due to HOBs being seeded on a stiffer collagen matrix (Han et al., 2016). 
All these mechanical and chemical cues lead to the activation of the Wnt pathway and 
increased mineralisation. 
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We have shown that over 3 days there is an increase in the expression of αV, α5, β1 
and β3 integrins when cells are grown on mTG or TG2 crosslinked collagen compared to those 
grown on native collagen. Moreover, there was a decrease in α1 and α2 integrins, which are 
the integrins that HOBs express when they are exposed to collagen in the ECM. There are 
several reasons for this.  
The gaps between collagen fibres are shown to be significantly smaller in TG2 
crosslinked collagen than in native collagen as shown by the SEM images. Pore alignment 
and size have been shown to influence cell behaviour including migration and matrix 
production (Pawelec et al., 2015, Ashworth et al., 2016). There is also evidence that shows 
cells to be sensitive enough to detect and respond to differences on the nano-scale in changes 
to the environment (Boccaccini et al., 2010). Since HOBs will have more collagen fibres to bind 
and interact with, this could be a reason why αV, α5, β3 and β1 integrins are expressed more 
so in crosslinked collagen scaffolds than in native ones. 
As mentioned before another mechanical cue which is likely to be driving cell migration 
and differentiation is the difference is the stiffness between native and crosslinked collagen. 
While mechanical stiffness has not been measured in this thesis, Chau et al. have shown 
rheological differences and an increased mechanical stiffness in crosslinked collagen; this 
substrate stiffness can act as a cellular signal and lead to differences in cell behaviour (Discher 
et al., 2007). This increased stiffness of the matrix upon which HOBs are seeded on could also 
be a plausible reason why increase in LRP5 is being observed. Investigations into cells grown 
on matrices of varying stiffness show there are differences in cell behaviour. When grown on 
stiffer matrices, epithelial cells have been shown to upregulate LRP5/6 for example (Han et 
al., 2016). β3 integrin has been shown to also be upregulated in the literature (Orban et al., 
2004, Fortunati et al., 2014). A paper by Wozniak et al. showed that differences in mechanical 
stiffness of the collagen and vitronectin substrates can affect the clustering and expression of 
αVβ3 (Wozniak et al., 2000).   
Finally, one of the chemical characteristics that is likely to increase the expression of 
integrins is the increase of RGD binding sites. These peptides are revealed by crosslinked 
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collagen (Davidenko et al., 2018) when collagen is denatured into gelatin (Pawelec et al., 
2016). αV, α5 and β1 subunits all bind to RGD motifs which is why they increase in fold 
expression on HOBs grown on crosslinked collagen (Orban et al., 2004).   
Native collagen does not reveal these RGD binding sites. Collagen recognition by 
HOBs is via a different binding site: GFOGER, which is dependent on collagen's helical 
structure (Knight et al., 2000). α1 and α2 integrins are reported to bind to collagen (Orban et 
al., 2004) and this is likely to be why expression of these integrins drops by around 0.5 fold in 
HOBs on TG2 crosslinked collagen. The HOBs are less able to bind to GFOGER sites on 
crosslinked collagen and are expressed less on HOBs surface. It is still uncertain as to why 
cells seeded on mTG crosslinked collagen did not show a fold decrease in expression of α1 
and α2 integrins, although it is clear that the two transglutaminases crosslink collagen 
differently (Chau et al., 2005). It is clear that there is a difference in the micro-molecular 
structures between TG2 and mTG crosslinked collagen such as the mean pore size of collagen 
fibres and this may explain the observed behaviour of HOBs seeded on the respective 
scaffolds. 
An even greater expression of the αVβ3 and α5β1 integrin pairs were shown when 
HOBs had been seeded onto crosslinked collagen scaffolds with 45S5 bioglass particles 
incorporated into them. Xynos et al. 2001 have shown that these bioglass nanoparticles are 
capable of stimulating osteogenesis and have an impact on the upregulation of many genes. 
Hench et al. have also shown that the HCA layer formed between cells and collagen fibres 
which we hypothesise could also be leading to the HOBs behaving differently (increasing 
integrin expression) when seeded on these scaffolds.  
 Whilst β1 expression did not increase in HOBs seeded on native collagen with bioglass, 
we have shown that both α5 and β1 integrins are increased on cells seeded on crosslinked 
collagen with bioglass. This leads to integrins sending extracellular signals across the plasma 
membrane, resulting in the activation of various intracellular signalling cascades including the 
Wnt pathway (Schneider et al., 2001). Increased osteoblast mineralisation would be explained 
by this activation of the Wnt pathway and is also shown in the literature; it has been shown 
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that by exposing α5 and β1 integrins to function blocking antibodies directed at the integrins, 
there is a significant decrease in osteoblast mineralisation (Schneider et al., 2001).  
 The collective increase in expression of integrins direct the behaviour of the cells to 
proliferate and spread and ultimately differentiation and mineralisation (Lai and Cheng, 2005). 
The increased mineralisation also comes from the exposure to either TG2 itself or cells 
upregulating LRP5/6 on the cell surface and triggering the destruction of the GSK3 complex. 
The β-catenin released from this complex is then able to displace Groucho protein to bind to 
TCF1 in order to set cell differentiation in motion and mineralisation (Holmen et al. 2005). 
 
6.3 Conclusions 
  
In summary, data presented here suggests that treating native collagen with 
transglutaminases alters it in such a way that it is perceived differently by HOBs during culture. 
It is theorised that this modified collagen presents itself as being almost gelatin-like with  stiffer 
mechanical properties and a smaller pore size. This behaviour is inferred by the altered integrin 
expression profile on HOBs. Consequently, this leads to greater expression of LRP5 protein, 
resulting in the downstream processing required for the observed increased mineralisation.  
In this thesis, we have shown that crosslinked collagen mixed with 45S5 bioglass could 
potentially be used as a biomaterial that enhances mineralisation in bone scaffolds for non-
union bone breaks. These crosslinked collagen scaffolds with 45S5 bioglass are more 
biocompatible than native collagen and also show increased rates of mineralisation. The 
scaffolds would have low immunogenicity and could grow with the host. This would be a distinct 
advantage over the titanium plates currently used. 
 As stated in the introduction, 10% of all bone breaks are non-union and require metal 
plates and screws in order for the bone to heal. Here we have characterised a base scaffold 
upon which future development and research can take place.  
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An immune response against collagen mainly targets epitopes in the telopeptide 
region at each end of the tropocollagen molecule (Scmitt et al. 1964; Davison et al., 1967) 
However, the conformation of the helical part and the amino acid sequence on the surface of 
the polymerized collagen fibril, also influence the immunologic profile of the collagen 
molecule (Michaeli et al., 1969). Thus, the difference of immunogenicity between 
polymerized collagen and their smaller counterpart lies on the accessibility of the antigenic 
determinants that decrease during the polymerisation process. This is certainly something to 
consider when creating a collagen scaffold to be used as an implant in an animal model. 
Despite this type I collagen is still considered a suitable material for implantation since only a 
small amount of people possess humoral immunity against it and a simple serologic test can 
verify if a patient is susceptible to an allergic reaction in response to this collagen-based 
biomaterial (Charriere et al. 1989).  
Further rheological studies as well as characterisation and optimisation of the 
crosslinked scaffold, could one day lead to a low immunogenic, simple and effective implant 
that can be transplanted into humans.  
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